Long ID;Short ID;Promise ID;Sex;Date Of Birth;Blood Group;Rhesus Factor;Initials First Name;Initials Last Name;Date Diagnosis;Main Diagnosis;Subclass Diagnosis;Treatment CIC;Treatment Type;Treatment Date;Number HCT;Number Allo HCT;Performance Status At Treatment Scale;Performance Status At Treatment Score;Disease Status At Treatment;CMV Status Donor;CMV Status Patient;Donor Type;Source Stem Cells;Source Stem Cells 2;Match Type;Conditioning Regimen Type;Prep Regimen Bendamustine;Prep Regimen Busulfan;Prep Regimen Cyclophosphamide;Prep Regimen Fludarabine;Prep Regimen Melphalan;Prep Regimen Thiotepa;Prep Regimen Treosulfan;Prophylaxis;Prophylaxis Drug 1;Prophylaxis Drug 2;Prophylaxis Drug 3;Prophylaxis Drug 4;Prophylaxis Drug 5;Prophylaxis Drug 6;TBI;TBI Dose Gray;Date Of Last Follow Up;First aGvHD Maximum Score;First Agvhd Occurrence;First Agvhd Occurrence Date;First cGvHD Maximum NIH Score;First Cgvhd Occurrence;First Cgvhd Occurrence Date;First Relapse;First Relapse Date;First Best Response;First Best Response Date;Platelet Reconstitution;Date Platelet Reconstitution;Anc Recovery;Date Anc Recovery;Date Subsequent Treatment;Performance Scale At Last FU;Performance Score At Last FU;Cgvhd Maximum Nih Score At Last Fu;Cgvhd Occurrence At Last Fu;Status Last Follow Up;Death Cause;Death Date
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;21/09/1964 00:00;A;positive;X;X;10/11/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;160;Allogeneic HCT;05/03/2023 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;;;Yes;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;methotrexate;;;;No;;13/06/2023 00:00;;No evidence of;;;No evidence of;;No;;In full remission;11/06/2023 00:00;Yes;23/03/2023 00:00;Yes;23/03/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;19/03/1972 00:00;O;positive;XX;XX;23/01/2021 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;160;Allogeneic HCT;11/07/2021 00:00;1.0;1.0;Karnofsky performance status;90;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;;;yes;mycophenolate mofetil;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;18/02/2023 00:00;Unknown;Yes;20/07/2021 00:00;Extensive;Yes;22/11/2021 00:00;No;;In full remission;07/08/2021 00:00;Yes;22/07/2021 00:00;Yes;24/07/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;16/12/1973 00:00;A;positive;X;X;30/07/2023 00:00;Acute leukemia;Acute myeloid leukemia, disease;160;Allogeneic HCT;26/12/2024 23:59;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;No;;03/07/2024 00:00;Grade 1;Yes;;;No evidence of;;Yes;01/05/2024 00:00;In full remission;28/02/2024 00:00;Yes;10/01/2024 00:00;Yes;13/01/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;29/08/1960 00:00;O;negative;XX;XX;01/11/2018 00:00;Myelodysplastic syndrome;MDS with ring sideroblasts (MDS-RS);160;Allogeneic HCT;06/06/2022 00:00;1.0;1.0;Karnofsky performance status;80;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;;;;No;;01/06/2023 00:00;;No evidence of;;;No evidence of;;No;;Patient's condition improved;11/09/2022 00:00;Yes;20/06/2022 00:00;Yes;25/06/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;13/11/1970 00:00;A;positive;XX;XX;19/10/2020 00:00;Chronic leukemia;Prolymphocytic (PLL) and other chronic leukaemias;160;Allogeneic HCT;05/03/2021 00:00;1.0;1.0;Karnofsky performance status;80;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Bone marrow;;Mismatch;Myeloablative conditioning regimen;;;;Yes;;;;yes;cyclosporine;mycophenolate mofetil;;;;;Yes;8.0;24/05/2023 00:00;;No evidence of;;Moderate;Yes;27/04/2022 00:00;No;;In full remission;28/04/2021 00:00;Yes;02/04/2021 00:00;Yes;29/03/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;19/07/1955 00:00;A;positive;XX;XX;17/12/2022 23:59;Myelodysplastic syndrome;MDS with single lineage dysplasia (MDS-SLD);160;Allogeneic HCT;06/07/2022 00:00;1.0;1.0;Karnofsky performance status;100;Progressive disease;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;Yes;;;;;yes;cyclosporine;mycophenolate mofetil;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;06/10/2022 00:00;Grade 1;Yes;29/07/2022 00:00;;No evidence of;;No;;Never in CR;03/10/2022 00:00;Yes;20/07/2022 00:00;Yes;26/07/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;24/07/1971 00:00;A;positive;XX;XX;30/05/2021 00:00;Acute leukemia;Acute myeloid leukemia, disease;160;Allogeneic HCT;31/08/2021 00:00;1.0;1.0;Karnofsky performance status;100;Primary induction failure;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;Yes;;;;;yes;mycophenolate mofetil;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;30/03/2024 00:00;Grade 1;Yes;;Moderate;Yes;29/12/2022 23:59;No;;In full remission;26/09/2021 00:00;Yes;08/09/2021 00:00;Yes;18/09/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;26/02/1987 00:00;B;positive;XX;XX;09/04/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;160;Allogeneic HCT;02/11/2022 00:00;1.0;1.0;Karnofsky performance status;90;In partial remission;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclosporine;mycophenolate mofetil;cyclophosphamide;;;;No;;10/02/2023 00:00;;No evidence of;;;No evidence of;;No;;Never in CR;08/02/2023 00:00;Yes;24/11/2022 00:00;Yes;25/11/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;20/05/1956 00:00;A;positive;XX;XX;18/07/2021 00:00;Myelodysplastic/myeloproliferative disease;Chronic myelomonocytic leukemia;160;Allogeneic HCT;08/05/2023 00:00;2.0;2.0;Karnofsky performance status;60;;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;cyclosporine;mycophenolate mofetil;;;;;Yes;2.0;19/12/2023 00:00;Grade 1;Yes;26/06/2023 00:00;;No evidence of;;Yes;;Progressive disease;20/08/2023 00:00;Yes;19/05/2023 00:00;Yes;24/05/2023 00:00;;;;;;Dead;Relapse/progression;19/12/2023 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;10/01/1955 00:00;A;positive;X;X;09/09/2022 00:00;Myelodysplastic syndrome;MDS with multilineage dysplasia (MDS-MLD);160;Allogeneic HCT;19/03/2023 00:00;1.0;1.0;;;;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;;;yes;mycophenolate mofetil;;;;;;No;;24/06/2023 00:00;;;;;;;;;In full remission;24/06/2023 00:00;Yes;30/03/2023 00:00;Yes;01/04/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;11/12/2014 00:00;O;positive;XX;XX;14/08/2021 00:00;Inborn Errors;Primary immune deficiency disorder;201;Allogeneic HCT;01/01/2021 00:00;1.0;1.0;Lansky performance status;Unknown;;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;alemtuzumab;cyclosporine;cyclophosphamide;;;No;;31/01/2022 00:00;;No evidence of;;;No evidence of;;;;Never in CR;31/01/2022 00:00;;;;;14/02/2022 00:00;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;18/04/2024 00:00;O;negative;X;X;17/05/2024 00:00;Inborn Errors;Primary immune deficiency disorder;201;Allogeneic HCT;03/08/2024 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;cyclosporine;mycophenolate mofetil;;;;;No;;09/11/2024 00:00;;;;;;;;;;;;;Yes;20/08/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;27/11/2006 00:00;A;positive;XX;XX;17/04/2007 00:00;Inborn Errors;Primary immune deficiency disorder;201;Allogeneic HCT;16/06/2021 00:00;1.0;1.0;Lansky performance status;Unknown;;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Bone marrow;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;cyclosporine;cyclophosphamide;alemtuzumab;mycophenolate mofetil;;;No;;02/08/2021 00:00;;No evidence of;;;No evidence of;;Yes;02/08/2021 00:00;Never in CR;02/08/2021 00:00;;;;;;;;;;Dead;Other;02/08/2021 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;26/05/2022 00:00;O;positive;X;X;09/04/2023 00:00;Inborn Errors;Primary immune deficiency disorder;201;Allogeneic HCT;23/01/2024 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;mycophenolate mofetil;cyclophosphamide;cyclosporine;;;;No;;19/04/2024 00:00;Grade 2;Yes;21/02/2024 00:00;;No evidence of;;No;;;;Yes;03/02/2024 00:00;Yes;13/02/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;27/06/2020 00:00;unknown;unknown;XX;XX;01/07/2020 00:00;Other Diagnosis;Other;201;Allogeneic HCT;19/09/2020 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;mycophenolate mofetil;cyclosporine;alemtuzumab;;;;No;;28/12/2021 23:59;;No evidence of;;;No evidence of;;No;;Patient's condition improved;12/12/2021 23:59;Yes;30/09/2020 00:00;Yes;02/10/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;20/08/2012 00:00;A;positive;X;X;27/08/2012 00:00;Hemoglobinopathy;Sickle cell-hemoglobin SS disease;201;Allogeneic HCT;26/02/2024 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;mycophenolate mofetil;cyclosporine;;;;;No;;23/05/2024 00:00;;;;;;;No;;;;;;Yes;17/03/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;30/11/2013 00:00;B;positive;XX;XX;17/01/2014 00:00;Hemoglobinopathy;Sickle cell-hemoglobin SS disease;201;Allogeneic HCT;02/02/2019 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;mycophenolate mofetil;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;11/02/2023 00:00;;No evidence of;;;No evidence of;;No;;Never in CR;13/05/2019 00:00;;;Yes;09/03/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;12/06/2023 00:00;B;positive;X;X;15/05/2023 00:00;Inborn Errors;Primary immune deficiency disorder;201;Allogeneic HCT;30/06/2023 00:00;1.0;1.0;Lansky performance status;;;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;;;Yes;;Yes;Yes;yes;cyclosporine;mycophenolate mofetil;;;;;No;;29/07/2024 00:00;;;;;;;No;;In full remission;29/07/2024 00:00;;;Yes;15/07/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;29/12/2017 00:00;unknown;unknown;X;X;20/10/2020 00:00;Inborn Errors;Primary immune deficiency disorder;201;Allogeneic HCT;30/01/2023 00:00;1.0;1.0;Lansky performance status;Unknown;;;;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;unknown;;;;;;;No;;16/02/2023 00:00;;Unknown;;;No evidence of;;;;Never in CR;16/02/2023 00:00;Yes;13/02/2023 00:00;Yes;13/02/2023 00:00;;;;;;Dead;HCT-related cause of death;16/02/2023 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;20/10/2021 00:00;A;positive;XX;XX;06/01/2022 00:00;Inborn Errors;Primary immune deficiency disorder;201;Allogeneic HCT;10/02/2022 00:00;1.0;1.0;Lansky performance status;Unknown;;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Bone marrow;;Match;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;cyclosporine;mycophenolate mofetil;;;;;No;;25/02/2023 00:00;;No evidence of;;;No evidence of;;No;;Patient's condition improved;13/05/2022 00:00;;;Yes;01/03/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;28/04/1966 00:00;AB;positive;X;X;17/11/2023 00:00;Acute leukemia;Acute myeloid leukemia, disease;207;Allogeneic HCT;13/04/2024 00:00;1.0;1.0;ECOG Performance Status score;0;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;mycophenolate mofetil;;;;No;;22/07/2024 00:00;;;;;;;No;;In full remission;07/07/2024 00:00;;;Yes;04/05/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;14/02/1975 00:00;O;negative;XX;XX;29/04/2021 00:00;Myelodysplastic/myeloproliferative disease;;207;Allogeneic HCT;14/09/2021 00:00;1.0;1.0;Karnofsky performance status;80;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;methotrexate;cyclosporine;;;;No;;07/11/2021 00:00;Grade 3;Yes;26/09/2021 00:00;;No evidence of;;No;;Not assessed;07/11/2021 00:00;;;Yes;28/09/2021 00:00;;;;;;Dead;HCT-related cause of death;07/11/2021 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;02/07/1974 00:00;B;positive;XX;XX;17/06/2019 00:00;Acute leukemia;Other;207;Allogeneic HCT;18/03/2021 00:00;1.0;1.0;Karnofsky performance status;80;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;mycophenolate mofetil;cyclosporine;cyclophosphamide;;;;No;;11/02/2022 00:00;;No evidence of;;Mild;Yes;23/10/2021 00:00;No;;In full remission;26/06/2021 00:00;Yes;05/04/2021 00:00;Yes;11/04/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;14/12/1984 00:00;A;positive;XX;XX;12/04/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;207;Allogeneic HCT;26/10/2022 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclophosphamide;mycophenolate mofetil;cyclosporine;;;;No;;27/10/2023 00:00;Grade 2;Yes;15/11/2022 00:00;Mild;Yes;11/04/2023 00:00;No;;In full remission;03/02/2023 00:00;Yes;10/11/2022 00:00;Yes;17/11/2022 00:00;;;;Mild;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;20/02/1979 00:00;O;positive;X;X;01/02/2024 00:00;Acute leukemia;Acute lymphoid leukemia;207;Allogeneic HCT;06/08/2024 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;Yes;;;;;yes;methotrexate;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;;;;Yes;12.0;14/11/2024 00:00;Grade 3;Yes;03/09/2024 00:00;;No evidence of;;No;;In full remission;07/10/2024 00:00;;;Yes;02/09/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;28/05/1970 00:00;O;positive;XX;XX;25/07/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;207;Allogeneic HCT;16/01/2023 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;mycophenolate mofetil;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;18/01/2025 00:00;Grade 1;Yes;31/01/2023 00:00;Mild;Yes;06/08/2023 00:00;No;;In full remission;25/03/2023 00:00;Yes;29/01/2023 00:00;Yes;30/01/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;18/01/2006 00:00;A;positive;XX;XX;27/10/2022 00:00;Bone Marrow Failure incl. Aplastic Anemia;Genetic Bone Marrow Failure;207;Allogeneic HCT;07/05/2023 00:00;1.0;1.0;Karnofsky performance status;100;;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Bone marrow;;;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;;;yes;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;mycophenolate mofetil;;;;No;;16/08/2023 00:00;;;;;;;No;;In full remission;11/08/2023 00:00;Yes;19/05/2023 00:00;Yes;19/05/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;17/08/1958 00:00;B;positive;XX;XX;30/07/2020 00:00;Chronic leukemia;Chronic myeloid leukemia;207;Allogeneic HCT;25/12/2020 00:00;1.0;1.0;Karnofsky performance status;80;Chronic phase;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;mycophenolate mofetil;;;;No;;04/10/2022 00:00;;No evidence of;;Mild;Yes;06/08/2021 00:00;No;;;;Yes;08/01/2020 00:00;Yes;20/01/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;17/04/1973 00:00;O;positive;XX;XX;26/02/2021 00:00;Lymphoma;;207;Allogeneic HCT;02/10/2021 00:00;1.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclosporine;mycophenolate mofetil;cyclophosphamide;;;;No;;07/10/2022 00:00;Grade 2;Yes;26/10/2021 00:00;;No evidence of;;No;;In full remission;09/01/2021 00:00;Yes;28/10/2021 00:00;Yes;30/10/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;04/12/1997 00:00;O;positive;XX;XX;28/11/2014 00:00;Acute leukemia;Acute lymphoid leukemia;207;Allogeneic HCT;10/05/2019 00:00;1.0;1.0;Karnofsky performance status;100;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;;;Yes;;;;yes;methotrexate;cyclosporine;;;;;Yes;8.0;25/10/2022 00:00;;No evidence of;;;No evidence of;;Yes;21/01/2020 00:00;In full remission;18/08/2019 00:00;Yes;28/05/2019 00:00;Yes;05/06/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;09/03/1955 00:00;O;negative;;;10/04/2023 00:00;Acute leukemia;Acute myeloid leukemia, disease;209;Allogeneic HCT;30/08/2023 00:00;1.0;1.0;;;;Transplant donor cytomegalovirus antibody negative;Positive;;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;cyclosporine;;;;;No;;08/09/2024 00:00;;;;;;;No;;Sustained Full Remission;10/10/2023 00:00;Yes;14/09/2023 00:00;Yes;15/09/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;25/05/1968 00:00;O;positive;;;10/11/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;209;Allogeneic HCT;28/03/2021 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;;;;No;;30/03/2024 00:00;Grade 2;Yes;02/05/2021 00:00;Severe;Yes;26/09/2021 00:00;No;;In full remission;04/07/2021 00:00;Yes;13/04/2021 00:00;Yes;11/04/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;10/11/1957 00:00;A;positive;;;06/03/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;209;Allogeneic HCT;11/07/2022 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;Yes;Yes;Yes;;;;yes;tacrolimus;mycophenolate mofetil;;;;;No;;30/06/2024 00:00;Grade 2;Yes;14/07/2022 00:00;;No evidence of;;No;;In full remission;23/08/2022 00:00;Yes;30/07/2022 00:00;Yes;25/07/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;22/03/1957 00:00;O;positive;;;07/01/2023 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with low blasts;209;Allogeneic HCT;21/07/2024 00:00;1.0;1.0;Karnofsky performance status;90;;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;cyclosporine;;;;;No;;29/10/2024 00:00;;;;;;;No;;;;Yes;31/07/2024 00:00;Yes;05/08/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;26/09/2018 00:00;AB;positive;X;X;20/03/2024 00:00;Inborn Errors;;209;Allogeneic HCT;10/06/2024 00:00;1.0;1.0;;;;Transplant donor cytomegalovirus antibody negative;;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;;;Yes;;;Yes;yes;cyclosporine;mycophenolate mofetil;;;;;No;;12/10/2024 00:00;;;;;;;No;;;;Yes;26/06/2024 00:00;Yes;04/07/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;03/07/1965 00:00;A;positive;;;03/03/2020 00:00;Plasma cell neoplasm;Multiple myeloma;209;Allogeneic HCT;10/07/2020 00:00;1.0;1.0;Karnofsky performance status;100;Very good partial remission (VGPR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;;;;Yes;;;no;;;;;;;No;;21/08/2024 00:00;;No evidence of;;;No evidence of;;Yes;17/09/2022 00:00;In full remission;29/09/2020 00:00;Yes;25/07/2020 00:00;Yes;20/07/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;14/09/1958 00:00;O;positive;;;26/09/2017 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-1;209;Allogeneic HCT;22/03/2018 00:00;1.0;1.0;Karnofsky performance status;90;Patient's condition improved;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;cyclosporine;mycophenolate mofetil;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;15/03/2019 00:00;;No evidence of;;;No evidence of;;Yes;19/10/2018 00:00;In full remission;04/05/2018 00:00;Yes;06/04/2018 00:00;Yes;09/04/2018 00:00;;;;;;Dead;Relapse/progression;15/03/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXX)""";male;04/11/1961 00:00;B;positive;XX;X;16/10/2016 00:00;Lymphoma;B-cell non-Hodgkin's lymphoma;209;Allogeneic HCT;17/08/2019 00:00;2.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;;;;No;;26/08/2024 00:00;Grade 1;Yes;11/10/2019 00:00;Mild;Yes;09/01/2019 00:00;No;;In full remission;22/11/2019 00:00;Yes;01/09/2019 00:00;Yes;01/09/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;15/07/1971 00:00;AB;negative;;;29/03/2021 00:00;Bone Marrow Failure incl. Aplastic Anemia;Bone marrow Failure Syndromes incl. AA acquired;209;Allogeneic HCT;27/10/2021 00:00;1.0;1.0;Karnofsky performance status;100;;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;mycophenolate mofetil;;;;No;;25/12/2025 23:59;Grade 3;Yes;28/12/2022 23:59;Moderate;Yes;29/01/2022 00:00;No;;In full remission;30/11/2021 00:00;Yes;09/11/2021 00:00;Yes;13/11/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;20/12/1967 00:00;A;positive;;;06/03/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;209;Allogeneic HCT;28/07/2020 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;cyclosporine;;;;No;;05/06/2022 00:00;;No evidence of;;;No evidence of;;Yes;26/04/2022 00:00;In full remission;04/10/2020 00:00;Yes;14/08/2020 00:00;Yes;13/08/2020 00:00;;;;;;Dead;Relapse/progression;05/06/2022 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;25/12/1955 00:00;unknown;unknown;XX;XX;05/06/2013 00:00;Myeloproliferative disorder;Essential or primary thrombocythaemia (ET);215;Allogeneic HCT;30/03/2018 00:00;1.0;1.0;Karnofsky performance status;100;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;lymphocyte immune globulin, anti-thymocyte globulin;tacrolimus;;;;No;;30/11/2020 00:00;Grade 4;Yes;01/02/2019 00:00;;No evidence of;;No;;In full remission;07/05/2018 00:00;Yes;23/05/2018 00:00;Yes;29/04/2018 00:00;;;;;;Dead;HCT-related cause of death;30/11/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;07/07/2017 00:00;AB;positive;XX;XX;20/07/2017 00:00;Acute leukemia;Acute lymphoid leukemia;215;Allogeneic HCT;09/05/2018 00:00;1.0;1.0;Lansky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;;;Yes;;Yes;Yes;yes;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;methotrexate;;;;No;;02/06/2020 00:00;Grade 1;Yes;04/09/2018 00:00;Moderate;Yes;27/12/2019 23:59;Yes;03/08/2018 00:00;In full remission;29/06/2018 00:00;Yes;06/07/2018 00:00;Yes;24/05/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;28/03/1986 00:00;unknown;unknown;XX;XX;22/02/2018 00:00;Lymphoma;T-cell lymphoma (clinical);215;Allogeneic HCT;23/11/2022 00:00;1.0;1.0;Karnofsky performance status;90;In partial remission;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;Yes;;;yes;tacrolimus;mycophenolate mofetil;;;;;No;;25/12/2024 00:00;Grade 1;Yes;28/11/2022 00:00;Moderate;Yes;25/12/2024 00:00;Yes;22/12/2023 00:00;Never in CR;29/12/2022 00:00;Yes;28/12/2022 00:00;Yes;11/12/2022 00:00;;;;Moderate;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;31/01/1951 00:00;unknown;unknown;X;X;11/07/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;215;Allogeneic HCT;12/06/2023 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Mismatch;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;mycophenolate mofetil;cyclosporine;;;;;Yes;2.0;26/03/2024 00:00;;;;;;;Yes;17/02/2024 00:00;Sustained Full Remission;11/07/2023 00:00;Yes;25/07/2023 00:00;Yes;05/07/2023 00:00;;;;;;Dead;Relapse/progression;26/03/2024 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;18/05/1965 00:00;O;positive;X;X;18/05/2024 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;215;Allogeneic HCT;13/10/2024 00:00;1.0;1.0;Karnofsky performance status;90;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;Yes;;;yes;tacrolimus;mycophenolate mofetil;;;;;No;;26/01/2025 00:00;;;;;;;No;;In full remission;09/11/2024 00:00;Yes;29/10/2024 00:00;Yes;23/10/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;10/09/2012 00:00;B;positive;XX;XX;28/08/2012 00:00;Hemoglobinopathy;Sickle cell-hemoglobin SS disease;215;Allogeneic HCT;27/10/2023 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;methotrexate;cyclosporine;;;;No;;01/02/2024 00:00;;;;;;;No;;In full remission;21/11/2023 00:00;Yes;17/11/2023 00:00;Yes;14/11/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;29/05/1958 00:00;unknown;unknown;XX;XX;21/12/2021 23:59;Lymphoma;B-cell non-Hodgkin's lymphoma;215;Allogeneic HCT;01/09/2021 00:00;1.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;Yes;;;yes;mycophenolate mofetil;tacrolimus;cyclophosphamide;;;;No;;12/09/2021 00:00;;No evidence of;;;No evidence of;;No;;Not assessed;12/09/2021 00:00;;;;;;;;;;Dead;HCT-related cause of death;12/09/2021 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;24/12/1989 00:00;unknown;unknown;XX;XX;15/05/2020 00:00;Inborn Errors;Primary immune deficiency disorder;215;Allogeneic HCT;08/02/2021 00:00;1.0;1.0;Karnofsky performance status;100;;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;Yes;;;yes;tacrolimus;lymphocyte immune globulin, anti-thymocyte globulin;mycophenolate mofetil;;;;No;;26/11/2021 00:00;Grade 1;Yes;22/03/2021 00:00;;No evidence of;;No;;Never in CR;19/05/2021 00:00;Yes;24/02/2021 00:00;Yes;23/02/2021 00:00;;;;;;Dead;Other;26/11/2021 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;22/09/1986 00:00;unknown;unknown;XX;XX;19/03/2019 00:00;Acute leukemia;Acute lymphoid leukemia;215;Allogeneic HCT;14/04/2020 00:00;1.0;1.0;Karnofsky performance status;100;Third or higher Complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;;Yes;;;;;yes;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;;;Yes;12.0;13/05/2020 00:00;;No evidence of;;;No evidence of;;No;;Not assessed;13/05/2020 00:00;;;Yes;02/05/2020 00:00;;;;;;Dead;HCT-related cause of death;13/05/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;07/01/1976 00:00;unknown;unknown;XX;XX;23/01/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;215;Allogeneic HCT;23/04/2019 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;cyclosporine;methotrexate;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;13/10/2024 00:00;Grade 1;Yes;03/06/2019 00:00;Mild;Yes;07/03/2022 00:00;No;;In full remission;12/08/2019 00:00;Yes;14/05/2019 00:00;Yes;11/05/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;17/08/1973 00:00;B;negative;XX;XX;12/09/2021 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;230;Allogeneic HCT;20/02/2022 00:00;1.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclophosphamide;mycophenolate mofetil;cyclosporine;;;;No;;17/12/2024 23:59;Grade 1;Yes;02/04/2022 00:00;;No evidence of;;No;;In full remission;23/04/2022 00:00;Yes;15/03/2022 00:00;Yes;09/03/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;03/03/1946 00:00;O;positive;XX;XX;14/06/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;230;Allogeneic HCT;10/12/2021 23:59;1.0;1.0;Karnofsky performance status;80;Other;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;mycophenolate mofetil;cyclosporine;cyclophosphamide;;;;Yes;2.0;25/03/2022 00:00;Grade 3;Yes;05/12/2021 00:00;;No evidence of;;Yes;09/04/2021 00:00;Progressive disease;09/04/2021 00:00;;;Yes;05/01/2021 00:00;;;;;;Dead;Relapse/progression;25/03/2022 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;07/01/1950 00:00;O;negative;XX;XX;01/10/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;230;Allogeneic HCT;31/01/2023 00:00;1.0;1.0;Karnofsky performance status;60;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;cyclophosphamide;mycophenolate mofetil;cyclosporine;;;;Yes;2.0;19/05/2023 00:00;Grade 1;Yes;03/03/2023 00:00;;No evidence of;;No;;In full remission;15/03/2023 00:00;Yes;14/02/2023 00:00;Yes;17/02/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;11/03/1947 00:00;O;positive;XX;XX;28/04/2019 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-1;230;Allogeneic HCT;06/12/2019 00:00;1.0;1.0;Karnofsky performance status;Unknown;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;cyclophosphamide;cyclosporine;mycophenolate mofetil;;;;Yes;2.0;13/11/2023 00:00;Grade 2;Yes;15/01/2020 00:00;;No evidence of;;No;;Other;01/03/2020 00:00;Yes;10/01/2020 00:00;Yes;10/01/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;27/10/1972 00:00;O;negative;XX;XX;08/03/2022 00:00;Myeloproliferative disorder;Primary myelofibrosis;230;Allogeneic HCT;28/12/2023 23:59;2.0;2.0;Karnofsky performance status;80;Other;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;;;Yes;;;;yes;mycophenolate mofetil;lymphocyte immune globulin, anti-thymocyte globulin;cyclophosphamide;cyclosporine;;;Yes;2.0;09/04/2023 00:00;;;;;;;No;;Not assessed;09/04/2023 00:00;;;Yes;13/02/2023 00:00;25/04/2023 00:00;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;02/09/1954 00:00;A;positive;XX;XX;02/05/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;230;Allogeneic HCT;17/05/2021 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;mycophenolate mofetil;cyclophosphamide;cyclosporine;;;;No;;02/12/2023 00:00;Grade 2;Yes;10/07/2021 00:00;;No evidence of;;No;;In full remission;16/07/2021 00:00;;;Yes;13/06/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;12/01/1966 00:00;O;negative;XX;XX;17/09/2020 00:00;Lymphoma;B-cell non-Hodgkin's lymphoma;230;Allogeneic HCT;01/02/2022 00:00;1.0;1.0;Karnofsky performance status;80;In full remission;Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;cyclosporine;cyclophosphamide;mycophenolate mofetil;;;;Yes;2.0;17/04/2024 00:00;Grade 0 (none);Yes;27/02/2022 00:00;;No evidence of;;No;;In full remission;31/05/2022 00:00;Yes;18/02/2022 00:00;Yes;17/02/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";female;16/10/1969 00:00;O;positive;XX;XX;24/04/2018 00:00;Lymphoma;B-cell non-Hodgkin's lymphoma;230;Allogeneic HCT;02/03/2021 00:00;1.0;1.0;Karnofsky performance status;80;In full remission;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;mycophenolate mofetil;cyclosporine;cyclophosphamide;;;;Yes;2.0;08/06/2024 00:00;Unknown;Yes;01/07/2021 00:00;Severe;Yes;01/07/2021 00:00;Yes;27/10/2020 00:00;In full remission;05/06/2021 00:00;Yes;29/03/2021 00:00;Yes;23/03/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;01/05/1961 00:00;O;positive;XX;XX;10/04/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;230;Allogeneic HCT;28/04/2020 00:00;1.0;1.0;Karnofsky performance status;Unknown;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;cyclosporine;cyclophosphamide;mycophenolate mofetil;;;;Yes;2.0;11/06/2024 00:00;;No evidence of;;;No evidence of;;No;;Not assessed;05/08/2020 00:00;;;Yes;25/05/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;27/06/1977 00:00;O;positive;X;X;03/03/1993 00:00;Lymphoma;Hodgkin's disease (clinical);230;Allogeneic HCT;17/11/2021 00:00;2.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;mycophenolate mofetil;cyclosporine;cyclophosphamide;;;;Yes;2.0;19/04/2024 00:00;Grade 3;Yes;05/12/2021 00:00;Severe;Yes;16/03/2022 00:00;No;;Not assessed;02/03/2022 00:00;;;Yes;05/12/2021 00:00;;;;Unknown;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;15/07/1955 00:00;A;positive;XX;XX;17/11/2017 00:00;Acute leukemia;Acute myeloid leukemia, disease;233;Allogeneic HCT;18/09/2018 00:00;1.0;1.0;Karnofsky performance status;60;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;cyclosporine;;;;No;;02/11/2020 00:00;Grade 2;Yes;20/11/2018 00:00;Limited;Yes;16/12/2019 23:59;Yes;19/10/2018 00:00;Progressive disease;19/10/2018 00:00;Yes;25/09/2018 00:00;Yes;08/10/2018 00:00;;;;;;Dead;Relapse/progression;02/11/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;04/01/1966 00:00;A;positive;XX;XX;11/04/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;233;Allogeneic HCT;29/08/2019 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;methotrexate;;;;No;;25/10/2024 00:00;Grade 1;Yes;10/11/2019 00:00;;No evidence of;;No;;In full remission;01/12/2019 00:00;Yes;10/09/2019 00:00;Yes;12/09/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;10/03/1956 00:00;A;positive;XX;XX;10/03/2021 00:00;Myelodysplastic/myeloproliferative disease;Chronic myelomonocytic leukemia;233;Allogeneic HCT;11/08/2021 00:00;1.0;1.0;Karnofsky performance status;80;Patient's condition improved;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;mycophenolate mofetil;;;;No;;11/03/2024 00:00;;No evidence of;;;No evidence of;;No;;In full remission;13/09/2021 00:00;;;Yes;01/09/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;06/10/1959 00:00;O;negative;XX;XX;02/06/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;233;Allogeneic HCT;12/04/2022 00:00;1.0;1.0;Karnofsky performance status;80;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;mycophenolate mofetil;;;;No;;06/04/2024 00:00;Grade 1;Yes;10/05/2022 00:00;;No evidence of;;No;;In full remission;07/05/2022 00:00;Yes;23/04/2022 00:00;Yes;01/05/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;02/12/1956 00:00;unknown;unknown;XX;XX;22/04/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;233;Allogeneic HCT;02/10/2019 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;;No;;13/11/2024 00:00;Grade 2;Yes;19/10/2019 00:00;Limited;Yes;17/05/2020 00:00;No;;In full remission;29/12/2020 23:59;Yes;11/10/2019 00:00;Yes;18/10/2019 00:00;;;;Mild;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;04/02/1959 00:00;O;positive;X;X;12/04/2019 00:00;Myelodysplastic/myeloproliferative disease;Chronic myelomonocytic leukemia;233;Allogeneic HCT;17/11/2023 00:00;1.0;1.0;;;;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;;;Yes;yes;mycophenolate mofetil;cyclosporine;;;;;No;;06/04/2024 00:00;Grade 2;Yes;02/05/2024 00:00;;No evidence of;;No;;;;Yes;28/11/2023 00:00;Yes;28/11/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;16/11/1952 00:00;A;positive;XX;XX;11/11/2017 00:00;Acute leukemia;Acute myeloid leukemia, disease;233;Allogeneic HCT;16/11/2018 00:00;1.0;1.0;Karnofsky performance status;80;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;mycophenolate mofetil;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;10/05/2021 00:00;Grade 1;Yes;21/12/2018 00:00;Limited;Yes;20/02/2019 00:00;Yes;13/06/2019 00:00;In full remission;11/12/2018 00:00;;;Yes;07/12/2018 00:00;;;;;;Dead;Relapse/progression;10/05/2021 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;31/07/1955 00:00;B;positive;XX;XX;03/05/2020 00:00;Acute leukemia;Acute lymphoid leukemia;233;Allogeneic HCT;20/12/2021 23:59;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;;Yes;;;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;;Yes;8.0;01/03/2024 00:00;Grade 2;Yes;22/01/2021 00:00;;No evidence of;;No;;In full remission;20/05/2021 00:00;Yes;04/01/2021 00:00;Yes;02/01/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;28/09/1997 00:00;A;positive;XX;XX;26/11/2018 00:00;Acute leukemia;Acute lymphoid leukemia;233;Allogeneic HCT;15/10/2019 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;;;;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;;Yes;12.0;11/02/2022 00:00;Grade 2;Yes;25/11/2019 00:00;Extensive;Yes;18/05/2020 00:00;No;;In full remission;22/01/2020 00:00;Yes;30/10/2019 00:00;Yes;03/11/2019 00:00;;;;;;Dead;HCT-related cause of death;11/02/2022 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;28/05/1968 00:00;unknown;unknown;XX;XX;24/04/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;233;Allogeneic HCT;15/08/2019 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;;No;;21/03/2024 00:00;Grade 2;Yes;12/09/2019 00:00;;No evidence of;;No;;In full remission;14/11/2019 00:00;Yes;24/08/2019 00:00;Yes;10/09/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;07/10/1947 00:00;A;positive;XX;XX;06/06/2019 00:00;Myelodysplastic/myeloproliferative disease;Chronic myelomonocytic leukemia;234;Allogeneic HCT;28/02/2020 00:00;1.0;1.0;Karnofsky performance status;100;;Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;tacrolimus;mycophenolate mofetil;;;;;Yes;2.0;05/06/2020 00:00;;No evidence of;;;No evidence of;;Yes;19/05/2020 00:00;In full remission;11/04/2020 00:00;Yes;09/03/2020 00:00;Yes;17/03/2020 00:00;;;;;;Dead;Relapse/progression;05/06/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;13/06/1975 00:00;A;positive;XX;XX;25/03/2017 00:00;Acute leukemia;Acute lymphoid leukemia;234;Allogeneic HCT;14/07/2019 00:00;1.0;1.0;Karnofsky performance status;100;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;Yes;;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;methotrexate;cyclosporine;;;;Yes;12.0;05/05/2023 00:00;;No evidence of;;;No evidence of;;No;;In full remission;18/10/2019 00:00;Yes;07/08/2019 00:00;Yes;03/08/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;03/04/1956 00:00;A;positive;XX;XX;24/06/2009 00:00;Myeloproliferative disorder;Primary myelofibrosis;234;Allogeneic HCT;14/04/2018 00:00;1.0;1.0;Karnofsky performance status;100;;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;methotrexate;;;;;;03/07/2021 00:00;;No evidence of;;;No evidence of;;No;;Not assessed;23/07/2018 00:00;Yes;11/05/2018 00:00;Yes;02/05/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;27/12/1969 00:00;A;positive;XX;XX;17/12/2012 00:00;Lymphoma;T-cell lymphoma (clinical);234;Allogeneic HCT;18/09/2018 00:00;2.0;1.0;Karnofsky performance status;80;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;;;Yes;Yes;;;yes;tacrolimus;lymphocyte immune globulin, anti-thymocyte globulin;mycophenolate mofetil;;;;No;;07/03/2019 00:00;Grade 2;Yes;27/10/2018 00:00;Mild;Yes;27/11/2018 00:00;Yes;29/10/2018 00:00;In full remission;27/10/2018 00:00;;;Yes;30/09/2018 00:00;;;;;;Dead;Relapse/progression;07/03/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";male;26/07/1958 00:00;unknown;unknown;XX;XX;22/02/2022 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-1;234;Allogeneic HCT;11/12/2022 00:00;1.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Bone marrow;;;Reduced intensity conditioning (RIC);;;;Yes;Yes;;;yes;mycophenolate mofetil;tacrolimus;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;21/08/2023 00:00;Grade 2;Yes;03/04/2023 00:00;;No evidence of;;Yes;30/05/2023 00:00;In full remission;20/03/2023 00:00;Yes;05/01/2022 00:00;Yes;26/12/2022 00:00;;;;;;Dead;Relapse/progression;21/08/2023 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;18/03/1957 00:00;A;positive;XX;XX;08/09/2010 00:00;Acute leukemia;Acute myeloid leukemia, disease;234;Allogeneic HCT;14/08/2018 00:00;1.0;1.0;Karnofsky performance status;80;;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;methotrexate;;;;No;;22/11/2018 00:00;;No evidence of;;Mild;Yes;27/11/2018 00:00;No;;In full remission;08/10/2018 00:00;;;Yes;02/09/2018 00:00;10/01/2019 00:00;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";female;12/09/1959 00:00;unknown;unknown;XX;XX;03/10/2016 00:00;Myeloproliferative disorder;Primary myelofibrosis;234;Allogeneic HCT;22/05/2019 00:00;1.0;1.0;Karnofsky performance status;70;Primary refractory phase (no change);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;Yes;;;yes;cyclosporine;mycophenolate mofetil;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;12/06/2024 00:00;Grade 1;Yes;25/06/2019 00:00;;No evidence of;;No;;In full remission;16/07/2019 00:00;Yes;13/06/2019 00:00;Yes;05/06/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;14/12/1966 00:00;A;positive;XX;XX;18/07/2020 00:00;Lymphoma;T-cell lymphoma (clinical);234;Allogeneic HCT;18/12/2023 23:59;2.0;1.0;Karnofsky performance status;90;In partial remission;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;;;Yes;Yes;;;yes;tacrolimus;lymphocyte immune globulin, anti-thymocyte globulin;mycophenolate mofetil;;;;No;;28/03/2023 00:00;;No evidence of;;;No evidence of;;;;Not assessed;28/03/2023 00:00;;;Yes;01/01/2023 00:00;;;;;;Dead;HCT-related cause of death;28/03/2023 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;22/05/1971 00:00;B;positive;XX;XX;01/06/2023 00:00;Acute leukemia;Acute myeloid leukemia, disease;234;Allogeneic HCT;10/11/2023 00:00;1.0;1.0;;;;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;;;Yes;;;;yes;mycophenolate mofetil;tacrolimus;lymphocyte immune globulin, anti-thymocyte globulin;;;;Yes;8.0;07/02/2024 00:00;;;;;;;No;;In full remission;15/12/2023 00:00;Yes;02/12/2023 00:00;Yes;29/11/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;30/10/1960 00:00;O;positive;XX;XX;20/10/2020 00:00;Myeloproliferative disorder;Primary myelofibrosis;234;Allogeneic HCT;13/04/2023 00:00;1.0;1.0;;;;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;Yes;;;yes;mycophenolate mofetil;tacrolimus;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;09/09/2023 00:00;;;;;;;No;;In partial remission;09/09/2023 00:00;Yes;19/05/2023 00:00;Yes;24/04/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;10/10/1977 00:00;B;negative;X;X;27/03/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;250;Allogeneic HCT;24/07/2020 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;methotrexate;;;;No;;14/09/2020 00:00;;No evidence of;;;No evidence of;;No;;In full remission;21/08/2020 00:00;Yes;10/09/2020 00:00;Yes;12/08/2020 00:00;;;;;;Dead;Other;14/09/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;09/04/1968 00:00;O;positive;X;X;22/11/2021 00:00;Acute leukemia;Acute myeloid leukemia, disease;250;Allogeneic HCT;01/06/2022 00:00;1.0;1.0;Not assessed;;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Bone marrow;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;mycophenolate mofetil;cyclosporine;cyclophosphamide;;;;No;;16/06/2024 00:00;;;;;;;No;;In full remission;02/07/2022 00:00;Yes;06/07/2022 00:00;Yes;23/06/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;09/07/1945 00:00;O;positive;X;X;22/07/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;250;Allogeneic HCT;13/09/2020 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Mismatch;;;;;;;;;no;;;;;;;;;11/10/2020 00:00;;No evidence of;;;;;;;In full remission;11/10/2020 00:00;Yes;24/09/2020 00:00;Yes;23/09/2020 00:00;13/12/2020 00:00;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;24/01/1952 00:00;A;positive;X;X;18/11/2019 00:00;Myelodysplastic/myeloproliferative disease;Chronic myelomonocytic leukemia;250;Allogeneic HCT;16/05/2021 00:00;1.0;1.0;Karnofsky performance status;100;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclophosphamide;cyclosporine;mycophenolate mofetil;;;;No;;14/09/2021 00:00;Grade 2;Yes;18/05/2021 00:00;;No evidence of;;No;;In full remission;14/08/2021 00:00;Yes;09/06/2021 00:00;Yes;06/06/2021 00:00;;;;;;Dead;HCT-related cause of death;14/09/2021 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;09/08/1962 00:00;A;positive;X;X;21/07/2016 00:00;Myelodysplastic syndrome;MDS with single lineage dysplasia (MDS-SLD);250;Allogeneic HCT;13/08/2022 00:00;1.0;1.0;Karnofsky performance status;80;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclophosphamide;mycophenolate mofetil;tacrolimus;;;;No;;26/09/2024 00:00;;No evidence of;;Mild;Yes;;No;;In full remission;08/09/2022 00:00;Yes;07/09/2022 00:00;Yes;29/08/2022 00:00;;;;Mild;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;17/07/1969 00:00;A;positive;X;X;23/11/2023 00:00;Acute leukemia;Acute lymphoid leukemia;250;Allogeneic HCT;30/04/2024 00:00;1.0;1.0;ECOG Performance Status score;0;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;methotrexate;cyclosporine;;;;Yes;8.0;18/08/2024 00:00;;;;;;;No;;In full remission;30/05/2024 00:00;Yes;12/05/2024 00:00;Yes;16/05/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;14/06/1993 00:00;O;positive;X;X;25/10/2016 00:00;Acute leukemia;Acute myeloid leukemia, disease;250;Allogeneic HCT;28/04/2018 00:00;1.0;1.0;Karnofsky performance status;100;Other;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;cyclosporine;;;;;;No;;15/11/2020 00:00;;No evidence of;;Severe;Yes;29/07/2018 00:00;Yes;03/11/2019 00:00;In full remission;27/07/2018 00:00;Yes;12/05/2018 00:00;Yes;17/05/2018 00:00;;;;;;Dead;Relapse/progression;15/11/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;27/05/1961 00:00;A;positive;X;X;16/08/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;250;Allogeneic HCT;09/01/2019 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Bone marrow;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclophosphamide;cyclosporine;;;;;No;;29/03/2022 00:00;Grade 1;Yes;15/02/2019 00:00;Mild;Yes;13/05/2019 00:00;No;;In full remission;14/04/2019 00:00;Yes;26/01/2019 00:00;Yes;24/01/2019 00:00;;;;Mild;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;02/05/1955 00:00;O;positive;X;X;09/04/2017 00:00;Lymphoma;T-cell lymphoma (clinical);250;Allogeneic HCT;25/02/2018 00:00;2.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;;;;;No;;20/02/2022 00:00;Grade 1;Yes;30/03/2018 00:00;Extensive;Yes;02/09/2018 00:00;No;;In full remission;25/05/2018 00:00;Yes;08/03/2018 00:00;Yes;12/03/2018 00:00;;;;Moderate;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;03/06/1961 00:00;AB;positive;X;X;28/01/2019 00:00;Myeloproliferative disorder;Systemic mast cell disease;250;Allogeneic HCT;09/07/2019 00:00;1.0;1.0;Karnofsky performance status;80;Primary refractory phase (no change);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;methotrexate;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;;;;No;;14/10/2019 00:00;;;;Moderate;Yes;30/03/2020 00:00;No;;In full remission;09/08/2019 00:00;Yes;23/08/2019 00:00;Yes;22/07/2019 00:00;15/06/2020 00:00;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;17/07/1997 00:00;B;positive;XX;XX;19/10/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;251;Allogeneic HCT;15/11/2019 00:00;1.0;1.0;Karnofsky performance status;100;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;methotrexate;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;03/04/2024 00:00;;;;;;;No;;In full remission;16/05/2020 00:00;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;22/09/1949 00:00;A;positive;X;X;22/08/2019 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with isolated del(5q);251;Allogeneic HCT;07/02/2020 00:00;1.0;1.0;Karnofsky performance status;90;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Bone marrow;;Mismatch;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;Yes;;yes;mycophenolate mofetil;cyclosporine;cyclophosphamide;;;;No;;26/03/2021 00:00;;;;;;;Yes;23/12/2021 23:59;In full remission;07/05/2020 00:00;;;;;;;;;;Dead;HCT-related cause of death;26/03/2021 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;28/03/1969 00:00;O;positive;X;X;10/05/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;251;Allogeneic HCT;11/03/2021 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;Yes;Yes;;;;yes;cyclosporine;mycophenolate mofetil;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;26/02/2023 00:00;;No evidence of;;;No evidence of;;No;;In full remission;08/04/2021 00:00;Yes;25/03/2021 00:00;Yes;28/03/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;07/08/1950 00:00;O;positive;X;X;27/08/2017 00:00;Acute leukemia;Acute myeloid leukemia, disease;251;Allogeneic HCT;05/02/2018 00:00;1.0;1.0;Karnofsky performance status;60;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;;;;;No;;19/09/2018 00:00;;No evidence of;;Moderate;Yes;11/06/2018 00:00;No;;In full remission;05/03/2018 00:00;Yes;15/02/2018 00:00;Yes;25/02/2018 00:00;;;;Severe;Yes;Dead;HCT-related cause of death;19/09/2018 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;30/07/1960 00:00;O;positive;X;X;08/09/2017 00:00;Myeloproliferative disorder;Primary myelofibrosis;251;Allogeneic HCT;09/06/2018 00:00;1.0;1.0;Karnofsky performance status;80;Other;Transplant donor cytomegalovirus antibody positive;Not assessed;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;mycophenolate mofetil;;;;No;;06/04/2022 00:00;;No evidence of;;;No evidence of;;No;;Not assessed;09/09/2018 00:00;;;Yes;10/07/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;21/10/1996 00:00;A;positive;X;X;24/09/2014 00:00;Acute leukemia;Acute lymphoid leukemia;251;Allogeneic HCT;22/03/2018 00:00;1.0;1.0;Karnofsky performance status;100;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;Yes;;;;;yes;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;;;Yes;12.0;06/07/2018 00:00;Grade 1;Yes;26/04/2018 00:00;;No evidence of;;Yes;18/02/2020 00:00;In full remission;26/04/2018 00:00;Yes;04/04/2018 00:00;Yes;13/04/2018 00:00;22/04/2020 00:00;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;04/05/1974 00:00;O;positive;X;X;14/09/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;251;Allogeneic HCT;01/02/2019 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Bone marrow;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclophosphamide;cyclosporine;mycophenolate mofetil;;;;No;;13/02/2019 00:00;;No evidence of;;;No evidence of;;No;;Not assessed;13/02/2019 00:00;;;;;;;;;;Dead;HCT-related cause of death;13/02/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;15/04/1961 00:00;A;positive;X;X;15/12/2017 00:00;Acute leukemia;Acute lymphoid leukemia;251;Allogeneic HCT;08/06/2018 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;mycophenolate mofetil;;;;No;;31/03/2022 00:00;;No evidence of;;;No evidence of;;No;;In full remission;07/09/2018 00:00;;;Yes;30/06/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;23/11/1959 00:00;O;positive;XX;XX;25/06/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;251;Allogeneic HCT;04/12/2019 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;Yes;;yes;lymphocyte immune globulin, anti-thymocyte globulin;mycophenolate mofetil;cyclosporine;cyclophosphamide;;;No;;19/05/2024 00:00;;;;;;;No;;In full remission;12/12/2020 00:00;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;29/08/1948 00:00;O;positive;X;X;12/01/2017 00:00;Acute leukemia;Acute myeloid leukemia, disease;251;Allogeneic HCT;17/04/2018 00:00;1.0;1.0;Karnofsky performance status;Unknown;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Not assessed;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;Yes;;yes;cyclosporine;mycophenolate mofetil;;;;;No;;09/09/2018 00:00;Grade 2;Yes;13/05/2018 00:00;;No evidence of;;No;;In full remission;18/05/2018 00:00;Yes;14/05/2018 00:00;Yes;09/05/2018 00:00;;;;;;Dead;HCT-related cause of death;09/09/2018 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;23/04/1982 00:00;O;positive;XX;XX;26/02/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;252;Allogeneic HCT;24/07/2018 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;Yes;;;;;yes;cyclosporine;methotrexate;;;;;Yes;10.0;14/12/2020 00:00;;No evidence of;;;No evidence of;;No;;In full remission;05/11/2018 00:00;Yes;10/08/2018 00:00;Yes;14/08/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;28/06/1976 00:00;B;positive;XX;XX;05/06/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;252;Allogeneic HCT;15/12/2020 00:00;1.0;1.0;Karnofsky performance status;100;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;cyclosporine;methotrexate;;;;;No;;12/06/2022 00:00;;No evidence of;;;No evidence of;;Yes;27/07/2021 00:00;;;;;Yes;05/01/2021 00:00;;;;;;Dead;Relapse/progression;12/06/2022 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;26/12/1959 00:00;O;positive;XX;XX;06/07/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;252;Allogeneic HCT;16/12/2020 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;methotrexate;;;;No;;07/10/2022 00:00;;No evidence of;;;No evidence of;;No;;;;;;Yes;31/12/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;04/11/1955 00:00;O;positive;XX;XX;27/06/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;252;Allogeneic HCT;16/10/2019 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;methotrexate;cyclosporine;;;;No;;09/03/2020 00:00;Grade 1;Yes;13/12/2019 00:00;;No evidence of;;Yes;07/12/2019 00:00;;;;;Yes;06/11/2019 00:00;;;;;;Dead;HCT-related cause of death;09/03/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;31/05/1952 00:00;A;positive;XX;XX;12/03/2023 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;252;Allogeneic HCT;18/09/2023 00:00;1.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;cyclosporine;;;;;No;;22/09/2024 00:00;;;;;;;No;;;;Yes;29/09/2023 00:00;Yes;03/10/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;10/10/1965 00:00;A;positive;XX;XX;18/09/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;252;Allogeneic HCT;19/02/2019 00:00;1.0;1.0;Karnofsky performance status;90;Improvement of status;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;mycophenolate mofetil;;;;No;;24/05/2020 00:00;Grade 3;Yes;12/04/2019 00:00;;No evidence of;;Yes;24/11/2019 00:00;;;Yes;24/02/2019 00:00;Yes;06/03/2019 00:00;;;;;;Dead;HCT-related cause of death;24/05/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;24/08/1972 00:00;O;positive;XX;XX;08/07/2021 00:00;Myelodysplastic/myeloproliferative disease;;252;Allogeneic HCT;14/01/2022 00:00;1.0;1.0;Karnofsky performance status;90;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;methotrexate;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;No;;15/01/2023 00:00;;No evidence of;;;No evidence of;;No;;In full remission;23/04/2022 00:00;;;Yes;30/01/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;16/11/1964 00:00;A;positive;XX;XX;15/05/2021 00:00;Lymphoma;T-cell lymphoma (clinical);252;Allogeneic HCT;16/08/2022 00:00;2.0;1.0;Karnofsky performance status;80;Untreated relapse or progression;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;;No;;24/11/2022 00:00;;No evidence of;;;No evidence of;;Yes;13/09/2022 00:00;;;Yes;27/08/2022 00:00;Yes;27/08/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;27/04/1947 00:00;A;positive;XX;XX;30/07/2015 00:00;Myelodysplastic syndrome;;252;Allogeneic HCT;03/03/2019 00:00;1.0;1.0;Karnofsky performance status;80;;Transplant donor cytomegalovirus antibody positive;;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;mycophenolate mofetil;;;;No;;14/12/2020 00:00;Grade 2;Yes;06/04/2019 00:00;;No evidence of;;No;;;;;;Yes;18/03/2019 00:00;;;;;;Dead;;14/12/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;10/05/1965 00:00;A;positive;XX;XX;02/11/2017 00:00;Acute leukemia;Other;252;Allogeneic HCT;06/04/2018 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;methotrexate;cyclosporine;;;;No;;30/10/2020 00:00;;No evidence of;;;No evidence of;;No;;In full remission;29/08/2018 00:00;;;Yes;17/04/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";male;19/04/2007 00:00;A;positive;X;X;23/04/2007 00:00;Hemoglobinopathy;Sickle cell-hemoglobin SS disease;253;Allogeneic HCT;19/10/2020 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;methotrexate;cyclosporine;;;;No;;12/11/2021 00:00;;No evidence of;;;No evidence of;;No;;In full remission;01/02/2021 00:00;Yes;22/11/2020 00:00;Yes;13/11/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;21/01/2006 00:00;A;positive;X;X;19/05/2023 00:00;Acute leukemia;Acute myeloid leukemia, disease;253;Allogeneic HCT;16/09/2023 00:00;1.0;1.0;Lansky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;cyclosporine;mycophenolate mofetil;;;;;No;;07/03/2024 00:00;;;;;;;Yes;29/02/2024 00:00;In full remission;18/10/2023 00:00;Yes;30/09/2023 00:00;Yes;28/09/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";male;10/09/1968 00:00;A;positive;XX;XX;21/10/2010 00:00;Myeloproliferative disorder;Essential or primary thrombocythaemia (ET);253;Allogeneic HCT;26/06/2019 00:00;1.0;1.0;Karnofsky performance status;100;Progressive disease;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;;Yes;;;;;yes;cyclophosphamide;;;;;;Yes;2.0;25/06/2020 00:00;Grade 2;Yes;01/08/2019 00:00;Moderate;Yes;27/11/2019 00:00;No;;In full remission;07/10/2019 00:00;Yes;12/07/2019 00:00;Yes;11/07/2019 00:00;;;;Mild;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;02/11/1971 00:00;O;positive;X;X;31/08/2017 00:00;Lymphoma;T-cell lymphoma (clinical);253;Allogeneic HCT;08/01/2019 00:00;2.0;1.0;Karnofsky performance status;80;In partial remission;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;Yes;;yes;cyclophosphamide;cyclosporine;mycophenolate mofetil;lymphocyte immune globulin, anti-thymocyte globulin;;;No;;26/09/2019 00:00;Grade 1;Yes;20/01/2019 00:00;;No evidence of;;No;;Not assessed;17/04/2019 00:00;;;Yes;22/01/2019 00:00;;;;;;Dead;Secondary malignant;26/09/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";male;13/12/2003 00:00;AB;positive;X;X;03/03/2012 00:00;Chronic leukemia;Chronic myeloid leukemia;253;Allogeneic HCT;08/07/2018 00:00;1.0;1.0;Lansky performance status;70;Chronic phase;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Cord blood;;;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;mycophenolate mofetil;cyclosporine;;;;;No;;30/09/2019 00:00;;No evidence of;;;No evidence of;;Yes;22/04/2019 00:00;;;Yes;06/09/2018 00:00;Yes;02/08/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";female;28/12/1968 00:00;A;positive;X;X;26/12/2018 23:59;Myeloproliferative disorder;Primary myelofibrosis;253;Allogeneic HCT;04/10/2018 00:00;1.0;1.0;Karnofsky performance status;60;Patient's condition improved;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Bone marrow;;Match;Reduced intensity conditioning (RIC);;Yes;Yes;;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;;;;;No;;06/09/2022 00:00;;No evidence of;;;No evidence of;;No;;In full remission;31/01/2019 00:00;Yes;30/10/2018 00:00;Yes;17/10/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";male;08/08/1967 00:00;A;positive;X;X;11/03/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;253;Allogeneic HCT;09/11/2019 00:00;2.0;2.0;Karnofsky performance status;100;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;cyclosporine;mycophenolate mofetil;cyclophosphamide;;;;Yes;2.0;14/01/2020 00:00;Grade 4;Yes;16/12/2019 00:00;;No evidence of;;No;;Death;14/01/2020 00:00;;;Yes;02/12/2019 00:00;;;;;;Dead;HCT-related cause of death;14/01/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";male;02/02/1991 00:00;unknown;unknown;XX;XX;25/01/2021 00:00;Bone Marrow Failure incl. Aplastic Anemia;Bone marrow Failure Syndromes incl. AA acquired;253;Allogeneic HCT;23/03/2022 00:00;1.0;1.0;Karnofsky performance status;100;;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Match;Reduced intensity conditioning (RIC);;;Yes;;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;methotrexate;;;;No;;04/01/2022 00:00;;No evidence of;;;No evidence of;;No;;In full remission;07/07/2022 00:00;Yes;16/04/2022 00:00;Yes;08/04/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";female;06/05/1956 00:00;O;positive;X;X;14/12/2017 00:00;Acute leukemia;Acute myeloid leukemia, disease;253;Allogeneic HCT;05/05/2018 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;;;;;yes;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;mycophenolate mofetil;;;;No;;18/11/2022 00:00;;Unknown;;;Unknown;;No;;In full remission;16/07/2018 00:00;Yes;15/05/2018 00:00;Yes;25/05/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";female;18/04/1970 00:00;A;positive;X;X;06/06/2018 00:00;Acute leukemia;Acute lymphoid leukemia;253;Allogeneic HCT;29/11/2018 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;mycophenolate mofetil;;;;No;;25/07/2019 00:00;Grade 1;Yes;08/01/2018 00:00;;No evidence of;;Yes;10/01/2018 00:00;Progressive disease;09/03/2019 00:00;Yes;09/12/2018 00:00;Yes;09/12/2018 00:00;;;;;;Dead;Relapse/progression;25/07/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;14/02/1964 00:00;unknown;unknown;X;X;30/08/2016 00:00;Acute leukemia;Acute myeloid leukemia, disease;261;Allogeneic HCT;24/06/2018 00:00;2.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;cyclophosphamide;tacrolimus;mycophenolate mofetil;;;;Yes;2.0;15/07/2024 00:00;Grade 1;Yes;31/07/2018 00:00;Moderate;Yes;21/11/2018 00:00;No;;In full remission;02/10/2018 00:00;Yes;04/07/2018 00:00;Yes;07/07/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;23/04/1972 00:00;unknown;unknown;X;X;26/10/2014 00:00;Plasma cell neoplasm;Multiple myeloma;261;Allogeneic HCT;03/06/2020 00:00;3.0;1.0;Karnofsky performance status;100;In partial remission;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;;Yes;Yes;yes;methotrexate;tacrolimus;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;07/03/2022 00:00;;No evidence of;;;No evidence of;;Yes;26/10/2020 00:00;In full remission;06/07/2020 00:00;Yes;04/07/2020 00:00;Yes;24/06/2020 00:00;;;;;;Dead;;07/03/2022 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";male;17/12/1975 00:00;unknown;unknown;X;X;18/07/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;261;Allogeneic HCT;27/01/2021 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;;;Yes;;;Yes;yes;tacrolimus;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;cyclophosphamide;;;No;;01/02/2023 00:00;Grade 3;Yes;29/04/2021 00:00;;No evidence of;;No;;In full remission;07/05/2021 00:00;;;Yes;28/02/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";female;16/08/1960 00:00;unknown;unknown;X;XX;06/11/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;261;Allogeneic HCT;15/03/2021 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;;;Yes;;;Yes;yes;cyclophosphamide;mycophenolate mofetil;tacrolimus;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;No;;19/03/2023 00:00;Grade 2;Yes;16/04/2021 00:00;;No evidence of;;No;;In full remission;23/06/2021 00:00;Yes;12/04/2021 00:00;Yes;04/04/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";male;20/04/1954 00:00;unknown;unknown;X;X;14/11/2019 00:00;Acute leukemia;Acute lymphoid leukemia;261;Allogeneic HCT;20/06/2020 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Bone marrow;Peripheral blood;;Myeloablative conditioning regimen;;;;Yes;;;;yes;tacrolimus;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;methotrexate;;;;Yes;8.0;15/02/2025 00:00;Grade 1;Yes;08/05/2021 00:00;;No evidence of;;No;;In full remission;28/09/2020 00:00;Yes;15/07/2020 00:00;Yes;08/07/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";female;05/01/1975 00:00;unknown;unknown;X;XX;23/08/2021 00:00;Acute leukemia;Acute myeloid leukemia, disease;261;Allogeneic HCT;01/01/2021 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;;;Yes;;;Yes;yes;tacrolimus;methotrexate;;;;;No;;28/01/2023 00:00;Grade 1;Yes;12/01/2021 00:00;Moderate;Yes;10/05/2022 00:00;No;;In full remission;12/04/2022 00:00;Yes;14/01/2021 00:00;Yes;05/02/2021 00:00;;;;Not done;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";female;11/12/1958 00:00;unknown;unknown;X;X;10/04/2022 00:00;Myelodysplastic syndrome;MDS with multilineage dysplasia (MDS-MLD);261;Allogeneic HCT;12/11/2024 00:00;2.0;2.0;Karnofsky performance status;90;;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;;;;yes;antilymphocyte immunoglobulin;tacrolimus;methotrexate;;;;Yes;6.0;19/02/2025 00:00;Grade 1;Yes;12/12/2024 00:00;;No evidence of;;No;;In full remission;16/12/2024 00:00;Yes;27/11/2024 00:00;Yes;28/11/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";female;18/11/1956 00:00;unknown;unknown;X;XX;18/08/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;261;Allogeneic HCT;20/12/2019 23:59;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;;Yes;;;Yes;yes;methotrexate;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;tacrolimus;;;;No;;11/01/2023 00:00;Grade 2;Yes;17/01/2019 00:00;Mild;Yes;03/09/2019 00:00;No;;In full remission;30/03/2019 00:00;Yes;01/01/2019 00:00;Yes;01/01/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;15/09/1946 00:00;unknown;unknown;XX;X;20/02/2018 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;261;Allogeneic HCT;06/06/2018 00:00;1.0;1.0;Karnofsky performance status;90;Patient's condition improved;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;;;;yes;mycophenolate mofetil;cyclosporine;;;;;Yes;2.0;06/12/2018 00:00;Grade 1;Yes;12/07/2018 00:00;;No evidence of;;;;Never in CR;08/07/2018 00:00;;;Yes;30/06/2018 00:00;;;;;;Dead;Relapse/progression;06/12/2018 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";female;04/12/1954 00:00;unknown;unknown;X;X;22/02/2022 00:00;Acute leukemia;Acute lymphoid leukemia;261;Allogeneic HCT;18/08/2022 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;;Yes;;;;yes;tacrolimus;methotrexate;lymphocyte immune globulin, anti-thymocyte globulin;;;;Yes;8.0;02/07/2024 00:00;Grade 2;Yes;06/09/2022 00:00;Mild;Yes;22/02/2023 00:00;No;;In full remission;15/09/2022 00:00;Yes;01/09/2022 00:00;Yes;03/09/2022 00:00;;;;Mild;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;01/07/1952 00:00;A;positive;XX;XX;03/04/2016 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;262;Allogeneic HCT;01/05/2018 00:00;1.0;1.0;Karnofsky performance status;100;In partial remission;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;05/09/2019 00:00;;No evidence of;;Severe;Yes;12/09/2018 00:00;No;;;;Yes;09/05/2018 00:00;Yes;13/05/2018 00:00;;;;;;Dead;HCT-related cause of death;05/09/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;16/07/1958 00:00;A;positive;XX;XX;22/06/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;262;Allogeneic HCT;01/07/2020 00:00;1.0;1.0;Karnofsky performance status;90;First relapse;Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;Yes;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;;;;;No;;28/09/2020 00:00;Grade 2;Yes;13/07/2020 00:00;;;;No;;In full remission;13/08/2020 00:00;Yes;11/07/2020 00:00;Yes;13/07/2020 00:00;;;;;;Dead;HCT-related cause of death;28/09/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;13/12/1975 00:00;O;positive;XX;XX;22/08/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;262;Allogeneic HCT;09/06/2020 00:00;1.0;1.0;;;;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;methotrexate;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;31/01/2021 00:00;;No evidence of;;Moderate;Yes;24/01/2021 00:00;;;In full remission;17/09/2020 00:00;Yes;20/06/2020 00:00;Yes;23/06/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;27/11/1963 00:00;A;positive;XX;XX;27/01/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;262;Allogeneic HCT;13/06/2019 00:00;1.0;1.0;Karnofsky performance status;80;Not in complete remission;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;Yes;;;yes;sirolimus;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;04/04/2020 00:00;Grade 3;Yes;03/07/2019 00:00;;No evidence of;;No;;In full remission;21/09/2019 00:00;;;Yes;24/06/2019 00:00;;;;;;Dead;HCT-related cause of death;04/04/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;26/10/2002 00:00;B;positive;XX;XX;13/08/2022 00:00;Lymphoma;T-cell lymphoma (clinical);262;Allogeneic HCT;31/03/2023 00:00;1.0;1.0;;;In partial remission;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;methotrexate;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;05/07/2023 00:00;;;;;;;;;;;Yes;12/04/2023 00:00;Yes;12/04/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;08/11/1972 00:00;O;positive;XX;XX;05/09/2017 00:00;Acute leukemia;Acute myeloid leukemia, disease;262;Allogeneic HCT;25/08/2018 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;methotrexate;cyclosporine;;;;;No;;31/07/2020 00:00;Grade 1;Yes;04/10/2018 00:00;Moderate;Yes;23/02/2019 00:00;No;;In full remission;03/12/2018 00:00;Yes;16/09/2018 00:00;Yes;13/09/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;23/06/1949 00:00;B;positive;XX;XX;15/07/2021 00:00;Acute leukemia;Acute myeloid leukemia, disease;262;Allogeneic HCT;16/01/2022 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;methotrexate;;;;No;;24/07/2022 00:00;Grade 4;Yes;13/06/2022 00:00;;;;No;;In full remission;30/04/2022 00:00;Yes;29/01/2022 00:00;Yes;05/02/2022 00:00;;;;;;Dead;HCT-related cause of death;24/07/2022 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;04/05/1981 00:00;O;positive;XX;XX;29/10/2017 00:00;Acute leukemia;Acute myeloid leukemia, disease;262;Allogeneic HCT;22/03/2018 00:00;1.0;1.0;Karnofsky performance status;80;Progressive relapsing (malignant);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;Yes;;;;;yes;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;;;No;;09/03/2019 00:00;;No evidence of;;;;;Yes;04/06/2018 00:00;;;Yes;30/03/2018 00:00;Yes;06/04/2018 00:00;;;;;;Dead;Relapse/progression;09/03/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;24/01/1959 00:00;A;positive;XX;XX;26/11/2015 00:00;Lymphoma;T-cell lymphoma (clinical);262;Allogeneic HCT;26/04/2018 00:00;2.0;1.0;Karnofsky performance status;100;Chemorefractory relapse or progression, including primary refractory disease;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Bone marrow;;Mismatch;Reduced intensity conditioning (RIC);;;Yes;Yes;Yes;;;yes;cyclophosphamide;;;;;;No;;22/05/2018 00:00;;No evidence of;;;;;No;;;;Yes;17/05/2018 00:00;Yes;13/05/2018 00:00;;;;;;Dead;HCT-related cause of death;22/05/2018 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;17/12/1980 00:00;O;positive;XX;XX;07/02/2005 00:00;Acute leukemia;Acute lymphoid leukemia;262;Allogeneic HCT;10/04/2019 00:00;2.0;2.0;Karnofsky performance status;80;Third or higher Complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;tacrolimus;cyclophosphamide;lymphocyte immune globulin, anti-thymocyte globulin;mycophenolate mofetil;;;No;;09/08/2022 00:00;;No evidence of;;Moderate;Yes;03/03/2022 00:00;Yes;23/06/2020 00:00;In full remission;19/07/2019 00:00;;;Yes;21/04/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;06/12/1950 00:00;O;negative;XX;XX;27/09/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;264;Allogeneic HCT;31/03/2019 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;mycophenolate mofetil;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;14/07/2019 00:00;Grade 2;Yes;02/06/2019 00:00;Not done;Yes;02/06/2019 00:00;Yes;20/05/2019 00:00;Progressive disease;20/05/2019 00:00;Yes;15/04/2019 00:00;Yes;20/04/2019 00:00;;;;Not done;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;25/08/1961 00:00;A;positive;XX;XX;09/12/2021 00:00;Acute leukemia;Acute myeloid leukemia, disease;264;Allogeneic HCT;24/08/2022 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;mycophenolate mofetil;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;No;;24/08/2023 00:00;;No evidence of;;;No evidence of;;No;;Sustained Full Remission;13/10/2022 00:00;Yes;02/09/2022 00:00;Yes;05/09/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;15/09/1964 00:00;A;negative;XX;XX;10/04/2021 00:00;Acute leukemia;Acute myeloid leukemia, disease;264;Allogeneic HCT;14/11/2021 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;mycophenolate mofetil;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;No;;04/11/2022 00:00;Grade 2;Yes;14/12/2021 00:00;;No evidence of;;No;;In full remission;18/12/2021 00:00;Yes;24/11/2021 00:00;Yes;02/12/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;12/11/1965 00:00;AB;positive;XX;XX;04/09/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;264;Allogeneic HCT;20/02/2021 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Bone marrow;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclophosphamide;mycophenolate mofetil;cyclosporine;;;;No;;11/02/2022 00:00;;No evidence of;;;No evidence of;;No;;In full remission;05/04/2021 00:00;;;Yes;13/03/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;17/08/1978 00:00;B;positive;XX;XX;04/12/2015 00:00;Acute leukemia;Acute myeloid leukemia, disease;264;Allogeneic HCT;03/06/2018 00:00;3.0;3.0;Karnofsky performance status;80;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;Yes;;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;;;No;;03/06/2019 00:00;Grade 1;Yes;08/07/2018 00:00;Limited;Yes;05/10/2018 00:00;No;;Not assessed;05/10/2018 00:00;Yes;18/06/2018 00:00;Yes;19/06/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;18/04/2000 00:00;A;positive;XX;XX;26/09/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;264;Allogeneic HCT;13/04/2019 00:00;1.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Bone marrow;;Mismatch;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;Yes;;yes;mycophenolate mofetil;cyclophosphamide;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;No;;23/10/2019 00:00;Grade 4;Yes;06/05/2019 00:00;;No evidence of;;No;;In full remission;04/06/2019 00:00;Yes;01/05/2019 00:00;Yes;06/05/2019 00:00;;;;;;Dead;HCT-related cause of death;23/10/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;28/07/1966 00:00;O;positive;XX;XX;10/06/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;264;Allogeneic HCT;11/11/2022 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Bone marrow;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclophosphamide;cyclosporine;mycophenolate mofetil;;;;No;;15/11/2023 00:00;Grade 2;Yes;27/11/2022 00:00;;No evidence of;;No;;In full remission;11/01/2023 00:00;Yes;16/11/2022 00:00;Yes;28/11/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;08/12/2000 00:00;A;positive;XX;XX;29/04/2021 00:00;Acute leukemia;Acute myeloid leukemia, disease;264;Allogeneic HCT;05/09/2021 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;cyclosporine;methotrexate;;;;;No;;21/07/2024 00:00;;No evidence of;;Limited;Yes;09/01/2021 00:00;No;;In full remission;12/10/2021 00:00;Yes;21/09/2021 00:00;Yes;25/09/2021 00:00;17/11/2024 00:00;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;28/05/1980 00:00;B;negative;XX;XX;12/11/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;264;Allogeneic HCT;05/04/2019 00:00;2.0;2.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;mycophenolate mofetil;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;22/01/2023 00:00;;No evidence of;;Limited;Yes;06/01/2020 00:00;Yes;09/11/2022 00:00;In full remission;06/05/2019 00:00;Yes;21/04/2019 00:00;Yes;21/04/2019 00:00;23/03/2023 00:00;;;;;Dead;Relapse/progression;22/01/2023 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;24/12/1955 00:00;AB;positive;XX;XX;12/05/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;264;Allogeneic HCT;06/05/2019 00:00;1.0;1.0;Karnofsky performance status;80;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;No;;25/08/2019 00:00;Grade 3;Yes;09/07/2019 00:00;;No evidence of;;Yes;04/06/2019 00:00;Disease progression;09/07/2019 00:00;Yes;25/05/2019 00:00;Yes;24/05/2019 00:00;;;;;;Dead;Relapse/progression;25/08/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";male;26/05/1962 00:00;O;positive;XX;XX;03/12/2018 00:00;Lymphoma;T-cell lymphoma (clinical);267;Allogeneic HCT;17/12/2019 00:00;1.0;1.0;Karnofsky performance status;90;In full remission;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclophosphamide;mycophenolate mofetil;cyclosporine;;;;No;;21/01/2020 00:00;Grade 3;Yes;13/01/2020 00:00;;No evidence of;;No;;Not assessed;21/01/2020 00:00;Yes;04/01/2020 00:00;Yes;04/01/2020 00:00;;;;;;Dead;HCT-related cause of death;21/01/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";male;09/09/1968 00:00;O;positive;X;X;18/03/2016 00:00;Chronic leukemia;Chronic lymphoid leukemia, disease;267;Allogeneic HCT;27/10/2021 00:00;1.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;methotrexate;;;;No;;24/10/2022 00:00;;No evidence of;;Moderate;Yes;21/03/2022 00:00;No;;Not assessed;04/02/2022 00:00;;;Yes;14/11/2021 00:00;;;;Moderate;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";female;03/01/1963 00:00;A;negative;X;X;05/11/2021 00:00;Acute leukemia;Acute myeloid leukemia, disease;267;Allogeneic HCT;29/04/2022 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;methotrexate;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;10/05/2023 00:00;Grade 1;Yes;27/05/2022 00:00;Moderate;Yes;07/09/2022 00:00;No;;In full remission;04/08/2022 00:00;;;Yes;17/05/2022 00:00;;;;Moderate;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;06/08/1958 00:00;A;positive;XX;XX;24/05/2014 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-1;267;Allogeneic HCT;23/01/2024 00:00;1.0;1.0;;;;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;methotrexate;;;;;No;;09/05/2024 00:00;;;;;;;No;;In full remission;25/04/2024 00:00;Yes;02/02/2024 00:00;Yes;08/02/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;09/07/1986 00:00;A;positive;X;X;31/05/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;267;Allogeneic HCT;23/07/2019 00:00;2.0;1.0;Karnofsky performance status;90;Primary induction failure;Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;;No;;20/10/2019 00:00;;No evidence of;;;No evidence of;;Yes;07/08/2019 00:00;Progressive disease;20/10/2019 00:00;Yes;03/08/2019 00:00;;;;;;;;Dead;Relapse/progression;20/10/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";male;28/06/1966 00:00;O;negative;X;X;19/11/2020 00:00;Myeloproliferative disorder;Primary myelofibrosis;267;Allogeneic HCT;09/07/2022 00:00;1.0;1.0;Karnofsky performance status;100;Primary refractory phase (no change);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;mycophenolate mofetil;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;No;;05/09/2024 00:00;;No evidence of;;;No evidence of;;Yes;13/01/2023 00:00;In full remission;11/09/2022 00:00;Yes;17/07/2022 00:00;Yes;23/07/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";male;16/09/1962 00:00;O;positive;XX;XX;07/04/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;267;Allogeneic HCT;02/12/2019 00:00;1.0;1.0;Karnofsky performance status;90;In partial remission;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclosporine;cyclophosphamide;;;;;No;;22/06/2020 00:00;;No evidence of;;Mild;Yes;23/03/2020 00:00;Yes;20/05/2020 00:00;In full remission;09/03/2020 00:00;Yes;08/01/2020 00:00;Yes;21/12/2019 00:00;;;;Moderate;Yes;Dead;Relapse/progression;22/06/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;14/08/1999 00:00;A;negative;XX;XX;05/06/2022 00:00;Lymphoma;T-cell lymphoma (clinical);267;Allogeneic HCT;20/02/2024 00:00;1.0;1.0;ECOG Performance Status score;0;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclosporine;cyclophosphamide;mycophenolate mofetil;;;;No;;19/07/2024 00:00;Grade 2;Yes;07/04/2024 00:00;;No evidence of;;No;;In full remission;19/07/2024 00:00;Yes;22/03/2024 00:00;Yes;10/03/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";male;02/06/1957 00:00;O;positive;XX;XX;01/09/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;267;Allogeneic HCT;30/01/2019 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;methotrexate;cyclosporine;;;;No;;26/01/2023 00:00;;No evidence of;;;No evidence of;;No;;In full remission;16/04/2019 00:00;Yes;09/02/2019 00:00;Yes;17/02/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";female;04/01/1966 00:00;O;positive;X;X;09/02/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;267;Allogeneic HCT;26/06/2020 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;methotrexate;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;22/05/2021 00:00;;No evidence of;;Mild;Yes;05/11/2020 00:00;Yes;27/08/2020 00:00;Progressive disease;27/08/2020 00:00;Yes;09/07/2020 00:00;Yes;16/07/2020 00:00;;;;;;Dead;Relapse/progression;22/05/2021 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;09/07/2010 00:00;AB;positive;X;X;16/07/2010 00:00;Hemoglobinopathy;Sickle cell-hemoglobin SS disease;270;Allogeneic HCT;03/05/2023 00:00;2.0;2.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;Unknown;Match;Reduced intensity conditioning (RIC);;;;;;;;yes;sirolimus;alemtuzumab;;;;;Yes;3.0;25/07/2023 00:00;;No evidence of;;;No evidence of;;;;;;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;28/04/1954 00:00;O;positive;XX;XX;05/11/2023 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;270;Allogeneic HCT;23/03/2024 00:00;1.0;1.0;Karnofsky performance status;90;In full remission;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;tacrolimus;;;;;No;;06/07/2024 00:00;;;;;;;No;;In full remission;04/05/2024 00:00;;;Yes;03/04/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;12/06/1955 00:00;O;positive;XX;XX;;;;270;Allogeneic HCT;30/04/2024 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;;;;;yes;mycophenolate mofetil;tacrolimus;;;;;No;;11/08/2024 00:00;;;;;;;No;;In full remission;02/06/2024 00:00;Yes;13/05/2024 00:00;Yes;10/05/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;05/02/1962 00:00;O;positive;XX;XX;04/09/2022 00:00;Chronic leukemia;Prolymphocytic (PLL) and other chronic leukaemias;270;Allogeneic HCT;02/05/2023 00:00;1.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;tacrolimus;;;;;No;;23/02/2024 00:00;;No evidence of;;Mild;Yes;29/01/2024 00:00;No;;Sustained Full Remission;12/06/2023 00:00;Yes;19/05/2023 00:00;Yes;19/05/2023 00:00;;;;Mild;Yes;Dead;Relapse/progression;23/02/2024 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;23/09/1964 00:00;O;positive;XX;XX;23/08/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;270;Allogeneic HCT;06/02/2021 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;antilymphocyte immunoglobulin;cyclosporine;;;;No;;16/02/2022 00:00;Grade 1;Yes;24/02/2021 00:00;;No evidence of;;No;;In full remission;19/03/2021 00:00;;;Yes;27/02/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;24/11/1977 00:00;A;positive;XX;XX;15/01/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;270;Allogeneic HCT;26/06/2020 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;antilymphocyte immunoglobulin;cyclosporine;;;;;No;;12/11/2020 00:00;Grade 4;Yes;22/07/2020 00:00;Severe;Yes;04/10/2020 00:00;No;;In full remission;13/08/2020 00:00;Yes;13/07/2020 00:00;Yes;11/07/2020 00:00;;;;Severe;Yes;Dead;HCT-related cause of death;12/11/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;27/12/1950 00:00;O;positive;XX;XX;10/05/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;270;Allogeneic HCT;07/08/2018 00:00;1.0;1.0;Karnofsky performance status;80;Primary induction failure;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;;;;;;;no;;;;;;;No;;14/08/2019 00:00;;No evidence of;;;No evidence of;;No;;Stable disease;01/09/2018 00:00;;;;;11/09/2018 00:00;;;;;Dead;Relapse/progression;14/08/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;10/11/1979 00:00;O;negative;XX;XX;;;;270;Allogeneic HCT;26/03/2024 00:00;1.0;1.0;Karnofsky performance status;90;Patient's condition improved;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;;;Yes;;Yes;Yes;yes;tacrolimus;mycophenolate mofetil;cyclophosphamide;;;;No;;03/05/2024 00:00;;;;;;;No;;;;;;;;07/05/2024 00:00;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;04/02/1951 00:00;A;positive;XX;XX;15/01/2014 00:00;Lymphoma;B-cell non-Hodgkin's lymphoma;270;Allogeneic HCT;20/01/2021 00:00;2.0;1.0;Karnofsky performance status;100;In partial remission;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;;;yes;mycophenolate mofetil;cyclophosphamide;tacrolimus;;;;No;;05/02/2021 00:00;;No evidence of;;;No evidence of;;No;;Not assessed;05/02/2021 00:00;;;Yes;05/02/2021 00:00;;;;;;Dead;HCT-related cause of death;05/02/2021 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;30/04/1959 00:00;O;negative;XX;XX;18/12/2019 00:00;Myeloproliferative disorder;Other;270;Allogeneic HCT;08/07/2020 00:00;1.0;1.0;Karnofsky performance status;80;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclosporine;mycophenolate mofetil;cyclophosphamide;;;;No;;18/01/2023 00:00;Grade 1;Yes;20/08/2020 00:00;Moderate;Yes;05/01/2021 00:00;Unknown;;Not assessed;21/10/2020 00:00;;;Yes;31/07/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;30/11/1965 00:00;A;negative;XX;X;25/04/2014 00:00;Myelodysplastic syndrome;;272;Allogeneic HCT;14/06/2024 00:00;1.0;1.0;ECOG Performance Status score;0;;;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclophosphamide;cyclosporine;mycophenolate mofetil;;;;No;;02/01/2025 00:00;;;;;;;No;;Patient's condition improved;12/10/2024 00:00;Yes;11/07/2024 00:00;Yes;08/07/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;30/03/1958 00:00;O;positive;X;X;18/11/2019 00:00;Bone Marrow Failure incl. Aplastic Anemia;Bone marrow Failure Syndromes incl. AA acquired;272;Allogeneic HCT;04/08/2021 00:00;1.0;1.0;Karnofsky performance status;60;;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;;;;;;;No;;08/10/2023 00:00;;;;;;;No;;In full remission;09/10/2021 00:00;Yes;15/08/2021 00:00;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;02/12/1996 00:00;O;positive;X;X;17/08/2023 00:00;Acute leukemia;Acute myeloid leukemia, disease;272;Allogeneic HCT;25/01/2024 00:00;1.0;1.0;ECOG Performance Status score;0;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;;;;;;yes;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;methotrexate;;;;No;;02/05/2024 00:00;;;;;;;No;;In full remission;02/05/2024 00:00;Yes;07/02/2024 00:00;Yes;13/02/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;13/06/1963 00:00;AB;positive;X;X;18/07/2023 00:00;Acute leukemia;Acute myeloid leukemia, disease;272;Allogeneic HCT;12/05/2024 00:00;1.0;1.0;;;;Transplant donor cytomegalovirus antibody negative;;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;antilymphocyte immunoglobulin;cyclosporine;mycophenolate mofetil;;;;No;;20/08/2024 00:00;;;;;No evidence of;;No;;In full remission;20/08/2024 00:00;;;Yes;22/05/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;19/11/1966 00:00;A;positive;X;X;13/02/2023 00:00;Bone Marrow Failure incl. Aplastic Anemia;;272;Allogeneic HCT;02/09/2023 00:00;1.0;1.0;ECOG Performance Status score;0;;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Match;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;methotrexate;antilymphocyte immunoglobulin;cyclosporine;;;;No;;18/09/2024 00:00;Grade 1;Yes;30/10/2023 00:00;Moderate;Yes;;No;;In full remission;19/02/2024 00:00;Yes;21/09/2023 00:00;Yes;23/09/2023 00:00;;;;Moderate;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;25/10/1993 00:00;O;positive;XX;XX;11/08/2019 00:00;Lymphoma;T-cell lymphoma (clinical);272;Allogeneic HCT;20/10/2021 00:00;1.0;1.0;Karnofsky performance status;80;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;;;Yes;;;;yes;mycophenolate mofetil;cyclophosphamide;cyclosporine;;;;Yes;12.0;22/11/2023 00:00;Grade 3;Yes;04/11/2021 00:00;;No evidence of;;No;;In full remission;26/01/2022 00:00;;;Yes;09/11/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;12/03/1964 00:00;O;negative;X;X;05/05/2024 00:00;Myelodysplastic syndrome;;272;Allogeneic HCT;07/09/2024 00:00;1.0;1.0;ECOG Performance Status score;1;;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;No;;01/02/2025 00:00;Grade 2;Yes;27/09/2024 00:00;;No evidence of;;No;;In full remission;29/12/2024 00:00;Yes;19/09/2024 00:00;Yes;16/09/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;07/02/1975 00:00;O;positive;X;X;18/03/2024 00:00;Acute leukemia;Acute lymphoid leukemia;272;Allogeneic HCT;18/09/2024 00:00;1.0;1.0;ECOG Performance Status score;1;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;;;Yes;;;;yes;cyclosporine;cyclophosphamide;mycophenolate mofetil;;;;Yes;8.0;30/01/2025 00:00;Grade 1;Yes;16/10/2024 00:00;;No evidence of;;No;;In full remission;30/01/2025 00:00;Yes;12/10/2024 00:00;Yes;07/10/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;29/09/1985 00:00;O;negative;X;X;12/09/2023 00:00;Acute leukemia;Acute myeloid leukemia, disease;272;Allogeneic HCT;01/02/2024 00:00;1.0;1.0;ECOG Performance Status score;0;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;cyclosporine;antilymphocyte immunoglobulin;methotrexate;;;;No;;28/01/2025 00:00;;;;;;;No;;In full remission;18/02/2024 00:00;Yes;08/02/2024 00:00;Yes;16/02/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;18/09/1962 00:00;A;positive;XX;XX;03/03/2021 00:00;Acute leukemia;Acute lymphoid leukemia;272;Allogeneic HCT;09/08/2021 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;;;Yes;;;;yes;cyclosporine;mycophenolate mofetil;lymphocyte immune globulin, anti-thymocyte globulin;;;;Yes;8.0;08/08/2023 00:00;Grade 1;Yes;09/09/2021 00:00;;No evidence of;;No;;In full remission;17/11/2021 00:00;Yes;29/08/2021 00:00;Yes;26/08/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;16/03/1951 00:00;A;positive;XX;XX;05/10/2020 00:00;Myelodysplastic syndrome;MDS with ring sideroblasts (MDS-RS);273;Allogeneic HCT;04/06/2021 00:00;1.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;methotrexate;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;11/01/2022 00:00;;No evidence of;;;No evidence of;;No;;In full remission;29/08/2021 00:00;Yes;16/06/2021 00:00;Yes;22/06/2021 00:00;;;;;;Dead;HCT-related cause of death;11/01/2022 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;11/07/1990 00:00;O;positive;X;X;19/04/2023 00:00;Acute leukemia;Acute lymphoid leukemia;273;Allogeneic HCT;13/09/2023 00:00;1.0;1.0;ECOG Performance Status score;0;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;Yes;;;;;yes;methotrexate;cyclosporine;;;;;Yes;12.0;17/01/2024 00:00;Grade 2;Yes;14/10/2023 00:00;;No evidence of;;No;;Sustained Full Remission;13/12/2023 00:00;Yes;06/10/2023 00:00;Yes;23/09/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;29/11/1974 00:00;O;positive;XX;XX;04/06/2007 00:00;Myeloproliferative disorder;Polycythemia vera (clinical);273;Allogeneic HCT;27/09/2018 00:00;1.0;1.0;Karnofsky performance status;100;Patient's condition improved;Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;methotrexate;;;;No;;22/06/2022 00:00;;No evidence of;;Not done;Yes;31/03/2019 00:00;No;;Not assessed;10/02/2019 00:00;Yes;01/11/2018 00:00;Yes;15/11/2018 00:00;;;;Limited;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;15/05/1961 00:00;A;positive;XX;XX;16/02/2022 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;273;Allogeneic HCT;07/09/2022 00:00;1.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclosporine;mycophenolate mofetil;cyclophosphamide;;;;No;;29/12/2023 23:59;;No evidence of;;;No evidence of;;No;;In full remission;15/12/2022 00:00;Yes;17/09/2022 00:00;Yes;20/09/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;31/05/1958 00:00;A;positive;X;X;22/11/2023 00:00;Acute leukemia;Acute myeloid leukemia, disease;273;Allogeneic HCT;31/01/2024 00:00;1.0;1.0;ECOG Performance Status score;2;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclophosphamide;cyclosporine;mycophenolate mofetil;;;;No;;22/05/2024 00:00;Grade 1;Yes;05/03/2024 00:00;;No evidence of;;No;;Sustained Full Remission;08/05/2024 00:00;Yes;23/02/2024 00:00;Yes;17/02/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;25/12/1957 00:00;A;negative;XX;XX;14/02/2019 00:00;Acute leukemia;Acute lymphoid leukemia;273;Allogeneic HCT;10/10/2019 00:00;1.0;1.0;Not assessed;;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;methotrexate;;;;No;;19/07/2022 00:00;;No evidence of;;;No evidence of;;No;;In full remission;16/01/2020 00:00;;;Yes;24/10/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;08/05/1977 00:00;O;negative;XX;XX;07/10/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;273;Allogeneic HCT;01/01/2020 00:00;1.0;1.0;Not assessed;;Primary induction failure;Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;Yes;;yes;cyclophosphamide;cyclosporine;mycophenolate mofetil;;;;No;;05/12/2020 00:00;;No evidence of;;Severe;Yes;22/06/2020 00:00;Yes;27/10/2020 00:00;In full remission;17/02/2020 00:00;Yes;11/02/2020 00:00;Yes;30/01/2020 00:00;;;;Mild;Yes;Dead;Relapse/progression;05/12/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;08/07/1963 00:00;O;positive;XX;XX;29/11/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;273;Allogeneic HCT;02/09/2022 00:00;1.0;1.0;Karnofsky performance status;100;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;methotrexate;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;12/12/2022 00:00;;No evidence of;;;No evidence of;;No;;In full remission;05/12/2022 00:00;Yes;15/09/2022 00:00;Yes;17/09/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;22/01/1989 00:00;A;negative;XX;XX;24/02/2021 00:00;Acute leukemia;Acute lymphoid leukemia;273;Allogeneic HCT;10/08/2021 00:00;1.0;1.0;Karnofsky performance status;70;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;Yes;;;;;yes;cyclosporine;methotrexate;;;;;Yes;12.0;10/07/2022 00:00;Grade 1;Yes;01/09/2021 00:00;Moderate;Yes;07/01/2022 00:00;No;;In full remission;17/11/2021 00:00;Yes;30/08/2021 00:00;Yes;26/08/2021 00:00;;;;Moderate;Yes;Dead;HCT-related cause of death;10/07/2022 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;13/02/1958 00:00;O;positive;XX;XX;20/02/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;273;Allogeneic HCT;10/09/2022 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;methotrexate;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;24/12/2022 00:00;;No evidence of;;;No evidence of;;No;;In full remission;08/10/2022 00:00;;;Yes;28/09/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;18/08/1971 00:00;A;positive;XX;XX;12/07/2016 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;277;Allogeneic HCT;14/05/2018 00:00;2.0;2.0;Karnofsky performance status;100;Stable;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;;;Yes;;;;yes;cyclosporine;antilymphocyte immunoglobulin;methotrexate;lymphocyte immune globulin, anti-thymocyte globulin;;;Yes;8.0;27/04/2022 00:00;;No evidence of;;;No evidence of;;No;;In full remission;22/10/2018 00:00;Yes;25/05/2018 00:00;Yes;03/06/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;27/10/1960 00:00;A;positive;XX;XX;02/10/2022 00:00;Myeloproliferative disorder;Primary myelofibrosis;277;Allogeneic HCT;09/01/2023 00:00;1.0;1.0;ECOG Performance Status score;0;Progressive disease;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;methotrexate;;;;;Yes;10.0;13/04/2024 00:00;;;;;;;No;;In full remission;13/04/2024 00:00;Yes;13/02/2023 00:00;Yes;13/02/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;01/12/1960 00:00;AB;negative;XX;XX;26/08/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;277;Allogeneic HCT;15/05/2019 00:00;1.0;1.0;Karnofsky performance status;100;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;cyclosporine;methotrexate;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;23/08/2019 00:00;;No evidence of;;;No evidence of;;No;;In full remission;19/08/2019 00:00;Yes;12/06/2019 00:00;Yes;03/06/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;02/01/1956 00:00;A;positive;XX;XX;09/11/2018 00:00;Myeloproliferative disorder;Primary myelofibrosis;277;Allogeneic HCT;24/05/2019 00:00;1.0;1.0;Karnofsky performance status;100;Progressive disease;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;mycophenolate mofetil;;;;No;;14/07/2022 00:00;;No evidence of;;;No evidence of;;No;;In full remission;08/09/2019 00:00;Yes;09/06/2019 00:00;Yes;13/06/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;07/09/1969 00:00;O;negative;XX;XX;12/06/2024 00:00;Acute leukemia;Acute myeloid leukemia, disease;277;Allogeneic HCT;24/10/2024 00:00;1.0;1.0;Karnofsky performance status;100;First relapse;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclosporine;cyclophosphamide;mycophenolate mofetil;;;;No;;24/10/2024 00:00;;;;;;;;;;;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;17/09/1961 00:00;O;positive;XX;XX;13/10/2020 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;277;Allogeneic HCT;03/04/2021 00:00;1.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;methotrexate;;;;No;;12/07/2021 00:00;;No evidence of;;;No evidence of;;No;;In full remission;12/07/2021 00:00;Yes;19/04/2021 00:00;Yes;24/04/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;07/03/1997 00:00;O;positive;XX;XX;08/12/2021 00:00;Lymphoma;B-cell lymphoma (clinical);277;Allogeneic HCT;13/03/2024 00:00;1.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclosporine;methotrexate;;;;;No;;13/03/2024 00:00;;;;;;;;;;;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;23/08/1988 00:00;O;positive;XX;XX;29/10/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;277;Allogeneic HCT;30/05/2021 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;methotrexate;;;;No;;07/09/2021 00:00;;No evidence of;;;No evidence of;;No;;In full remission;13/09/2021 00:00;Yes;11/06/2021 00:00;Yes;20/06/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;09/02/1999 00:00;A;positive;XX;XX;18/05/2020 00:00;Bone Marrow Failure incl. Aplastic Anemia;Bone marrow Failure Syndromes incl. AA acquired;277;Allogeneic HCT;18/12/2020 00:00;1.0;1.0;Karnofsky performance status;100;;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;lymphocyte immune globulin, anti-thymocyte globulin;methotrexate;cyclosporine;;;;No;;11/02/2022 00:00;;No evidence of;;;No evidence of;;No;;In full remission;04/04/2021 00:00;Yes;09/01/2021 00:00;Yes;13/01/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;11/05/1963 00:00;AB;positive;XX;XX;24/07/2021 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-1;277;Allogeneic HCT;21/03/2022 00:00;1.0;1.0;Karnofsky performance status;100;Stable;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;methotrexate;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;01/07/2022 00:00;Grade 2;Yes;16/04/2022 00:00;;No evidence of;;No;;In full remission;01/07/2022 00:00;Yes;01/04/2022 00:00;Yes;05/04/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;06/01/2006 00:00;O;positive;XX;XX;17/04/2021 00:00;Lymphoma;T-cell lymphoma (clinical);301;Allogeneic HCT;01/10/2021 00:00;1.0;1.0;Lansky performance status;90;In full remission;Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Bone marrow;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclosporine;antilymphocyte immunoglobulin;;;;;No;;01/10/2021 00:00;;;;;;;;;;;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;02/12/2012 00:00;O;positive;XX;XX;04/03/2020 00:00;Bone Marrow Failure incl. Aplastic Anemia;Bone marrow Failure Syndromes incl. AA acquired;301;Allogeneic HCT;25/04/2020 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;;Yes;;;;;yes;antilymphocyte immunoglobulin;methotrexate;cyclosporine;;;;No;;08/08/2020 00:00;;No evidence of;;;No evidence of;;No;;In full remission;08/08/2020 00:00;Yes;13/05/2020 00:00;Yes;24/05/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;23/04/2020 00:00;A;positive;XX;XX;25/06/2021 00:00;Inborn Errors;Primary immune deficiency disorder;301;Allogeneic HCT;10/12/2021 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Cord blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;cyclosporine;mycophenolate mofetil;;;;;No;;10/12/2021 00:00;;;;;;;;;;;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;23/02/2023 00:00;O;positive;;;14/02/2023 00:00;Acute leukemia;Acute lymphoid leukemia;301;Allogeneic HCT;13/06/2023 00:00;1.0;1.0;Lansky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclosporine;methotrexate;;;;;No;;16/06/2024 00:00;Grade 2;Yes;09/07/2023 00:00;;No evidence of;;No;;Sustained Full Remission;12/07/2023 00:00;Yes;11/07/2023 00:00;Yes;12/07/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;05/10/2007 00:00;O;positive;XX;XX;25/06/2014 00:00;Inborn Errors;Primary immune deficiency disorder;301;Allogeneic HCT;07/10/2018 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Bone marrow;;Mismatch;Myeloablative conditioning regimen;;;;Yes;Yes;;;yes;alemtuzumab;cyclosporine;cyclophosphamide;mycophenolate mofetil;;;No;;20/09/2021 00:00;;No evidence of;;;No evidence of;;No;;In full remission;28/01/2019 00:00;Yes;22/10/2018 00:00;Yes;24/10/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";male;12/07/2010 00:00;O;positive;XX;XX;28/04/2019 00:00;Acute leukemia;Acute lymphoid leukemia;301;Allogeneic HCT;08/11/2019 00:00;2.0;2.0;Lansky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Cord blood;;;Myeloablative conditioning regimen;;;Yes;Yes;;;;yes;mycophenolate mofetil;cyclosporine;;;;;Yes;12.0;12/11/2021 00:00;Grade 1;Yes;19/11/2019 00:00;;No evidence of;;No;;In full remission;20/02/2020 00:00;Yes;08/12/2019 00:00;Yes;27/11/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;01/04/2016 00:00;A;positive;XX;XX;16/09/2017 00:00;Acute leukemia;Acute myeloid leukemia, disease;301;Allogeneic HCT;12/03/2018 00:00;1.0;1.0;Lansky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Cord blood;;;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;mycophenolate mofetil;cyclosporine;;;;;No;;11/05/2021 00:00;Grade 1;Yes;25/03/2018 00:00;;Unknown;;No;;In full remission;23/06/2018 00:00;Yes;09/04/2018 00:00;Yes;30/03/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;18/04/2019 00:00;O;positive;XX;XX;11/04/2019 00:00;Inborn Errors;Primary immune deficiency disorder;301;Allogeneic HCT;07/05/2020 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;Yes;;;;;;yes;cyclosporine;methotrexate;;;;;No;;26/08/2020 00:00;;No evidence of;;;No evidence of;;No;;In full remission;26/08/2020 00:00;Yes;27/05/2020 00:00;Yes;30/05/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;11/07/2007 00:00;A;positive;XX;XX;15/04/2018 00:00;Acute leukemia;Acute lymphoid leukemia;301;Allogeneic HCT;26/11/2018 00:00;1.0;1.0;Lansky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;;;;;;;yes;cyclosporine;;;;;;Yes;12.0;12/10/2021 00:00;;No evidence of;;;No evidence of;;No;;In full remission;24/01/2019 00:00;Yes;11/12/2018 00:00;Yes;09/12/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXX)""";female;19/11/2005 00:00;O;positive;X;X;02/12/2010 23:59;Autoimmune disease;Haematological diseases;301;Allogeneic HCT;01/01/2022 00:00;1.0;1.0;Not assessed;;;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;methotrexate;cyclosporine;;;;No;;11/04/2023 00:00;Grade 4;Yes;07/03/2022 00:00;Severe;Yes;03/05/2022 00:00;Yes;11/04/2023 00:00;In full remission;11/04/2022 00:00;;;Yes;17/01/2022 00:00;;;;Severe;Yes;Dead;Secondary malignant;11/04/2023 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;15/05/1960 00:00;A;negative;XX;XX;25/03/2017 00:00;Acute leukemia;Acute myeloid leukemia, disease;305;Allogeneic HCT;26/07/2019 00:00;2.0;2.0;Karnofsky performance status;60;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;;Yes;;;Yes;Yes;yes;tacrolimus;mycophenolate mofetil;cyclophosphamide;;;;No;;03/07/2024 00:00;Grade 2;Yes;06/10/2019 00:00;Not done;Yes;;No;;In full remission;10/10/2019 00:00;Yes;28/08/2019 00:00;Yes;09/08/2019 00:00;;;;Mild;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;28/09/1960 00:00;unknown;unknown;XX;XX;10/12/2014 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;307;Allogeneic HCT;03/07/2018 00:00;2.0;2.0;Karnofsky performance status;50;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclosporine;methotrexate;;;;;No;;11/07/2024 00:00;Grade 1;Yes;05/08/2018 00:00;Mild;Yes;27/08/2019 00:00;No;;In full remission;08/10/2018 00:00;Yes;14/07/2018 00:00;Yes;21/07/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;04/01/2001 00:00;O;positive;XX;XX;31/01/2019 00:00;Acute leukemia;Acute lymphoid leukemia;349;Allogeneic HCT;27/09/2020 00:00;1.0;1.0;;;;;;;;;;;;;;;;;;;;;;;;;;;14/07/2023 00:00;;;;;;;Yes;17/01/2022 00:00;In full remission;17/01/2022 00:00;;;;;17/08/2023 00:00;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;20/05/2006 00:00;unknown;unknown;X;X;18/12/2013 23:59;Bone Marrow Failure incl. Aplastic Anemia;Genetic Bone Marrow Failure;369;Allogeneic HCT;31/08/2021 00:00;1.0;1.0;Lansky performance status;80;;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;;Yes;Yes;;;;yes;methotrexate;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;Yes;3.0;15/11/2024 00:00;;No evidence of;;;No evidence of;;No;;In full remission;09/12/2021 00:00;Yes;18/09/2021 00:00;Yes;10/09/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;27/07/2003 00:00;unknown;unknown;X;X;10/10/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;369;Allogeneic HCT;30/07/2020 00:00;1.0;1.0;Karnofsky performance status;80;Second relapse;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;Yes;Yes;;Yes;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;;No;;10/10/2020 00:00;;No evidence of;;;No evidence of;;No;;In full remission;20/08/2020 00:00;Yes;16/08/2020 00:00;Yes;11/08/2020 00:00;;;;;;Dead;Other;10/10/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;20/04/1962 00:00;unknown;unknown;X;X;24/07/2018 00:00;Myeloproliferative disorder;Primary myelofibrosis;369;Allogeneic HCT;05/04/2020 00:00;1.0;1.0;Karnofsky performance status;80;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;;No;;11/06/2022 00:00;;No evidence of;;Moderate;Yes;17/10/2020 00:00;No;;In full remission;14/07/2020 00:00;Yes;26/04/2020 00:00;Yes;17/04/2020 00:00;;;;;;Dead;HCT-related cause of death;11/06/2022 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;25/12/1991 00:00;unknown;unknown;X;X;05/11/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;369;Allogeneic HCT;04/03/2021 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;;No;;12/09/2024 00:00;;;;;;;No;;In full remission;13/06/2021 00:00;Yes;23/03/2021 00:00;Yes;23/03/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;21/08/2002 00:00;unknown;unknown;X;X;13/05/2021 00:00;Acute leukemia;Acute myeloid leukemia, disease;369;Allogeneic HCT;03/09/2021 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;cyclosporine;cyclophosphamide;;;No;;18/07/2023 00:00;Grade 3;Yes;04/01/2022 00:00;;No evidence of;;Yes;05/03/2023 00:00;In full remission;12/12/2021 00:00;Yes;19/09/2021 00:00;Yes;17/09/2021 00:00;;;;;;Dead;Relapse/progression;18/07/2023 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;18/03/2003 00:00;unknown;unknown;X;X;15/03/2014 00:00;Lymphoma;Hodgkin's disease (clinical);369;Allogeneic HCT;22/12/2021 00:00;2.0;1.0;Karnofsky performance status;80;In full remission;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;;Yes;Yes;;;;yes;cyclosporine;mycophenolate mofetil;;;;;Yes;2.0;24/10/2024 00:00;;No evidence of;;Moderate;Yes;;No;;In full remission;01/04/2022 00:00;Yes;07/01/2021 00:00;Yes;03/01/2021 00:00;;;;Moderate;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;09/10/1980 00:00;unknown;unknown;X;X;15/03/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;369;Allogeneic HCT;06/09/2022 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;;No;;15/12/2023 23:59;;No evidence of;;;No evidence of;;No;;In full remission;15/12/2023 23:59;Yes;16/09/2022 00:00;Yes;21/09/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;19/07/2006 00:00;unknown;unknown;X;X;30/05/2010 00:00;Acute leukemia;Acute lymphoid leukemia;369;Allogeneic HCT;09/07/2018 00:00;1.0;1.0;Lansky performance status;90;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;;Yes;;;;;yes;methotrexate;cyclosporine;;;;;Yes;12.0;23/10/2018 00:00;Grade 1;Yes;28/07/2018 00:00;;No evidence of;;Yes;30/09/2018 00:00;In full remission;23/10/2018 00:00;Yes;29/07/2018 00:00;Yes;25/07/2018 00:00;;;;;;Dead;Relapse/progression;23/10/2018 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;16/11/1997 00:00;unknown;unknown;X;X;02/03/2014 00:00;Acute leukemia;Acute lymphoid leukemia;369;Allogeneic HCT;31/03/2019 00:00;1.0;1.0;Karnofsky performance status;90;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;;Yes;;;;;yes;cyclosporine;;;;;;Yes;12.0;30/05/2019 00:00;;No evidence of;;;No evidence of;;No;;In full remission;30/05/2019 00:00;;;Yes;17/04/2019 00:00;;;;;;Dead;HCT-related cause of death;30/05/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;05/07/1951 00:00;A;unknown;X;X;13/11/2016 00:00;Acute leukemia;Acute myeloid leukemia, disease;369;Allogeneic HCT;15/12/2018 00:00;1.0;1.0;Karnofsky performance status;90;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;mycophenolate mofetil;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclophosphamide;cyclosporine;;;No;;10/10/2022 00:00;;No evidence of;;;No evidence of;;No;;In full remission;15/06/2019 00:00;Yes;10/01/2019 00:00;Yes;19/01/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;30/09/1964 00:00;unknown;unknown;X;X;24/07/2021 00:00;Acute leukemia;Acute lymphoid leukemia;389;Allogeneic HCT;10/10/2021 00:00;2.0;2.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;;;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;;;;;Yes;8.0;26/11/2021 00:00;;No evidence of;;;;;;;In full remission;26/11/2021 00:00;Yes;10/11/2021 00:00;Yes;06/11/2021 00:00;08/01/2021 00:00;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";male;06/07/1964 00:00;O;positive;XX;XX;25/06/2009 00:00;Myeloproliferative disorder;Essential or primary thrombocythaemia (ET);523;Allogeneic HCT;25/02/2022 00:00;1.0;1.0;Karnofsky performance status;100;Unknown;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;cyclosporine;;;;No;;05/03/2023 00:00;Grade 1;Yes;12/03/2022 00:00;Moderate;Yes;18/06/2022 00:00;No;;In full remission;11/06/2022 00:00;Yes;25/04/2022 00:00;Yes;12/03/2022 00:00;;;;Moderate;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;09/12/1964 00:00;O;positive;X;X;03/01/2016 00:00;Lymphoma;B-cell non-Hodgkin's lymphoma;523;Allogeneic HCT;20/05/2022 00:00;2.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclophosphamide;cyclosporine;mycophenolate mofetil;;;;No;;27/06/2022 00:00;Grade 3;Yes;22/05/2022 00:00;;No evidence of;;No;;In full remission;08/06/2022 00:00;Yes;15/06/2022 00:00;Yes;08/06/2022 00:00;;;;;;Dead;HCT-related cause of death;27/06/2022 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";male;25/02/1947 00:00;A;positive;XX;XX;31/07/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;523;Allogeneic HCT;08/04/2020 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Mismatch;;;;;;;;;no;;;;;;;;;26/05/2020 00:00;Grade 1;Yes;15/04/2020 00:00;;No evidence of;;No;;In full remission;12/05/2020 00:00;Yes;27/04/2020 00:00;Yes;21/04/2020 00:00;27/05/2020 00:00;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";male;22/10/1951 00:00;B;negative;XX;XX;25/11/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;523;Allogeneic HCT;11/05/2019 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclosporine;mycophenolate mofetil;cyclophosphamide;;;;No;;17/11/2019 00:00;Grade 2;Yes;03/06/2019 00:00;;No evidence of;;No;;In full remission;09/08/2019 00:00;Yes;18/07/2019 00:00;Yes;01/06/2019 00:00;;;;;;Dead;HCT-related cause of death;17/11/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";female;21/10/1978 00:00;O;positive;XX;XX;27/09/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;523;Allogeneic HCT;28/01/2020 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;cyclophosphamide;cyclosporine;;;No;;26/01/2022 00:00;Grade 3;Yes;05/02/2020 00:00;Moderate;Yes;27/02/2020 00:00;No;;In full remission;06/05/2020 00:00;Yes;13/02/2020 00:00;Yes;07/02/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;03/06/1999 00:00;A;positive;X;X;25/12/2016 23:59;Lymphoma;Hodgkin's disease (clinical);523;Allogeneic HCT;06/04/2023 00:00;2.0;1.0;Karnofsky performance status;100;In partial remission;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclosporine;cyclophosphamide;mycophenolate mofetil;;;;No;;03/08/2023 00:00;Grade 3;Yes;11/04/2023 00:00;;No evidence of;;No;;In full remission;03/08/2023 00:00;Yes;25/04/2023 00:00;Yes;25/04/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";female;18/06/1955 00:00;A;negative;XX;XX;04/05/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;523;Allogeneic HCT;09/12/2019 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;mycophenolate mofetil;;;;No;;21/12/2020 00:00;Grade 2;Yes;03/01/2019 00:00;Moderate;Yes;02/02/2020 00:00;No;;In full remission;23/03/2020 00:00;;;Yes;27/12/2019 00:00;;;;Severe;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";female;15/03/1972 00:00;O;positive;XX;XX;14/07/2021 00:00;Lymphoma;T-cell lymphoma (clinical);523;Allogeneic HCT;13/01/2023 00:00;1.0;1.0;Karnofsky performance status;100;In partial remission;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;mycophenolate mofetil;;;;No;;07/07/2023 00:00;Grade 4;Yes;11/02/2023 00:00;Mild;Yes;22/06/2023 00:00;No;;In full remission;20/04/2023 00:00;Yes;27/01/2023 00:00;Yes;26/01/2023 00:00;;;;Mild;Yes;Dead;HCT-related cause of death;07/07/2023 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";female;14/04/1977 00:00;A;positive;XX;XX;28/05/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;523;Allogeneic HCT;16/09/2018 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;mycophenolate mofetil;;;;No;;05/04/2023 00:00;Grade 1;Yes;12/11/2018 00:00;;No evidence of;;Yes;10/03/2023 00:00;In full remission;08/12/2018 00:00;Yes;28/09/2018 00:00;Yes;02/10/2018 00:00;08/07/2023 00:00;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";male;27/04/1948 00:00;A;positive;XX;XX;23/11/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;523;Allogeneic HCT;21/06/2020 00:00;2.0;2.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Mismatch;;;;;;;;;no;;;;;;;;;08/08/2020 00:00;;No evidence of;;;No evidence of;;No;;In full remission;01/08/2020 00:00;Yes;03/07/2020 00:00;Yes;01/07/2020 00:00;09/08/2020 00:00;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;04/04/2012 00:00;unknown;unknown;X;X;05/04/2018 00:00;Solid tumor configuration;Neuroblastoma;528;Allogeneic HCT;31/12/2020 00:00;2.0;1.0;Lansky performance status;100;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Mismatch;Myeloablative conditioning regimen;;;;Yes;Yes;Yes;;yes;tacrolimus;mycophenolate mofetil;cyclophosphamide;;;;No;;08/11/2022 00:00;Grade 1;Yes;23/02/2021 00:00;;No evidence of;;Yes;19/08/2021 00:00;In full remission;16/04/2021 00:00;Yes;28/01/2020 00:00;Yes;19/01/2020 00:00;;;;;;Dead;Relapse/progression;08/11/2022 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;26/09/2020 00:00;O;positive;X;X;21/01/2024 00:00;Acute leukemia;Acute lymphoid leukemia;613;Allogeneic HCT;08/06/2024 00:00;1.0;1.0;Lansky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;;;;;;yes;cyclosporine;methotrexate;;;;;Yes;12.0;27/09/2024 00:00;Grade 2;Yes;30/06/2024 00:00;;No evidence of;;No;;In full remission;12/07/2024 00:00;Yes;06/07/2024 00:00;Yes;06/07/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;30/03/2016 00:00;O;positive;X;X;14/12/2022 00:00;Acute leukemia;Acute lymphoid leukemia;613;Allogeneic HCT;01/08/2024 00:00;1.0;1.0;Lansky performance status;80;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Mismatch;Myeloablative conditioning regimen;;;Yes;Yes;;;;yes;mycophenolate mofetil;cyclosporine;;;;;Yes;12.0;14/11/2024 00:00;Grade 1;Yes;24/08/2024 00:00;;No evidence of;;Yes;31/10/2024 00:00;In full remission;04/09/2024 00:00;Yes;11/09/2024 00:00;Yes;06/09/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;04/06/2014 00:00;O;positive;X;X;15/01/2024 00:00;Lymphoma;T-cell lymphoma (clinical);613;Allogeneic HCT;26/05/2024 00:00;1.0;1.0;Lansky performance status;90;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;;Yes;;;;;yes;cyclosporine;;;;;;Yes;12.0;10/09/2024 00:00;;;;;;;No;;In full remission;25/06/2024 00:00;Yes;19/06/2024 00:00;Yes;18/06/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";female;28/02/1967 00:00;A;positive;X;X;09/03/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;624;Allogeneic HCT;02/08/2018 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;02/02/2024 00:00;Grade 1;Yes;12/08/2018 00:00;Unknown;Yes;25/07/2020 00:00;No;;In full remission;07/11/2018 00:00;;;Yes;24/08/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";male;14/08/1962 00:00;A;positive;X;X;08/04/2019 00:00;Acute leukemia;Acute lymphoid leukemia;624;Allogeneic HCT;21/01/2020 00:00;1.0;1.0;Karnofsky performance status;80;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;;Yes;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;methotrexate;cyclosporine;;;;Yes;8.0;21/05/2020 00:00;;No evidence of;;;No evidence of;;Yes;13/04/2020 00:00;Progressive disease;13/04/2020 00:00;Yes;29/01/2020 00:00;Yes;07/02/2020 00:00;;;;;;Dead;Relapse/progression;21/05/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;08/02/2006 00:00;A;positive;X;X;27/09/2023 00:00;Chronic leukemia;Chronic myeloid leukemia;624;Allogeneic HCT;20/04/2024 00:00;1.0;1.0;ECOG Performance Status score;0;Chronic phase;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;Yes;;;;;yes;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;methotrexate;;;;Yes;12.0;06/08/2024 00:00;Grade 2;Yes;08/05/2024 00:00;;No evidence of;;No;;Chronic phase;17/07/2024 00:00;Yes;08/05/2024 00:00;Yes;06/05/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";male;20/08/1953 00:00;O;positive;X;X;22/12/2021 23:59;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;624;Allogeneic HCT;12/08/2021 00:00;1.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Cord blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclosporine;mycophenolate mofetil;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;19/01/2023 00:00;;;;;;;Yes;24/07/2022 00:00;In full remission;18/11/2021 00:00;Yes;20/09/2021 00:00;Yes;30/08/2021 00:00;;;;;;Dead;Relapse/progression;19/01/2023 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;13/11/1963 00:00;O;positive;X;X;26/07/2023 00:00;Myelodysplastic/myeloproliferative disease;Chronic myelomonocytic leukemia;624;Allogeneic HCT;26/12/2024 23:59;1.0;1.0;ECOG Performance Status score;1;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;mycophenolate mofetil;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;30/11/2024 00:00;;;;;;;No;;In full remission;24/03/2024 00:00;Yes;08/01/2024 00:00;Yes;08/01/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";male;23/04/1968 00:00;A;positive;X;X;09/04/2021 00:00;Myeloproliferative disorder;Essential or primary thrombocythaemia (ET);624;Allogeneic HCT;22/02/2023 00:00;1.0;1.0;Karnofsky performance status;100;Patient's condition improved;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;;;yes;cyclosporine;mycophenolate mofetil;;;;;No;;11/12/2024 00:00;Grade 1;Yes;02/05/2023 00:00;;No evidence of;;No;;In partial remission;27/05/2023 00:00;Yes;14/03/2023 00:00;Yes;06/03/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;18/12/1962 00:00;AB;positive;X;X;02/08/2023 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-1;624;Allogeneic HCT;01/02/2024 00:00;1.0;1.0;ECOG Performance Status score;1;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;mycophenolate mofetil;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;23/01/2025 00:00;Grade 1;Yes;07/03/2024 00:00;;No evidence of;;No;;Primary refractory phase (no change);19/05/2024 00:00;Yes;15/02/2024 00:00;Yes;17/02/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";male;10/09/1971 00:00;O;positive;X;X;07/06/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;624;Allogeneic HCT;30/09/2020 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Bone marrow;Peripheral blood;Match;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;mycophenolate mofetil;;;;No;;24/08/2022 00:00;;No evidence of;;;No evidence of;;Yes;24/07/2022 00:00;In full remission;29/12/2020 00:00;;;Yes;13/10/2020 00:00;;;;;;Dead;Relapse/progression;24/08/2022 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";female;18/01/1958 00:00;O;positive;X;X;01/04/2022 00:00;Myelodysplastic/myeloproliferative disease;;624;Allogeneic HCT;31/03/2023 00:00;1.0;1.0;Karnofsky performance status;100;Primary refractory phase (no change);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;;;yes;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;mycophenolate mofetil;;;;No;;20/03/2024 00:00;Grade 3;Yes;14/06/2023 00:00;;No evidence of;;No;;In full remission;13/07/2023 00:00;Yes;14/04/2023 00:00;Yes;14/04/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;04/08/1965 00:00;O;positive;XX;XX;03/02/2022 00:00;Myelodysplastic syndrome;MDS with single lineage dysplasia (MDS-SLD);624;Allogeneic HCT;12/07/2022 00:00;2.0;2.0;Karnofsky performance status;100;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;mycophenolate mofetil;;;;No;;20/06/2024 00:00;Grade 1;Yes;16/02/2023 00:00;;No evidence of;;No;;In full remission;20/10/2022 00:00;Yes;27/07/2022 00:00;Yes;23/07/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;14/10/2015 00:00;unknown;unknown;XX;X;31/10/2018 00:00;Bone Marrow Failure incl. Aplastic Anemia;Bone marrow Failure Syndromes incl. AA acquired;631;Allogeneic HCT;04/10/2019 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Cord blood;;Mismatch;Myeloablative conditioning regimen;;Yes;Yes;Yes;;;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;;Yes;2.0;04/10/2019 00:00;;;;;;;;;;;;;;;23/11/2019 00:00;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;22/10/2008 00:00;AB;negative;X;X;19/02/2021 00:00;Acute leukemia;Acute lymphoid leukemia;631;Allogeneic HCT;13/12/2023 00:00;1.0;1.0;;;;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;;;;;;;yes;cyclosporine;methotrexate;;;;;Yes;12.0;13/12/2023 00:00;;;;;;;;;;;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;21/01/2012 00:00;unknown;unknown;X;X;12/03/2021 00:00;Acute leukemia;Acute myeloid leukemia, disease;631;Allogeneic HCT;23/06/2021 00:00;1.0;1.0;Lansky performance status;70;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;cyclosporine;mycophenolate mofetil;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;02/06/2023 00:00;;No evidence of;;;No evidence of;;No;;In full remission;06/10/2021 00:00;Yes;06/10/2021 00:00;Yes;10/07/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;05/03/2008 00:00;unknown;unknown;X;X;31/12/2021 23:59;Acute leukemia;Acute lymphoid leukemia;631;Allogeneic HCT;12/07/2021 00:00;1.0;1.0;Lansky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;;;;;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;methotrexate;;;;Yes;12.0;30/05/2023 00:00;Grade 2;Yes;28/07/2021 00:00;;No evidence of;;No;;In full remission;26/10/2021 00:00;Yes;26/10/2021 00:00;Yes;01/08/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;29/03/2003 00:00;unknown;unknown;XX;XX;25/08/2018 00:00;Acute leukemia;Acute lymphoid leukemia;631;Allogeneic HCT;30/04/2019 00:00;3.0;3.0;Lansky performance status;100;Second relapse;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;;Yes;Yes;;;;yes;;;;;;;Yes;4.0;26/05/2020 00:00;;No evidence of;;;No evidence of;;No;;In full remission;10/08/2019 00:00;Yes;24/05/2019 00:00;Yes;16/05/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;19/01/2018 00:00;O;positive;X;X;19/01/2023 00:00;Bone Marrow Failure incl. Aplastic Anemia;Bone marrow Failure Syndromes incl. AA acquired;631;Allogeneic HCT;18/12/2023 00:00;2.0;1.0;;;;Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Bone marrow;;;Reduced intensity conditioning (RIC);;;;Yes;;;;yes;mycophenolate mofetil;tacrolimus;;;;;Yes;2.0;05/12/2025 00:00;Grade 0 (none);Yes;09/04/2024 00:00;;No evidence of;;No;;In partial remission;25/02/2024 00:00;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;11/09/2009 00:00;O;positive;XX;XX;26/11/2020 00:00;Hemoglobinopathy;Sickle cell-hemoglobin SS disease;631;Allogeneic HCT;11/05/2022 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;cyclosporine;methotrexate;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;25/08/2022 00:00;;No evidence of;;;No evidence of;;No;;Never in CR;25/08/2022 00:00;Yes;25/08/2022 00:00;Yes;29/05/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;29/03/2018 00:00;B;positive;X;X;25/04/2023 00:00;Acute leukemia;Acute lymphoid leukemia;631;Allogeneic HCT;15/09/2023 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;;;;;;yes;cyclosporine;methotrexate;;;;;Yes;12.0;06/01/2024 00:00;;;;;;;No;;In full remission;12/10/2023 00:00;Yes;04/10/2023 00:00;Yes;08/10/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;27/11/2017 00:00;unknown;unknown;X;X;11/12/2018 23:59;Acute leukemia;Acute lymphoid leukemia;631;Allogeneic HCT;10/06/2018 00:00;1.0;1.0;Lansky performance status;80;Primary induction failure;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Bone marrow;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclophosphamide;cyclosporine;mycophenolate mofetil;;;;No;;02/09/2019 00:00;;No evidence of;;;No evidence of;;No;;;;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;26/12/2005 00:00;B;positive;X;X;05/12/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;631;Allogeneic HCT;06/01/2020 00:00;1.0;1.0;Lansky performance status;100;Third or higher Complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclosporine;methotrexate;;;;;No;;10/03/2022 00:00;Grade 1;Yes;17/04/2021 00:00;;No evidence of;;No;;In full remission;06/02/2021 00:00;Yes;10/02/2020 00:00;Yes;10/02/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";male;24/02/1958 00:00;O;positive;X;X;17/08/2018 00:00;Lymphoma;Hodgkin's disease (clinical);632;Allogeneic HCT;30/07/2022 00:00;2.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;;;yes;tacrolimus;mycophenolate mofetil;;;;;No;;18/09/2022 00:00;;No evidence of;;;No evidence of;;;;Not assessed;18/09/2022 00:00;;;Yes;21/08/2022 00:00;;;;;;Dead;Relapse/progression;18/09/2022 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";male;02/08/1962 00:00;A;positive;X;X;10/03/2018 00:00;Lymphoma;T-cell lymphoma (clinical);632;Allogeneic HCT;29/10/2022 00:00;2.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;Yes;Yes;Yes;;;;yes;mycophenolate mofetil;tacrolimus;;;;;No;;13/07/2024 00:00;;No evidence of;;;No evidence of;;No;;Sustained Full Remission;01/02/2023 00:00;Yes;02/12/2022 00:00;Yes;14/11/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;15/12/1981 00:00;A;positive;X;X;19/04/2023 00:00;Lymphoma;T-cell lymphoma (clinical);650;Allogeneic HCT;27/04/2024 00:00;1.0;1.0;Karnofsky performance status;;Chemorefractory relapse or progression, including primary refractory disease;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;;;Yes;;;;yes;cyclosporine;;;;;;Yes;8.0;14/08/2024 00:00;Grade 2;Yes;15/05/2024 00:00;;No evidence of;;No;;In partial remission;14/08/2024 00:00;Yes;13/05/2024 00:00;Yes;14/05/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";female;02/02/1970 00:00;O;positive;XX;XX;03/12/2017 00:00;Acute leukemia;Acute lymphoid leukemia;650;Allogeneic HCT;14/05/2018 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;;Yes;;;;yes;methotrexate;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;Yes;8.0;08/09/2020 00:00;;No evidence of;;;No evidence of;;Yes;08/09/2019 00:00;In full remission;12/08/2018 00:00;Yes;02/06/2018 00:00;Yes;05/06/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";male;23/07/1970 00:00;A;positive;X;X;25/12/2021 00:00;Acute leukemia;Acute myeloid leukemia, disease;650;Allogeneic HCT;29/04/2022 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;cyclosporine;methotrexate;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;29/04/2023 00:00;;No evidence of;;;No evidence of;;No;;In full remission;29/05/2022 00:00;;;Yes;12/05/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";female;06/03/1962 00:00;O;positive;XX;XX;02/01/2015 00:00;Myelodysplastic syndrome;MDS with multilineage dysplasia (MDS-MLD);650;Allogeneic HCT;27/03/2018 00:00;1.0;1.0;Karnofsky performance status;90;Primary refractory phase (no change);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;cyclosporine;;;;;No;;28/05/2018 00:00;;No evidence of;;;No evidence of;;Yes;29/04/2018 00:00;Not assessed;28/05/2018 00:00;;;;;;;;;;Dead;Secondary malignant;28/05/2018 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";female;04/03/1955 00:00;A;positive;XX;XX;09/09/2017 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;650;Allogeneic HCT;22/05/2018 00:00;1.0;1.0;Karnofsky performance status;100;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;cyclosporine;;;;;No;;31/05/2021 00:00;Grade 2;Yes;01/07/2018 00:00;;No evidence of;;No;;In full remission;01/08/2018 00:00;Yes;08/06/2018 00:00;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";female;02/10/1961 00:00;A;positive;XX;XX;25/06/2017 00:00;Acute leukemia;Acute lymphoid leukemia;650;Allogeneic HCT;22/03/2018 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;;Yes;;;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;methotrexate;;;;Yes;8.0;13/08/2020 00:00;Grade 2;Yes;07/05/2018 00:00;Limited;Yes;14/08/2018 00:00;No;;In full remission;22/04/2018 00:00;;;Yes;15/04/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";female;02/06/1981 00:00;A;positive;X;X;26/01/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;650;Allogeneic HCT;08/05/2019 00:00;1.0;1.0;Karnofsky performance status;100;Unknown;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;;;;;yes;mycophenolate mofetil;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;11/05/2020 00:00;Unknown;Yes;08/06/2019 00:00;;No evidence of;;Yes;11/05/2020 00:00;In full remission;18/06/2019 00:00;Yes;27/05/2019 00:00;Yes;27/05/2019 00:00;29/08/2020 00:00;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";male;12/05/1966 00:00;A;positive;XX;XX;15/01/2018 00:00;Lymphoma;T-cell lymphoma (clinical);650;Allogeneic HCT;14/10/2021 00:00;1.0;1.0;Karnofsky performance status;90;In partial remission;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;Yes;;;yes;cyclosporine;methotrexate;;;;;No;;22/01/2022 00:00;Grade 1;Yes;26/11/2021 00:00;;No evidence of;;No;;In full remission;21/02/2022 00:00;Yes;24/10/2021 00:00;Yes;30/10/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;22/09/1981 00:00;A;negative;X;X;13/01/2023 00:00;Chronic leukemia;Chronic myeloid leukemia;650;Allogeneic HCT;02/11/2024 00:00;1.0;1.0;Karnofsky performance status;90;Chronic phase;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;mycophenolate mofetil;cyclosporine;cyclophosphamide;;;;No;;10/02/2025 00:00;;;;;;;No;;Chronic phase;01/02/2025 00:00;Yes;07/12/2024 00:00;Yes;29/11/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";male;22/08/1951 00:00;A;positive;XX;XX;27/09/2014 00:00;Acute leukemia;Acute lymphoid leukemia;650;Allogeneic HCT;25/09/2018 00:00;1.0;1.0;Karnofsky performance status;90;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclophosphamide;mycophenolate mofetil;cyclosporine;;;;No;;20/05/2020 00:00;;No evidence of;;;No evidence of;;Yes;03/03/2019 00:00;Not assessed;02/01/2018 00:00;Yes;24/10/2018 00:00;;;;;;;;Dead;Relapse/progression;20/05/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";female;09/02/1965 00:00;A;positive;XX;XX;25/04/2019 00:00;Myelodysplastic syndrome;MDS with multilineage dysplasia (MDS-MLD);659;Allogeneic HCT;03/10/2019 00:00;1.0;1.0;Karnofsky performance status;80;Progressive disease;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;mycophenolate mofetil;prednisolone;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;No;;27/08/2022 00:00;Grade 2;Yes;17/11/2019 00:00;Mild;Yes;01/10/2020 00:00;No;;In full remission;26/12/2020 23:59;Yes;15/10/2019 00:00;Yes;18/10/2019 00:00;;;;Moderate;Yes;Dead;HCT-related cause of death;27/08/2022 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;30/12/2001 00:00;AB;negative;XX;XX;17/04/2016 00:00;Bone Marrow Failure incl. Aplastic Anemia;Bone marrow Failure Syndromes incl. AA acquired;659;Allogeneic HCT;27/06/2023 00:00;1.0;1.0;ECOG Performance Status score;2;;Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;cyclosporine;;;;;;No;;10/06/2024 00:00;Grade 1;Yes;21/09/2023 00:00;;No evidence of;;No;;In full remission;31/08/2023 00:00;Yes;07/07/2023 00:00;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";female;11/06/1949 00:00;A;positive;XX;XX;04/05/2005 00:00;Myeloproliferative disorder;Essential or primary thrombocythaemia (ET);659;Allogeneic HCT;12/02/2018 00:00;1.0;1.0;Karnofsky performance status;80;Progressive disease;Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;cyclosporine;mycophenolate mofetil;cyclophosphamide;;;;Yes;2.0;14/10/2018 00:00;Grade 3;Yes;06/03/2018 00:00;;No evidence of;;No;;In full remission;18/05/2018 00:00;Yes;27/02/2018 00:00;Yes;03/03/2018 00:00;;;;;;Dead;Secondary malignant;14/10/2018 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";male;23/10/1955 00:00;B;positive;XX;XX;21/03/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;659;Allogeneic HCT;09/10/2022 00:00;1.0;1.0;Karnofsky performance status;70;Primary induction failure;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;;Yes;Yes;;;yes;prednisone;mycophenolate mofetil;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;;;No;;03/12/2022 00:00;Grade 3;Yes;29/10/2022 00:00;;No evidence of;;No;;In full remission;15/11/2022 00:00;Yes;19/10/2022 00:00;Yes;20/10/2022 00:00;;;;;;Dead;HCT-related cause of death;03/12/2022 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";female;06/07/1953 00:00;O;positive;XX;XX;30/08/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;659;Allogeneic HCT;17/03/2023 00:00;1.0;1.0;Karnofsky performance status;80;First relapse;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;mycophenolate mofetil;;;;No;;29/02/2024 00:00;Grade 2;Yes;23/06/2023 00:00;Moderate;Yes;23/06/2023 00:00;No;;In full remission;28/04/2023 00:00;Yes;25/03/2023 00:00;Yes;06/04/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;28/04/1969 00:00;O;positive;XX;XX;10/12/2022 00:00;Lymphoma;T-cell lymphoma (clinical);659;Allogeneic HCT;15/10/2023 00:00;2.0;2.0;ECOG Performance Status score;0;In partial remission;Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;cyclosporine;mycophenolate mofetil;;;;;No;;27/02/2024 00:00;;;;;;;No;;In full remission;17/11/2023 00:00;;;Yes;30/10/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";female;18/11/1951 00:00;A;positive;XX;XX;27/02/2017 00:00;Acute leukemia;Acute myeloid leukemia, disease;659;Allogeneic HCT;25/01/2020 00:00;1.0;1.0;Karnofsky performance status;80;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclophosphamide;mycophenolate mofetil;cyclosporine;;;;No;;19/11/2021 00:00;Grade 2;Yes;13/02/2020 00:00;Mild;Yes;18/07/2021 00:00;No;;In full remission;28/03/2020 00:00;Yes;07/02/2020 00:00;Yes;13/02/2020 00:00;;;;Mild;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";male;11/02/1966 00:00;O;positive;XX;XX;20/02/2019 00:00;Myeloproliferative disorder;Primary myelofibrosis;659;Allogeneic HCT;15/04/2021 00:00;1.0;1.0;Karnofsky performance status;80;Progressive disease;Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;cyclosporine;mycophenolate mofetil;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;29/07/2022 00:00;;No evidence of;;;No evidence of;;No;;In full remission;24/07/2021 00:00;Yes;29/05/2021 00:00;Yes;09/05/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;08/04/1954 00:00;O;positive;XX;XX;26/05/2023 00:00;Acute leukemia;Acute myeloid leukemia, disease;659;Allogeneic HCT;14/04/2024 00:00;1.0;1.0;ECOG Performance Status score;1;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;cyclosporine;;;;;No;;17/07/2024 00:00;Grade 4;Yes;10/05/2024 00:00;;No evidence of;;No;;In full remission;11/05/2024 00:00;;;Yes;27/04/2024 00:00;;;;;;Dead;Other;17/07/2024 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";male;27/08/1953 00:00;A;positive;XX;XX;19/12/2015 00:00;Lymphoma;Hodgkin's disease (clinical);659;Allogeneic HCT;09/12/2018 00:00;2.0;1.0;Karnofsky performance status;80;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclophosphamide;mycophenolate mofetil;cyclosporine;;;;No;;27/12/2018 00:00;;No evidence of;;;No evidence of;;No;;In full remission;27/12/2018 00:00;;;;;;;;;;Dead;HCT-related cause of death;27/12/2018 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;12/01/1956 00:00;AB;positive;X;X;17/01/2001 00:00;Myeloproliferative disorder;Polycythemia vera (clinical);661;Allogeneic HCT;15/06/2018 00:00;1.0;1.0;Karnofsky performance status;80;Primary refractory phase (no change);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Bone marrow;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclosporine;cyclophosphamide;mycophenolate mofetil;;;;No;;09/06/2024 00:00;Grade 2;Yes;18/07/2018 00:00;Moderate;Yes;12/10/2018 00:00;No;;In full remission;22/08/2018 00:00;Yes;21/09/2018 00:00;Yes;06/07/2018 00:00;;;;Mild;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;01/08/1964 00:00;AB;positive;XX;XX;08/11/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;661;Allogeneic HCT;20/03/2020 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;;No;;26/01/2024 00:00;Grade 1;Yes;07/04/2020 00:00;;No evidence of;;No;;In full remission;22/06/2020 00:00;Yes;06/04/2020 00:00;Yes;06/04/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";female;06/08/2007 00:00;A;positive;XX;XX;31/08/2018 00:00;Bone Marrow Failure incl. Aplastic Anemia;Bone marrow Failure Syndromes incl. AA acquired;661;Allogeneic HCT;11/02/2019 00:00;1.0;1.0;Lansky performance status;90;;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;;Yes;Yes;;;;yes;alemtuzumab;cyclosporine;;;;;No;;14/01/2024 00:00;;No evidence of;;;No evidence of;;No;;In full remission;31/05/2019 00:00;Yes;04/03/2019 00:00;Yes;11/03/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;09/12/1961 00:00;O;positive;X;X;10/11/2021 00:00;Acute leukemia;Acute myeloid leukemia, disease;661;Allogeneic HCT;02/09/2022 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;mycophenolate mofetil;;;;No;;22/03/2023 00:00;Grade 3;Yes;10/09/2022 00:00;;No evidence of;;Yes;22/03/2023 00:00;In full remission;01/12/2022 00:00;;;;;;;;;;Dead;Relapse/progression;22/03/2023 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;07/07/1965 00:00;O;positive;X;X;29/08/2019 00:00;Lymphoma;B-cell non-Hodgkin's lymphoma;661;Allogeneic HCT;04/03/2023 00:00;1.0;1.0;Karnofsky performance status;90;In partial remission;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;cyclophosphamide;mycophenolate mofetil;cyclosporine;;;;Yes;2.0;29/03/2024 00:00;Grade 2;Yes;09/04/2023 00:00;Mild;Yes;08/09/2023 00:00;No;;In full remission;01/06/2023 00:00;Yes;22/03/2023 00:00;Yes;18/03/2023 00:00;;;;Mild;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;10/01/1950 00:00;O;positive;XX;XX;27/06/2018 00:00;Acute leukemia;Acute lymphoid leukemia;661;Allogeneic HCT;03/04/2019 00:00;1.0;1.0;Karnofsky performance status;100;First partial remission (PR1);Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Bone marrow;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclophosphamide;cyclosporine;mycophenolate mofetil;;;No;;06/04/2024 00:00;;No evidence of;;;No evidence of;;No;;In full remission;30/06/2019 00:00;Yes;25/05/2019 00:00;Yes;26/04/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";male;16/09/2014 00:00;O;positive;XX;XX;13/10/2021 00:00;Acute leukemia;Acute lymphoid leukemia;661;Allogeneic HCT;24/05/2022 00:00;1.0;1.0;Lansky performance status;100;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;;;;;;;yes;methotrexate;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;Yes;12.0;22/12/2024 00:00;Unknown;Yes;12/06/2022 00:00;;No evidence of;;No;;In full remission;06/09/2022 00:00;Yes;25/06/2022 00:00;Yes;11/06/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";male;11/05/2016 00:00;A;negative;XX;XX;01/07/2021 00:00;Acute leukemia;Acute lymphoid leukemia;661;Allogeneic HCT;28/05/2022 00:00;1.0;1.0;Lansky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;;;;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;methotrexate;cyclosporine;;;;Yes;12.0;30/12/2024 00:00;Grade 3;Yes;17/06/2022 00:00;;No evidence of;;No;;In full remission;01/07/2022 00:00;Yes;24/06/2022 00:00;Yes;19/06/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;04/01/1963 00:00;A;positive;X;X;02/06/2017 00:00;Lymphoma;T-cell lymphoma (clinical);661;Allogeneic HCT;09/10/2018 00:00;2.0;1.0;Karnofsky performance status;90;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;tacrolimus;mycophenolate mofetil;cyclosporine;;;No;;26/04/2024 00:00;Grade 2;Yes;14/12/2018 00:00;Mild;Yes;10/07/2019 00:00;No;;In full remission;07/11/2018 00:00;Yes;20/10/2018 00:00;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXX)""";female;08/05/2020 00:00;A;positive;XX;XX;29/04/2021 00:00;Inborn Errors;Inborn error of metabolism;661;Allogeneic HCT;05/09/2021 00:00;1.0;1.0;Lansky performance status;90;;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;mycophenolate mofetil;cyclosporine;;;;No;;02/12/2023 00:00;;No evidence of;;;No evidence of;;No;;In full remission;05/12/2021 00:00;Yes;24/09/2021 00:00;Yes;27/09/2021 00:00;20/04/2022 00:00;;;;;Dead;;02/12/2023 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXX)""";male;10/02/1951 00:00;O;positive;XX;XX;27/02/2018 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;665;Allogeneic HCT;24/02/2020 00:00;1.0;1.0;Karnofsky performance status;90;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;mycophenolate mofetil;;;;No;;30/10/2020 00:00;Grade 2;Yes;04/03/2020 00:00;;No evidence of;;No;;In full remission;28/04/2020 00:00;Yes;08/03/2020 00:00;Yes;06/03/2020 00:00;;;;;;Dead;HCT-related cause of death;30/10/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;16/02/1978 00:00;O;positive;XX;XX;31/08/2023 00:00;Acute leukemia;Other;665;Allogeneic HCT;25/01/2024 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclophosphamide;cyclosporine;mycophenolate mofetil;;;;No;;02/02/2025 00:00;;No evidence of;;Severe;Yes;12/08/2024 00:00;No;;Sustained Full Remission;27/03/2024 00:00;Yes;07/03/2024 00:00;Yes;13/02/2024 00:00;;;;Severe;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXX)""";female;01/01/1974 00:00;B;positive;XX;XX;13/03/2015 00:00;Myeloproliferative disorder;Primary myelofibrosis;665;Allogeneic HCT;16/04/2018 00:00;2.0;2.0;Karnofsky performance status;100;Relapse phase;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;mycophenolate mofetil;cyclosporine;;;;;No;;19/12/2018 00:00;;No evidence of;;;No evidence of;;Disease progression;;Progressive disease;10/06/2018 00:00;Yes;03/05/2018 00:00;Yes;30/04/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXX)""";male;16/08/1961 00:00;A;positive;XX;XX;28/05/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;665;Allogeneic HCT;08/09/2018 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;;;yes;mycophenolate mofetil;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;08/01/2019 00:00;Grade 2;Yes;24/09/2018 00:00;;No evidence of;;No;;In full remission;06/10/2018 00:00;Yes;20/09/2018 00:00;Yes;20/09/2018 00:00;;;;;;Dead;Other;08/01/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;16/05/1983 00:00;O;positive;XX;XX;09/10/2022 00:00;Myeloproliferative disorder;Primary myelofibrosis;665;Allogeneic HCT;16/12/2024 00:00;2.0;2.0;Karnofsky performance status;90;Relapse phase;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclophosphamide;mycophenolate mofetil;cyclosporine;;;;No;;16/12/2024 00:00;;;;;;;;;;;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;10/07/2002 00:00;A;negative;XX;XX;04/07/2023 00:00;Acute leukemia;Acute myeloid leukemia, disease;665;Allogeneic HCT;24/12/2024 23:59;1.0;1.0;Karnofsky performance status;100;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclosporine;mycophenolate mofetil;cyclophosphamide;;;;No;;24/12/2025 23:59;Grade 2;Yes;14/01/2024 00:00;;No evidence of;;No;;Sustained Full Remission;23/01/2024 00:00;Yes;11/01/2024 00:00;Yes;11/01/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXX)""";male;24/04/1974 00:00;A;positive;XX;XX;12/08/2020 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-1;665;Allogeneic HCT;14/10/2020 00:00;1.0;1.0;Karnofsky performance status;90;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;;;yes;cyclosporine;mycophenolate mofetil;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;08/09/2022 00:00;;No evidence of;;Mild;Yes;05/08/2021 00:00;No;;In full remission;27/11/2020 00:00;Yes;11/11/2020 00:00;Yes;11/11/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXX)""";female;15/05/1953 00:00;O;negative;XX;XX;29/03/2021 00:00;Acute leukemia;Acute myeloid leukemia, disease;665;Allogeneic HCT;18/06/2022 00:00;1.0;1.0;Karnofsky performance status;80;First relapse;Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;;;yes;mycophenolate mofetil;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;18/06/2024 00:00;Grade 3;Yes;16/07/2022 00:00;;No evidence of;;No;;In full remission;16/07/2022 00:00;Yes;30/06/2022 00:00;Yes;30/06/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXX)""";female;15/06/1953 00:00;O;positive;XX;XX;02/08/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;665;Allogeneic HCT;12/12/2023 23:59;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;;No;;21/02/2023 00:00;Grade 4;Yes;22/12/2023 23:59;;No evidence of;;No;;In full remission;08/01/2023 00:00;;;Yes;26/12/2023 23:59;;;;;;Dead;Other;21/02/2023 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXX)""";male;01/01/1963 00:00;O;positive;XX;XX;24/03/2022 00:00;Myeloproliferative disorder;Primary myelofibrosis;665;Allogeneic HCT;11/01/2023 00:00;1.0;1.0;Karnofsky performance status;70;Patient's condition improved;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;tacrolimus;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;;;;No;;24/02/2023 00:00;;No evidence of;;;No evidence of;;;;Not assessed;24/02/2023 00:00;Yes;23/01/2023 00:00;Yes;23/01/2023 00:00;;;;;;Dead;HCT-related cause of death;24/02/2023 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;02/04/1953 00:00;O;positive;X;X;07/08/2021 00:00;Myelodysplastic/myeloproliferative disease;Chronic myelomonocytic leukemia;666;Allogeneic HCT;12/04/2022 00:00;1.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;methotrexate;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;24/07/2022 00:00;;No evidence of;;;No evidence of;;No;;In full remission;14/05/2022 00:00;Yes;02/05/2022 00:00;Yes;26/04/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;17/12/1966 00:00;A;positive;X;X;27/07/2020 00:00;Acute leukemia;Acute lymphoid leukemia;666;Allogeneic HCT;02/02/2021 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;methotrexate;;;;Yes;8.0;28/01/2024 00:00;Grade 1;Yes;28/03/2021 00:00;;No evidence of;;No;;In full remission;06/03/2021 00:00;Yes;19/02/2021 00:00;Yes;16/02/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;05/06/1973 00:00;O;positive;X;X;14/02/2013 00:00;Chronic leukemia;Chronic lymphoid leukemia, disease;666;Allogeneic HCT;19/04/2018 00:00;1.0;1.0;Karnofsky performance status;80;In partial remission;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;Yes;;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;methotrexate;;;;Yes;6.0;06/04/2021 00:00;Grade 2;Yes;08/05/2018 00:00;Mild;Yes;02/07/2018 00:00;No;;In full remission;08/06/2018 00:00;Yes;09/05/2018 00:00;Yes;09/05/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;31/03/1956 00:00;A;positive;X;X;29/04/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;666;Allogeneic HCT;21/04/2019 00:00;1.0;1.0;Karnofsky performance status;80;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclosporine;cyclophosphamide;mycophenolate mofetil;;;;No;;23/11/2021 00:00;;No evidence of;;Limited;Yes;15/10/2019 00:00;No;;In full remission;20/05/2019 00:00;Yes;18/05/2019 00:00;Yes;06/05/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;21/07/1995 00:00;B;positive;X;X;08/02/2021 00:00;Acute leukemia;Acute lymphoid leukemia;666;Allogeneic HCT;05/07/2021 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;;Yes;;;;;yes;cyclosporine;methotrexate;;;;;Yes;12.0;24/10/2021 00:00;Grade 1;Yes;23/07/2021 00:00;;No evidence of;;No;;In full remission;02/08/2021 00:00;Yes;20/07/2021 00:00;Yes;23/07/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;01/06/1952 00:00;B;positive;X;X;25/11/2022 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;666;Allogeneic HCT;18/11/2023 00:00;1.0;1.0;ECOG Performance Status score;1;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;;;Yes;yes;cyclosporine;antilymphocyte immunoglobulin;methotrexate;;;;No;;01/12/2024 00:00;;;;;;;No;;In full remission;17/01/2024 00:00;Yes;10/01/2024 00:00;Yes;23/12/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;12/07/1960 00:00;A;positive;X;X;21/05/2021 00:00;Myeloproliferative disorder;Primary myelofibrosis;666;Allogeneic HCT;05/05/2023 00:00;1.0;1.0;ECOG Performance Status score;1;Patient's condition improved;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;methotrexate;;;;No;;22/12/2023 00:00;Grade 4;Yes;05/10/2023 00:00;;No evidence of;;No;;Sustained Full Remission;06/06/2023 00:00;Yes;24/05/2023 00:00;Yes;21/05/2023 00:00;;;;;;Dead;HCT-related cause of death;22/12/2023 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;31/10/1955 00:00;O;positive;X;X;14/06/2020 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-1;666;Allogeneic HCT;06/03/2021 00:00;1.0;1.0;Karnofsky performance status;80;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;methotrexate;;;;No;;18/02/2024 00:00;Grade 1;Yes;27/03/2021 00:00;Mild;Yes;11/06/2021 00:00;No;;In full remission;11/04/2021 00:00;Yes;23/03/2021 00:00;Yes;25/03/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;02/11/1951 00:00;O;positive;X;X;16/07/2021 00:00;Acute leukemia;Acute myeloid leukemia, disease;666;Allogeneic HCT;19/10/2022 00:00;2.0;2.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;cyclosporine;mycophenolate mofetil;cyclophosphamide;;;;Yes;2.0;19/10/2022 00:00;;;;;;;;;;;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;15/02/1985 00:00;B;positive;X;X;09/03/2022 00:00;Lymphoma;Hodgkin's disease (clinical);666;Allogeneic HCT;06/06/2023 00:00;1.0;1.0;ECOG Performance Status score;0;;Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;methotrexate;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;09/06/2024 00:00;;;;;;;Yes;08/05/2024 00:00;In full remission;06/09/2023 00:00;Yes;22/06/2023 00:00;Yes;20/06/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;20/09/1973 00:00;O;positive;X;X;25/06/2022 00:00;Acute leukemia;Acute lymphoid leukemia;671;Allogeneic HCT;30/12/2023 23:59;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Bone marrow;;Mismatch;Myeloablative conditioning regimen;;;;Yes;;;;yes;cyclosporine;cyclophosphamide;mycophenolate mofetil;;;;Yes;8.0;15/04/2023 00:00;Grade 2;Yes;22/01/2023 00:00;;No evidence of;;No;;In full remission;28/01/2023 00:00;Yes;14/01/2023 00:00;Yes;18/01/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;10/07/1964 00:00;A;positive;X;X;14/01/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;671;Allogeneic HCT;01/06/2023 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;mycophenolate mofetil;cyclophosphamide;cyclosporine;;;;No;;12/09/2023 00:00;Grade 2;Yes;31/07/2023 00:00;;No evidence of;;No;;In full remission;29/06/2023 00:00;Yes;21/06/2023 00:00;Yes;17/06/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;28/08/1961 00:00;O;positive;X;X;28/05/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;671;Allogeneic HCT;16/10/2020 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;Yes;;yes;cyclophosphamide;cyclosporine;mycophenolate mofetil;lymphocyte immune globulin, anti-thymocyte globulin;;;No;;22/11/2022 00:00;Grade 1;Yes;30/03/2021 00:00;;No evidence of;;No;;In full remission;12/11/2020 00:00;;;Yes;31/10/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;14/10/1962 00:00;A;positive;X;X;11/10/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;671;Allogeneic HCT;06/04/2020 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;methotrexate;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;;;;No;;01/04/2023 00:00;;No evidence of;;Moderate;Yes;24/08/2020 00:00;No;;In full remission;04/05/2020 00:00;;;Yes;23/04/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;15/05/1954 00:00;A;positive;X;X;20/07/2021 00:00;Myelodysplastic/myeloproliferative disease;Myelodysplastic/myeloproliferative neoplasm, unclassifiable;671;Allogeneic HCT;21/02/2022 00:00;1.0;1.0;Karnofsky performance status;100;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;Yes;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;mycophenolate mofetil;;;;No;;14/02/2023 00:00;Grade 1;Yes;26/03/2022 00:00;;No evidence of;;No;;In full remission;25/05/2022 00:00;Yes;24/04/2022 00:00;Yes;28/03/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;23/01/1958 00:00;O;positive;X;X;20/10/2023 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;671;Allogeneic HCT;10/11/2024 00:00;1.0;1.0;ECOG Performance Status score;0;In full remission;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;;;Yes;yes;cyclosporine;mycophenolate mofetil;;;;;No;;10/11/2024 00:00;;;;;;;;;;;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;23/06/1957 00:00;A;positive;X;X;06/09/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;671;Allogeneic HCT;16/02/2019 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;methotrexate;;;;No;;17/07/2019 00:00;Grade 2;Yes;18/04/2019 00:00;;No evidence of;;Yes;16/05/2019 00:00;In full remission;16/03/2019 00:00;Yes;27/02/2019 00:00;Yes;02/03/2019 00:00;;;;;;Dead;Relapse/progression;17/07/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;27/12/1999 00:00;AB;positive;X;X;29/01/2023 00:00;Bone Marrow Failure incl. Aplastic Anemia;Bone marrow Failure Syndromes incl. AA acquired;671;Allogeneic HCT;12/04/2023 00:00;1.0;1.0;Karnofsky performance status;100;;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Match;Reduced intensity conditioning (RIC);;;Yes;;;;;yes;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;;;No;;19/07/2023 00:00;;;;;;;No;;In full remission;15/05/2023 00:00;Yes;25/04/2023 00:00;Yes;29/04/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;10/07/1998 00:00;B;positive;X;X;24/10/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;671;Allogeneic HCT;06/05/2021 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;methotrexate;;;;No;;23/05/2023 00:00;Grade 2;Yes;11/06/2021 00:00;;No evidence of;;No;;In full remission;05/06/2021 00:00;Yes;16/05/2021 00:00;Yes;25/05/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;18/05/1961 00:00;A;positive;X;X;07/06/2023 00:00;Acute leukemia;Acute myeloid leukemia, disease;671;Allogeneic HCT;31/10/2023 00:00;1.0;1.0;ECOG Performance Status score;0;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;methotrexate;mycophenolate mofetil;;;;No;;04/02/2024 00:00;;;;;;;No;;In full remission;02/12/2023 00:00;Yes;11/11/2023 00:00;Yes;17/11/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;25/08/1956 00:00;A;negative;X;X;12/05/2017 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;672;Allogeneic HCT;06/04/2018 00:00;1.0;1.0;Karnofsky performance status;Unknown;In full remission;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;;No;;20/05/2018 00:00;;No evidence of;;;No evidence of;;No;;In full remission;26/04/2018 00:00;;;Yes;14/04/2018 00:00;;;;;;Dead;HCT-related cause of death;20/05/2018 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;06/02/1997 00:00;A;negative;X;X;07/08/2020 00:00;Acute leukemia;Acute lymphoid leukemia;672;Allogeneic HCT;11/05/2021 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;;;;;;yes;methotrexate;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;Yes;12.0;16/05/2022 00:00;;No evidence of;;;No evidence of;;No;;In full remission;04/06/2021 00:00;Yes;27/05/2021 00:00;Yes;04/06/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;26/12/2013 00:00;A;positive;X;X;10/12/2016 00:00;Bone Marrow Failure incl. Aplastic Anemia;Bone marrow Failure Syndromes incl. AA acquired;672;Allogeneic HCT;16/06/2018 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Bone marrow;;;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;alemtuzumab;cyclosporine;;;;;No;;24/09/2018 00:00;;No evidence of;;;No evidence of;;No;;In full remission;16/09/2018 00:00;Yes;04/07/2018 00:00;Yes;13/07/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;10/05/1969 00:00;A;positive;XX;XX;26/01/2012 00:00;Acute leukemia;Acute myeloid leukemia, disease;672;Allogeneic HCT;18/12/2018 23:59;2.0;2.0;Karnofsky performance status;Unknown;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;;No;;01/09/2020 00:00;Grade 3;Yes;09/01/2018 00:00;Limited;Yes;21/06/2018 00:00;Yes;10/05/2018 00:00;In full remission;16/01/2018 00:00;;;Yes;02/01/2018 00:00;;;;Extensive;Yes;Dead;HCT-related cause of death;01/09/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;22/02/1964 00:00;AB;positive;X;X;31/12/2009 00:00;Lymphoma;B-cell non-Hodgkin's lymphoma;672;Allogeneic HCT;16/11/2019 00:00;1.0;1.0;Karnofsky performance status;90;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;;No;;02/03/2024 00:00;Grade 1;Yes;02/02/2020 00:00;;Unknown;;No;;In full remission;11/12/2019 00:00;;;Yes;04/12/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;05/05/1965 00:00;O;positive;X;X;31/10/2013 00:00;Myeloproliferative disorder;Unknown;672;Allogeneic HCT;31/08/2018 00:00;1.0;1.0;Karnofsky performance status;80;Progressive disease;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;;No;;04/07/2024 00:00;;No evidence of;;;No evidence of;;Unknown;;Unknown;09/12/2018 00:00;Yes;29/11/2018 00:00;Yes;14/09/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;27/05/2000 00:00;O;positive;X;X;27/07/2019 00:00;Acute leukemia;Acute lymphoid leukemia;672;Allogeneic HCT;13/01/2019 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;Yes;;;;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;methotrexate;;;;Yes;12.0;22/05/2024 00:00;;No evidence of;;Not done;Yes;29/04/2020 00:00;No;;In full remission;08/02/2020 00:00;Yes;17/02/2019 00:00;Yes;17/02/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;07/03/1995 00:00;O;positive;X;X;24/05/2021 00:00;Acute leukemia;Acute lymphoid leukemia;672;Allogeneic HCT;27/01/2022 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;;;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;methotrexate;cyclosporine;;;;Yes;12.0;24/03/2024 00:00;Unknown;Yes;03/03/2022 00:00;;No evidence of;;No;;In full remission;15/02/2022 00:00;Yes;11/02/2022 00:00;Yes;13/02/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;27/11/1958 00:00;A;positive;X;X;03/06/2020 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;672;Allogeneic HCT;21/04/2021 00:00;1.0;1.0;Karnofsky performance status;90;Unknown;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;;No;;06/11/2021 00:00;;No evidence of;;;No evidence of;;Yes;07/09/2021 00:00;In full remission;09/05/2021 00:00;Yes;03/05/2021 00:00;Yes;06/05/2021 00:00;;;;;;Dead;Relapse/progression;06/11/2021 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;21/12/2012 00:00;A;positive;X;X;08/02/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;672;Allogeneic HCT;17/06/2021 00:00;1.0;1.0;Lansky performance status;90;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Cord blood;;;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;cyclosporine;;;;;;15/03/2022 00:00;;;;;;;;;In full remission;25/09/2021 00:00;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXX)""";male;19/03/1955 00:00;A;positive;X;X;17/04/2018 00:00;Myeloproliferative disorder;Primary myelofibrosis;676;Allogeneic HCT;21/02/2022 00:00;1.0;1.0;Karnofsky performance status;80;Progressive disease;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;;;;No;;07/11/2022 00:00;;No evidence of;;;No evidence of;;Yes;14/09/2022 00:00;In full remission;20/04/2022 00:00;Yes;28/03/2022 00:00;Yes;25/03/2022 00:00;23/11/2022 00:00;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;11/09/1974 00:00;O;positive;X;X;23/02/2022 00:00;Chronic leukemia;Chronic myeloid leukemia;676;Allogeneic HCT;25/04/2023 00:00;1.0;1.0;ECOG Performance Status score;1;Chronic phase;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;;;Yes;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;cyclosporine;;;;No;;02/08/2023 00:00;Grade 2;Yes;21/06/2023 00:00;;No evidence of;;No;;In full remission;31/05/2023 00:00;Yes;20/05/2023 00:00;Yes;22/05/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXX)""";female;25/04/1991 00:00;AB;positive;XX;XX;14/04/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;676;Allogeneic HCT;19/07/2018 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;Yes;Yes;Yes;;Yes;;yes;cyclophosphamide;mycophenolate mofetil;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;;;No;;15/04/2019 00:00;Grade 2;Yes;24/08/2018 00:00;Severe;Yes;21/02/2019 00:00;No;;In full remission;09/10/2018 00:00;Yes;06/08/2018 00:00;Yes;03/08/2018 00:00;;;;Severe;Yes;Dead;HCT-related cause of death;15/04/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXX)""";male;14/09/1999 00:00;A;positive;XX;XX;11/05/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;676;Allogeneic HCT;06/09/2018 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;methotrexate;cyclosporine;;;;;No;;03/11/2019 00:00;;No evidence of;;Mild;Yes;15/12/2018 00:00;Yes;02/05/2019 00:00;In full remission;08/10/2018 00:00;Yes;25/09/2018 00:00;Yes;25/09/2018 00:00;;;;;;Dead;Relapse/progression;03/11/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXX)""";female;26/09/1979 00:00;B;positive;X;X;17/03/2022 00:00;Acute leukemia;Acute lymphoid leukemia;676;Allogeneic HCT;03/10/2022 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;;Yes;;;;yes;cyclosporine;methotrexate;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;;;Yes;8.0;30/09/2023 00:00;Grade 1;Yes;03/11/2022 00:00;Mild;Yes;02/07/2023 00:00;No;;In full remission;10/11/2022 00:00;Yes;13/10/2022 00:00;Yes;16/10/2022 00:00;;;;Mild;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXX)""";female;16/10/1968 00:00;AB;positive;XX;XX;11/10/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;676;Allogeneic HCT;10/02/2019 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Bone marrow;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclophosphamide;mycophenolate mofetil;cyclosporine;;;;No;;17/01/2020 00:00;;No evidence of;;Mild;Yes;14/10/2019 00:00;No;;In full remission;10/03/2019 00:00;Yes;09/03/2019 00:00;Yes;04/03/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXX)""";male;10/01/1961 00:00;O;positive;XX;XX;03/05/2019 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;676;Allogeneic HCT;06/01/2020 00:00;1.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;30/07/2022 00:00;;No evidence of;;Severe;Yes;09/01/2021 00:00;No;;In full remission;03/02/2020 00:00;Yes;16/01/2020 00:00;Yes;20/01/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;16/04/1970 00:00;B;positive;X;X;26/02/2016 00:00;Acute leukemia;Other;676;Allogeneic HCT;03/10/2023 00:00;2.0;2.0;ECOG Performance Status score;0;Third or higher relapse;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;;;Yes;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;;No;;05/01/2024 00:00;Grade 4;Yes;31/10/2023 00:00;;No evidence of;;No;;In full remission;29/11/2023 00:00;;;;;;;;;;Dead;HCT-related cause of death;05/01/2024 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXX)""";female;23/11/1964 00:00;B;positive;X;X;25/04/2021 00:00;Acute leukemia;Acute myeloid leukemia, disease;676;Allogeneic HCT;26/10/2021 00:00;1.0;1.0;Karnofsky performance status;80;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;;;Yes;;;Yes;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;mycophenolate mofetil;;;;No;;11/02/2022 00:00;Grade 2;Yes;15/01/2022 00:00;;No evidence of;;No;;In full remission;21/11/2021 00:00;Yes;07/11/2021 00:00;Yes;07/11/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXX)""";male;30/10/1949 00:00;O;positive;XX;XX;03/05/2019 00:00;Myelodysplastic syndrome;MDS with multilineage dysplasia (MDS-MLD);676;Allogeneic HCT;15/09/2019 00:00;1.0;1.0;Karnofsky performance status;100;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclophosphamide;mycophenolate mofetil;cyclosporine;;;;No;;08/11/2019 00:00;Grade 4;Yes;11/10/2019 00:00;;No evidence of;;No;;In full remission;14/10/2019 00:00;Yes;03/10/2019 00:00;Yes;02/10/2019 00:00;;;;;;Dead;HCT-related cause of death;08/11/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;28/06/2014 00:00;unknown;unknown;X;X;10/01/2015 00:00;Bone Marrow Failure incl. Aplastic Anemia;Genetic Bone Marrow Failure;703;Allogeneic HCT;04/11/2019 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;;Yes;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;cyclosporine;cyclophosphamide;;;No;;06/03/2021 00:00;;No evidence of;;;No evidence of;;;;Never in CR;25/12/2020 23:59;Yes;18/11/2019 00:00;Yes;23/11/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;02/10/1986 00:00;unknown;unknown;X;X;17/04/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;703;Allogeneic HCT;17/10/2022 00:00;1.0;1.0;Karnofsky performance status;100;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;mycophenolate mofetil;cyclosporine;cyclophosphamide;;;;No;;26/12/2022 00:00;Grade 4;Yes;09/11/2022 00:00;;No evidence of;;No;;Not assessed;26/12/2022 00:00;Yes;08/11/2022 00:00;Yes;06/11/2022 00:00;;;;;;Dead;HCT-related cause of death;26/12/2022 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;16/08/1969 00:00;unknown;unknown;X;X;25/02/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;703;Allogeneic HCT;10/10/2019 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;methotrexate;;;;No;;06/08/2020 00:00;;No evidence of;;;No evidence of;;Yes;07/12/2019 00:00;In full remission;20/01/2020 00:00;Yes;18/10/2019 00:00;Yes;25/10/2019 00:00;;;;;;Dead;Relapse/progression;06/08/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;05/04/1987 00:00;unknown;unknown;X;X;11/10/2018 00:00;Bone Marrow Failure incl. Aplastic Anemia;Bone marrow Failure Syndromes incl. AA acquired;703;Allogeneic HCT;04/02/2019 00:00;1.0;1.0;Karnofsky performance status;100;;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;;Yes;;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;methotrexate;;;;No;;15/02/2021 00:00;;No evidence of;;;No evidence of;;No;;In full remission;19/03/2019 00:00;Yes;16/02/2019 00:00;Yes;24/02/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;26/10/1963 00:00;unknown;unknown;X;X;26/07/2021 00:00;Acute leukemia;Acute myeloid leukemia, disease;703;Allogeneic HCT;14/02/2022 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;cyclosporine;methotrexate;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;10/09/2022 00:00;;No evidence of;;;No evidence of;;No;;In full remission;25/05/2022 00:00;Yes;24/02/2022 00:00;Yes;27/02/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;09/04/2002 00:00;unknown;unknown;X;X;16/10/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;703;Allogeneic HCT;29/07/2021 00:00;1.0;1.0;Karnofsky performance status;100;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclosporine;mycophenolate mofetil;cyclophosphamide;;;;No;;09/04/2022 00:00;Grade 4;Yes;28/10/2021 00:00;;No evidence of;;No;;In full remission;06/11/2021 00:00;Yes;10/08/2021 00:00;Yes;11/08/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;04/06/1962 00:00;unknown;unknown;X;X;13/11/2010 00:00;Chronic leukemia;Chronic myeloid leukemia;703;Allogeneic HCT;07/11/2019 00:00;1.0;1.0;Karnofsky performance status;100;Chronic phase;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;cyclosporine;methotrexate;;;;;No;;07/06/2020 00:00;;No evidence of;;;No evidence of;;No;;In full remission;11/02/2020 00:00;Yes;19/11/2019 00:00;Yes;25/11/2019 00:00;;;;;;Dead;Other;07/06/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;23/07/1993 00:00;unknown;unknown;X;X;02/04/2022 00:00;Acute leukemia;Acute lymphoid leukemia;703;Allogeneic HCT;22/01/2023 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;methotrexate;cyclosporine;;;;;No;;09/03/2023 00:00;Grade 4;Yes;16/02/2023 00:00;;No evidence of;;No;;In full remission;09/03/2023 00:00;Yes;08/02/2023 00:00;Yes;06/02/2023 00:00;;;;;;Dead;HCT-related cause of death;09/03/2023 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;03/01/1977 00:00;unknown;unknown;X;X;21/07/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;703;Allogeneic HCT;12/12/2022 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;methotrexate;;;;No;;22/03/2023 00:00;;No evidence of;;;No evidence of;;No;;In full remission;22/03/2023 00:00;Yes;23/12/2022 00:00;Yes;25/12/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;30/03/1977 00:00;unknown;unknown;X;X;11/10/2021 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;703;Allogeneic HCT;07/10/2022 00:00;1.0;1.0;Karnofsky performance status;100;Primary refractory phase (no change);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;methotrexate;;;;No;;05/02/2023 00:00;;No evidence of;;;No evidence of;;No;;In full remission;06/11/2022 00:00;Yes;21/10/2022 00:00;Yes;23/10/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;30/01/1963 00:00;unknown;unknown;XX;XX;03/05/2021 00:00;Acute leukemia;Acute lymphoid leukemia;726;Allogeneic HCT;12/10/2021 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;tacrolimus;cyclophosphamide;mycophenolate mofetil;;;;No;;11/02/2023 00:00;;No evidence of;;;No evidence of;;No;;In full remission;30/01/2022 00:00;Yes;29/10/2021 00:00;Yes;27/10/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;27/06/1961 00:00;A;positive;X;XX;22/02/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;726;Allogeneic HCT;05/07/2018 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Bone marrow;;Mismatch;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;mycophenolate mofetil;tacrolimus;cyclophosphamide;;;;Yes;2.0;08/08/2019 00:00;;No evidence of;;Moderate;Yes;27/10/2018 00:00;Yes;27/09/2018 00:00;In full remission;14/08/2018 00:00;Yes;25/07/2018 00:00;Yes;25/07/2018 00:00;;;;;;Dead;Relapse/progression;08/08/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;03/11/1956 00:00;A;positive;X;XX;30/05/2019 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-1;726;Allogeneic HCT;04/02/2021 00:00;1.0;1.0;Karnofsky performance status;90;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;Yes;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;tacrolimus;mycophenolate mofetil;;;;No;;24/05/2021 00:00;Grade 2;Yes;21/02/2021 00:00;;No evidence of;;No;;In full remission;23/04/2021 00:00;Yes;15/02/2021 00:00;Yes;15/02/2021 00:00;;;;;;Dead;HCT-related cause of death;24/05/2021 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;29/03/2005 00:00;A;negative;X;XX;29/07/2018 00:00;Bone Marrow Failure incl. Aplastic Anemia;Bone marrow Failure Syndromes incl. AA acquired;726;Allogeneic HCT;01/08/2019 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;;Yes;Yes;;;;yes;methotrexate;rituximab;tacrolimus;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;sirolimus;;Yes;2.0;18/03/2021 00:00;;No evidence of;;;No evidence of;;No;;In full remission;13/10/2019 00:00;Yes;01/09/2019 00:00;Yes;18/08/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;09/11/1993 00:00;O;positive;X;XX;25/04/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;726;Allogeneic HCT;10/11/2021 00:00;2.0;2.0;Karnofsky performance status;70;First relapse;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;;Yes;;;;;yes;cyclophosphamide;mycophenolate mofetil;tacrolimus;;;;Yes;2.0;25/05/2022 00:00;Grade 2;Yes;27/11/2021 00:00;Severe;Yes;26/01/2022 00:00;Yes;25/12/2022 23:59;Never in CR;22/01/2022 00:00;Yes;11/12/2021 00:00;Yes;29/11/2021 00:00;;;;;;Dead;Relapse/progression;25/05/2022 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;17/07/1955 00:00;O;positive;X;XX;06/12/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;726;Allogeneic HCT;10/03/2020 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;Yes;;;yes;mycophenolate mofetil;tacrolimus;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;12/04/2021 00:00;Grade 2;Yes;20/04/2020 00:00;;No evidence of;;No;;In full remission;15/06/2020 00:00;Yes;18/03/2020 00:00;Yes;22/03/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;07/06/1968 00:00;B;positive;X;XX;25/05/2018 00:00;Myelodysplastic/myeloproliferative disease;Chronic myelomonocytic leukemia;726;Allogeneic HCT;01/04/2022 00:00;1.0;1.0;Karnofsky performance status;60;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclophosphamide;mycophenolate mofetil;tacrolimus;;;;No;;15/04/2022 00:00;;;;;;;;;;;;;;;;;;;;Dead;HCT-related cause of death;15/04/2022 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;26/03/1955 00:00;A;positive;X;XX;18/06/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;726;Allogeneic HCT;15/09/2019 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;Yes;;;yes;tacrolimus;lymphocyte immune globulin, anti-thymocyte globulin;mycophenolate mofetil;;;;No;;21/03/2020 00:00;Grade 2;Yes;25/10/2019 00:00;Severe;Yes;10/12/2020 23:59;No;;In full remission;25/10/2019 00:00;;;Yes;28/09/2019 00:00;;;;;;Dead;HCT-related cause of death;21/03/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;11/12/1945 00:00;unknown;unknown;X;XX;23/11/2017 00:00;Myelodysplastic syndrome;MDS with multilineage dysplasia (MDS-MLD);726;Allogeneic HCT;25/05/2021 00:00;2.0;1.0;Karnofsky performance status;70;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;Peripheral blood;Mismatch;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;mycophenolate mofetil;tacrolimus;cyclophosphamide;;;;Yes;2.0;28/01/2023 00:00;;No evidence of;;Severe;Yes;31/12/2022 23:59;Yes;10/05/2022 00:00;In full remission;03/07/2021 00:00;Yes;14/06/2021 00:00;Yes;10/06/2021 00:00;;;;Limited;Yes;Dead;Relapse/progression;28/01/2023 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;24/08/2002 00:00;A;positive;X;XX;16/12/2019 23:59;Bone Marrow Failure incl. Aplastic Anemia;Genetic Bone Marrow Failure;726;Allogeneic HCT;10/06/2019 00:00;1.0;1.0;Karnofsky performance status;90;;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;;Yes;Yes;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;rituximab;sirolimus;tacrolimus;methotrexate;;Yes;2.0;19/02/2020 00:00;;;;;;;;;;;;;;;10/08/2019 00:00;;;;;Dead;Secondary malignant;19/02/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;10/04/1973 00:00;A;negative;X;X;20/07/2017 00:00;Acute leukemia;Acute myeloid leukemia, disease;744;Allogeneic HCT;03/02/2018 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;tacrolimus;;;;No;;29/12/2019 23:59;;Unknown;;;Unknown;;Yes;24/05/2018 00:00;Never in CR;24/05/2018 00:00;;;Yes;23/02/2018 00:00;30/12/2019 23:59;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;29/10/1963 00:00;O;positive;XX;X;25/11/2015 00:00;Acute leukemia;Other;775;Allogeneic HCT;25/10/2020 00:00;2.0;2.0;Karnofsky performance status;90;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;mycophenolate mofetil;cyclophosphamide;;;No;;24/01/2021 00:00;Grade 1;Yes;18/12/2020 00:00;;No evidence of;;No;;In full remission;18/01/2021 00:00;Yes;27/11/2020 00:00;Yes;10/11/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;02/01/1956 00:00;B;positive;X;X;25/06/2024 00:00;Acute leukemia;Acute myeloid leukemia, disease;775;Allogeneic HCT;09/10/2024 00:00;1.0;1.0;ECOG Performance Status score;1;;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;mycophenolate mofetil;cyclophosphamide;;;No;;09/10/2024 00:00;;;;;;;;;;;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;07/03/1965 00:00;A;positive;X;X;13/06/2018 00:00;Acute leukemia;Acute lymphoid leukemia;775;Allogeneic HCT;22/11/2018 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;;;No;;11/07/2022 00:00;Grade 2;Yes;13/12/2019 23:59;Moderate;Yes;28/03/2019 00:00;No;;In full remission;26/12/2019 23:59;;;Yes;05/12/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;25/10/1956 00:00;A;negative;X;X;12/03/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;775;Allogeneic HCT;31/07/2018 00:00;1.0;1.0;Karnofsky performance status;90;Primary induction failure;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;Yes;Yes;Yes;;Yes;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;cyclophosphamide;cyclosporine;;;No;;23/01/2022 00:00;Grade 1;Yes;23/10/2018 00:00;Moderate;Yes;30/11/2018 00:00;No;;In full remission;01/09/2018 00:00;Yes;18/08/2018 00:00;Yes;16/08/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;27/08/1953 00:00;A;positive;X;X;31/03/2024 00:00;Myeloproliferative disorder;Primary myelofibrosis;775;Allogeneic HCT;10/08/2024 00:00;1.0;1.0;ECOG Performance Status score;1;Primary refractory phase (no change);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;lymphocyte immune globulin, anti-thymocyte globulin;mycophenolate mofetil;cyclosporine;;;;No;;10/08/2024 00:00;;;;;;;;;;;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;31/08/1948 00:00;A;positive;XX;X;15/11/2019 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;775;Allogeneic HCT;14/07/2021 00:00;1.0;1.0;Karnofsky performance status;80;Relapse phase;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;Yes;;yes;cyclophosphamide;mycophenolate mofetil;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;No;;14/07/2021 00:00;;;;;;;;;;;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;23/02/1989 00:00;AB;positive;X;X;14/04/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;775;Allogeneic HCT;02/08/2022 00:00;1.0;1.0;Karnofsky performance status;Unknown;Primary induction failure;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;Yes;;yes;lymphocyte immune globulin, anti-thymocyte globulin;mycophenolate mofetil;cyclophosphamide;cyclosporine;;;No;;01/12/2022 00:00;;Not assessed;;;No evidence of;;No;;In full remission;02/11/2022 00:00;Yes;01/09/2022 00:00;Yes;20/08/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;16/07/1978 00:00;O;positive;X;X;23/02/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;775;Allogeneic HCT;10/11/2022 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclophosphamide;mycophenolate mofetil;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;;;No;;21/02/2023 00:00;;No evidence of;;;No evidence of;;No;;In full remission;14/02/2023 00:00;Yes;03/12/2022 00:00;Yes;25/11/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;12/04/1958 00:00;O;positive;X;X;08/03/2020 00:00;Lymphoma;T-cell lymphoma (clinical);775;Allogeneic HCT;05/09/2021 00:00;1.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;Yes;;yes;mycophenolate mofetil;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;cyclophosphamide;;;No;;19/12/2021 00:00;Grade 3;Yes;31/10/2021 00:00;;No evidence of;;No;;In full remission;12/12/2021 00:00;;;Yes;23/09/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;22/02/1965 00:00;O;positive;X;X;15/06/2023 00:00;Acute leukemia;Acute myeloid leukemia, disease;775;Allogeneic HCT;29/11/2023 00:00;1.0;1.0;Karnofsky performance status;90;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclophosphamide;mycophenolate mofetil;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;No;;23/01/2023 00:00;Grade 2;Yes;02/01/2023 00:00;;No evidence of;;No;;In full remission;23/12/2023 00:00;Yes;12/12/2023 00:00;Yes;13/12/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;21/06/1976 00:00;unknown;unknown;X;X;12/02/2021 00:00;Acute leukemia;Acute myeloid leukemia, disease;819;Allogeneic HCT;12/06/2021 00:00;2.0;2.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;;Yes;;;yes;mycophenolate mofetil;tacrolimus;cyclophosphamide;;;;No;;28/09/2021 00:00;Grade 2;Yes;14/08/2021 00:00;;No evidence of;;No;;In full remission;28/09/2021 00:00;;;Yes;01/07/2021 00:00;;;;;;Dead;HCT-related cause of death;28/09/2021 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;07/02/1955 00:00;O;positive;X;X;27/02/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;926;Allogeneic HCT;03/06/2024 00:00;2.0;2.0;ECOG Performance Status score;1;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;cyclosporine;;;;;No;;14/10/2024 00:00;;;;;;;No;;In full remission;07/07/2024 00:00;Yes;14/06/2024 00:00;Yes;17/06/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;02/02/2014 00:00;O;positive;X;X;16/03/2023 00:00;Acute leukemia;Acute lymphoid leukemia;926;Allogeneic HCT;16/10/2023 00:00;1.0;1.0;Lansky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Cord blood;;;Myeloablative conditioning regimen;;;Yes;Yes;;;;yes;mycophenolate mofetil;cyclosporine;;;;;Yes;12.0;17/01/2023 00:00;Grade 1;Yes;31/10/2023 00:00;;No evidence of;;No;;In full remission;17/01/2023 00:00;Yes;14/11/2023 00:00;Yes;06/11/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;22/06/1984 00:00;O;positive;XX;XX;10/07/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;926;Allogeneic HCT;22/12/2019 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;;;yes;mycophenolate mofetil;cyclosporine;;;;;No;;16/02/2021 00:00;Grade 1;Yes;13/01/2019 00:00;;No evidence of;;No;;In full remission;28/03/2020 00:00;Yes;01/01/2019 00:00;Yes;06/01/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;02/05/1959 00:00;AB;positive;X;X;04/12/2020 00:00;Acute leukemia;Acute lymphoid leukemia;926;Allogeneic HCT;10/04/2023 00:00;1.0;1.0;Karnofsky performance status;100;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;Yes;;;;yes;methotrexate;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;Yes;6.0;28/07/2023 00:00;;No evidence of;;;No evidence of;;No;;In full remission;19/06/2023 00:00;Yes;21/04/2023 00:00;Yes;23/04/2023 00:00;05/01/2023 00:00;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;06/10/1957 00:00;O;positive;X;X;06/09/2021 00:00;Myelodysplastic syndrome;MDS with single lineage dysplasia (MDS-SLD);926;Allogeneic HCT;30/08/2022 00:00;1.0;1.0;Karnofsky performance status;90;In full remission;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;mycophenolate mofetil;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;30/06/2023 00:00;Grade 2;Yes;18/09/2022 00:00;Moderate;Yes;26/12/2022 00:00;No;;In full remission;20/11/2022 00:00;;;Yes;16/09/2022 00:00;;;;Severe;Yes;Dead;HCT-related cause of death;30/06/2023 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;30/03/1958 00:00;O;positive;X;X;08/05/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;926;Allogeneic HCT;01/03/2021 00:00;1.0;1.0;Karnofsky performance status;80;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;Peripheral blood;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;cyclosporine;;;;No;;10/09/2022 00:00;Grade 1;Yes;07/03/2021 00:00;;No evidence of;;No;;In full remission;05/06/2021 00:00;Yes;12/03/2021 00:00;Yes;15/03/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;05/05/1990 00:00;A;positive;XX;XX;19/12/2019 23:59;Bone Marrow Failure incl. Aplastic Anemia;Bone marrow Failure Syndromes incl. AA acquired;926;Allogeneic HCT;18/12/2020 23:59;1.0;1.0;Karnofsky performance status;90;;Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Bone marrow;;;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;methotrexate;cyclosporine;;;;Yes;2.0;29/06/2020 00:00;Grade 2;Yes;18/02/2020 00:00;;No evidence of;;No;;In partial remission;19/03/2020 00:00;Yes;25/12/2020 23:59;Yes;03/01/2020 00:00;;;;;;Dead;HCT-related cause of death;29/06/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;08/03/1956 00:00;O;positive;X;X;25/03/2018 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-1;926;Allogeneic HCT;29/05/2023 00:00;1.0;1.0;Karnofsky performance status;90;In full remission;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;No;;15/09/2023 00:00;Grade 1;Yes;;;No evidence of;;No;;Sustained Full Remission;09/09/2023 00:00;Yes;07/06/2023 00:00;Yes;10/06/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;03/05/1956 00:00;A;positive;XX;XX;22/09/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;926;Allogeneic HCT;02/02/2020 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;;No;;02/04/2021 00:00;Grade 1;Yes;25/02/2020 00:00;;No evidence of;;No;;In full remission;09/05/2020 00:00;;;Yes;21/02/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;24/01/2006 00:00;O;positive;XX;XX;05/12/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;926;Allogeneic HCT;15/02/2020 00:00;1.0;1.0;Lansky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Bone marrow;;;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;mycophenolate mofetil;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;Yes;2.0;31/03/2021 00:00;Grade 1;Yes;05/03/2020 00:00;;No evidence of;;No;;In full remission;13/05/2020 00:00;Yes;26/02/2020 00:00;Yes;29/02/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;14/11/2019 00:00;O;positive;X;X;05/11/2023 00:00;Bone Marrow Failure incl. Aplastic Anemia;Bone marrow Failure Syndromes incl. AA acquired;932;Allogeneic HCT;04/02/2024 00:00;1.0;1.0;;;;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Bone marrow;;;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;cyclosporine;methotrexate;;;;;No;;18/05/2024 00:00;;;;;;;No;;In full remission;27/02/2024 00:00;Yes;22/02/2024 00:00;Yes;23/02/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXXXX)""";male;14/12/2016 00:00;A;positive;X;X;11/06/2021 00:00;Myelodysplastic syndrome;Refractory cytopenia of childhood;932;Allogeneic HCT;27/01/2022 00:00;1.0;1.0;Lansky performance status;100;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Bone marrow;;Mismatch;Myeloablative conditioning regimen;;;;Yes;;Yes;Yes;yes;cyclosporine;cyclophosphamide;mycophenolate mofetil;;;;No;;02/02/2023 00:00;Grade 3;Yes;08/02/2022 00:00;;No evidence of;;No;;Patient's condition improved;10/03/2022 00:00;Yes;10/02/2022 00:00;Yes;10/02/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXXXX)""";male;22/11/2017 00:00;A;positive;X;X;30/01/2020 00:00;Bone Marrow Failure incl. Aplastic Anemia;Genetic Bone Marrow Failure;932;Allogeneic HCT;18/06/2020 00:00;1.0;1.0;Lansky performance status;90;;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Cord blood;;;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;mycophenolate mofetil;;;;Yes;2.0;21/04/2023 00:00;Grade 1;Yes;05/07/2020 00:00;;No evidence of;;No;;In partial remission;15/07/2020 00:00;Yes;22/08/2020 00:00;Yes;12/07/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;10/01/2010 00:00;O;positive;X;X;07/02/2023 00:00;Acute leukemia;Acute myeloid leukemia, disease;932;Allogeneic HCT;10/07/2023 00:00;1.0;1.0;;;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;methotrexate;cyclosporine;;;;;No;;26/10/2024 00:00;Grade 3;Yes;22/09/2023 00:00;;;;No;;;;Yes;31/07/2023 00:00;Yes;28/07/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXXXX)""";male;06/05/2015 00:00;A;positive;X;X;03/06/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;932;Allogeneic HCT;31/12/2020 00:00;1.0;1.0;Lansky performance status;90;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;methotrexate;cyclosporine;;;;;No;;10/06/2023 00:00;;No evidence of;;Severe;Yes;09/05/2022 00:00;No;;In full remission;01/02/2022 00:00;Yes;20/01/2021 00:00;Yes;17/01/2021 00:00;;;;Severe;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXXXX)""";male;06/10/2000 00:00;A;positive;X;X;23/02/2020 00:00;Acute leukemia;Acute myeloid leukemia, disease;932;Allogeneic HCT;10/06/2020 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;;Yes;;Yes;Yes;yes;methotrexate;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;;;;No;;02/05/2023 00:00;Grade 2;Yes;25/06/2020 00:00;;No evidence of;;No;;In full remission;09/07/2020 00:00;Yes;18/06/2020 00:00;Yes;24/06/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXXXX)""";male;24/04/2013 00:00;A;positive;X;X;30/04/2017 00:00;Acute leukemia;Acute lymphoid leukemia;932;Allogeneic HCT;09/02/2019 00:00;1.0;1.0;Lansky performance status;80;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;;;;;;;yes;methotrexate;lymphocyte immune globulin, anti-thymocyte globulin;cyclosporine;;;;Yes;12.0;18/05/2023 00:00;Grade 2;Yes;03/04/2019 00:00;;No evidence of;;Yes;26/12/2020 23:59;In full remission;19/06/2019 00:00;Yes;12/06/2019 00:00;Yes;15/03/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;15/05/2021 00:00;A;positive;X;X;18/02/2024 00:00;Acute leukemia;Acute lymphoid leukemia;932;Allogeneic HCT;09/08/2024 00:00;1.0;1.0;;;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Cord blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;;;;;;;Yes;12.0;25/11/2024 00:00;Grade 4;Yes;13/08/2024 00:00;;No evidence of;;No;;In full remission;07/09/2024 00:00;Yes;18/09/2024 00:00;Yes;02/09/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXXXXX)""";female;28/04/2017 00:00;A;positive;X;X;04/06/2019 00:00;Hemoglobinopathy;Sickle cell-hemoglobin SS disease;932;Allogeneic HCT;25/05/2021 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;methotrexate;;;;No;;10/05/2023 00:00;;No evidence of;;;No evidence of;;No;;In full remission;25/06/2021 00:00;;;Yes;17/06/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;19/09/2023 00:00;A;positive;X;X;09/05/2024 00:00;Acute leukemia;Acute myeloid leukemia, disease;932;Allogeneic HCT;16/08/2024 00:00;1.0;1.0;Lansky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;cyclosporine;methotrexate;;;;;No;;25/11/2024 00:00;Grade 2;Yes;31/08/2024 00:00;;No evidence of;;No;;;;Yes;25/11/2024 00:00;Yes;03/09/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";male;05/11/1947 00:00;AB;positive;XX;XX;12/02/2019 00:00;Acute leukemia;Other;941;Allogeneic HCT;12/10/2019 00:00;1.0;1.0;Karnofsky performance status;80;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;methotrexate;;;;No;;29/06/2020 00:00;;No evidence of;;;No evidence of;;Yes;21/01/2020 00:00;Not assessed;21/01/2020 00:00;;;Yes;30/10/2019 00:00;;;;;;Dead;Relapse/progression;29/06/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";male;04/08/1994 00:00;O;positive;XX;XX;04/06/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;941;Allogeneic HCT;22/10/2022 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;;No;;18/08/2023 00:00;;No evidence of;;;No evidence of;;Yes;18/08/2023 00:00;In full remission;18/11/2022 00:00;;;Yes;07/11/2022 00:00;08/10/2023 00:00;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";male;23/03/1966 00:00;A;positive;XX;XX;01/03/2015 00:00;Lymphoma;B-cell non-Hodgkin's lymphoma;941;Allogeneic HCT;17/03/2018 00:00;2.0;1.0;Karnofsky performance status;80;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclosporine;mycophenolate mofetil;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;08/04/2021 00:00;;No evidence of;;Moderate;Yes;27/06/2018 00:00;Yes;04/03/2020 00:00;In full remission;18/04/2018 00:00;Yes;26/03/2018 00:00;Yes;29/03/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";male;02/01/1993 00:00;O;negative;XX;XX;22/04/2019 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;941;Allogeneic HCT;18/12/2019 00:00;1.0;1.0;Karnofsky performance status;100;Patient's condition improved;Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;cyclosporine;;;;No;;10/01/2020 00:00;Grade 1;Yes;06/01/2019 00:00;;No evidence of;;Yes;11/03/2020 00:00;Patient's condition improved;15/01/2019 00:00;Yes;29/12/2019 00:00;Yes;04/01/2019 00:00;;;;;;Dead;Relapse/progression;10/01/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;27/09/2005 00:00;A;negative;XX;XX;26/02/2022 00:00;Acute leukemia;Acute myeloid leukemia, disease;941;Allogeneic HCT;28/12/2024 23:59;1.0;1.0;ECOG Performance Status score;0;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;methotrexate;cyclosporine;;;;No;;04/06/2024 00:00;;;;;;;No;;In full remission;04/06/2024 00:00;Yes;27/01/2024 00:00;Yes;18/01/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;21/03/1976 00:00;A;positive;XX;XX;17/05/2023 00:00;Acute leukemia;Acute myeloid leukemia, disease;941;Allogeneic HCT;02/11/2023 00:00;1.0;1.0;ECOG Performance Status score;0;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;Yes;;;yes;cyclosporine;mycophenolate mofetil;cyclophosphamide;;;;No;;24/02/2024 00:00;Grade 1;Yes;23/11/2023 00:00;;No evidence of;;No;;Sustained Full Remission;24/02/2024 00:00;Yes;05/11/2023 00:00;Yes;21/11/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";female;06/01/1969 00:00;O;positive;XX;XX;26/08/2020 00:00;Lymphoma;Hodgkin's disease (clinical);941;Allogeneic HCT;11/05/2022 00:00;1.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;mycophenolate mofetil;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;18/07/2022 00:00;Grade 2;Yes;24/06/2022 00:00;;No evidence of;;No;;In full remission;09/06/2022 00:00;Yes;01/06/2022 00:00;Yes;24/05/2022 00:00;;;;;;Dead;HCT-related cause of death;18/07/2022 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";male;21/01/1985 00:00;O;positive;XX;XX;26/06/2018 00:00;Lymphoma;T-cell lymphoma (clinical);941;Allogeneic HCT;29/09/2020 00:00;2.0;1.0;Karnofsky performance status;100;Chemorefractory relapse or progression, including primary refractory disease;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;Yes;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;;;;No;;14/12/2022 23:59;Grade 4;Yes;20/10/2020 00:00;Mild;Yes;10/02/2021 00:00;No;;In full remission;27/01/2021 00:00;Yes;10/10/2020 00:00;Yes;10/10/2020 00:00;;;;Mild;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";male;09/12/1963 00:00;O;positive;XX;XX;15/04/2018 00:00;Plasma cell neoplasm;Solitary osseous myeloma;941;Allogeneic HCT;12/02/2020 00:00;2.0;1.0;Karnofsky performance status;100;Very good partial remission (VGPR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;;No;;06/11/2021 00:00;;No evidence of;;;No evidence of;;No;;Very good partial remission (VGPR);20/05/2020 00:00;;;Yes;29/02/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXXXX)""";male;21/11/1958 00:00;O;positive;XX;XX;13/12/2016 00:00;Lymphoma;T-cell lymphoma (clinical);941;Allogeneic HCT;16/10/2018 00:00;1.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;;No;;17/03/2021 00:00;;No evidence of;;Not done;Yes;13/09/2019 00:00;No;;In full remission;04/12/2018 00:00;;;Yes;31/10/2018 00:00;;;;Severe;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;19/08/1980 00:00;A;negative;X;XX;21/05/2021 00:00;Myelodysplastic/myeloproliferative disease;Other;955;Allogeneic HCT;11/09/2021 00:00;1.0;1.0;Karnofsky performance status;80;Primary refractory phase (no change);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;Yes;;;;;yes;mycophenolate mofetil;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;14/12/2021 00:00;;No evidence of;;;No evidence of;;Yes;01/12/2021 00:00;In full remission;08/10/2021 00:00;Yes;25/09/2021 00:00;Yes;29/09/2021 00:00;;;;;;Dead;Relapse/progression;14/12/2021 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;09/03/1948 00:00;O;positive;XX;XX;06/09/2021 00:00;Acute leukemia;Acute myeloid leukemia, disease;955;Allogeneic HCT;11/05/2022 00:00;1.0;1.0;Not assessed;;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;cyclosporine;mycophenolate mofetil;;;;;No;;21/02/2024 00:00;;No evidence of;;;No evidence of;;Yes;21/02/2024 00:00;In full remission;12/06/2022 00:00;Yes;10/06/2022 00:00;Yes;03/06/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;05/11/1968 00:00;O;positive;X;XX;26/07/2020 00:00;Myelodysplastic syndrome;Myelodysplastic syndrome with excess blasts-2;955;Allogeneic HCT;11/01/2020 00:00;1.0;1.0;Karnofsky performance status;100;Stable;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;Yes;;;;;yes;cyclophosphamide;cyclosporine;mycophenolate mofetil;;;;No;;08/02/2022 00:00;Grade 2;Yes;16/02/2021 00:00;;No evidence of;;No;;In full remission;12/04/2021 00:00;Yes;15/02/2020 00:00;Yes;15/02/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;13/05/1957 00:00;A;positive;XX;XX;28/07/2015 00:00;Myelodysplastic/myeloproliferative disease;Chronic myelomonocytic leukemia;955;Allogeneic HCT;26/04/2021 00:00;1.0;1.0;Not assessed;;Stable;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;cyclosporine;methotrexate;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;01/01/2023 00:00;;No evidence of;;Mild;Yes;25/07/2021 00:00;No;;In full remission;30/05/2021 00:00;Yes;11/05/2021 00:00;Yes;16/05/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;06/08/1976 00:00;A;positive;X;XX;26/09/2021 00:00;Acute leukemia;Acute lymphoid leukemia;955;Allogeneic HCT;05/03/2022 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Bone marrow;;Mismatch;Myeloablative conditioning regimen;;;;Yes;;;;yes;cyclophosphamide;mycophenolate mofetil;cyclosporine;;;;Yes;8.0;02/03/2024 00:00;Grade 1;Yes;07/04/2022 00:00;Moderate;Yes;08/02/2024 00:00;Yes;02/03/2024 00:00;In full remission;07/04/2022 00:00;Yes;27/03/2022 00:00;Yes;29/03/2022 00:00;;;;Moderate;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;18/12/1959 00:00;O;negative;XX;XX;10/06/2018 00:00;Myelodysplastic syndrome;Unclassifiable myelodysplastic syndrome;955;Allogeneic HCT;10/02/2020 00:00;1.0;1.0;Not assessed;;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;mycophenolate mofetil;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;No;;09/01/2022 00:00;Grade 1;Yes;27/03/2020 00:00;;No evidence of;;No;;In full remission;15/05/2020 00:00;Yes;27/02/2020 00:00;Yes;28/02/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;27/01/1964 00:00;A;positive;X;X;03/05/2018 00:00;Lymphoma;B-cell non-Hodgkin's lymphoma;955;Allogeneic HCT;15/03/2019 00:00;1.0;1.0;Karnofsky performance status;100;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;Yes;;yes;mycophenolate mofetil;cyclosporine;cyclophosphamide;;;;No;;23/06/2020 00:00;;No evidence of;;Severe;Yes;15/11/2019 00:00;No;;In full remission;19/06/2019 00:00;Yes;28/03/2019 00:00;Yes;02/04/2019 00:00;;;;;;Dead;HCT-related cause of death;23/06/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;02/01/1980 00:00;A;positive;XX;XX;12/12/2019 00:00;Acute leukemia;Acute lymphoid leukemia;955;Allogeneic HCT;26/06/2020 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Bone marrow;;Mismatch;Myeloablative conditioning regimen;;;;Yes;;;;yes;mycophenolate mofetil;cyclophosphamide;cyclosporine;;;;Yes;12.0;30/03/2022 00:00;Grade 3;Yes;16/07/2020 00:00;;No evidence of;;No;;In full remission;25/07/2020 00:00;Yes;18/07/2020 00:00;Yes;18/07/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;01/05/1952 00:00;A;positive;XX;XX;21/01/2016 00:00;Myelodysplastic/myeloproliferative disease;Other;955;Allogeneic HCT;07/11/2018 00:00;1.0;1.0;Karnofsky performance status;80;Stable;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclophosphamide;cyclosporine;;;;;No;;07/12/2018 00:00;;No evidence of;;;No evidence of;;No;;Not assessed;07/12/2018 00:00;;;Yes;02/12/2018 00:00;;;;;;Dead;HCT-related cause of death;07/12/2018 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;27/03/2001 00:00;O;positive;X;X;04/08/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;955;Allogeneic HCT;15/01/2019 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;methotrexate;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;;No;;26/04/2022 00:00;Grade 2;Yes;03/03/2019 00:00;;No evidence of;;Yes;22/11/2021 00:00;In full remission;21/04/2019 00:00;Yes;31/01/2019 00:00;Yes;30/01/2019 00:00;25/05/2022 00:00;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;03/01/2009 00:00;B;positive;X;X;30/10/2019 00:00;Other Diagnosis;Other;963;Allogeneic HCT;06/01/2019 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Bone marrow;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;mycophenolate mofetil;cyclosporine;cyclophosphamide;alemtuzumab;;;No;;29/12/2020 00:00;;No evidence of;;;No evidence of;;;;In full remission;07/04/2020 00:00;Yes;10/02/2019 00:00;Yes;10/02/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;13/04/2005 00:00;O;positive;X;X;18/12/2018 00:00;Lymphoma;T-cell lymphoma (clinical);963;Allogeneic HCT;12/09/2019 00:00;1.0;1.0;Lansky performance status;100;In full remission;Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;;;;;;;yes;cyclosporine;;;;;;Yes;12.0;16/10/2020 00:00;Grade 1;Yes;08/10/2019 00:00;;No evidence of;;No;;In full remission;13/12/2019 00:00;Yes;24/09/2019 00:00;Yes;26/09/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;27/06/2010 00:00;O;negative;X;X;16/05/2016 00:00;Acute leukemia;Acute lymphoid leukemia;963;Allogeneic HCT;15/09/2022 00:00;1.0;1.0;Lansky performance status;100;First relapse;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;;;;;;;yes;cyclosporine;methotrexate;lymphocyte immune globulin, anti-thymocyte globulin;;;;Yes;12.0;24/12/2022 00:00;;;;;;;No;;In full remission;14/10/2022 00:00;Yes;11/10/2022 00:00;Yes;08/10/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;14/12/1999 00:00;O;positive;X;X;04/05/2016 00:00;Acute leukemia;Acute lymphoid leukemia;963;Allogeneic HCT;09/10/2018 00:00;1.0;1.0;Karnofsky performance status;100;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Bone marrow;;Mismatch;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclosporine;mycophenolate mofetil;cyclophosphamide;;;;No;;10/12/2018 00:00;;No evidence of;;;No evidence of;;;;Unknown;10/12/2018 00:00;;;Yes;07/11/2018 00:00;;;;;;Dead;HCT-related cause of death;10/12/2018 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;01/11/1997 00:00;O;positive;X;X;03/05/2014 00:00;Acute leukemia;Acute lymphoid leukemia;963;Allogeneic HCT;17/08/2018 00:00;1.0;1.0;Karnofsky performance status;90;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;;;;;;;yes;cyclosporine;methotrexate;lymphocyte immune globulin, anti-thymocyte globulin;;;;Yes;12.0;15/09/2019 00:00;Grade 1;Yes;11/02/2019 00:00;Moderate;Yes;13/01/2019 00:00;No;;In full remission;02/12/2018 00:00;Yes;08/09/2018 00:00;Yes;08/09/2018 00:00;;;;Mild;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;06/03/2016 00:00;A;positive;X;X;03/04/2020 00:00;Other Diagnosis;Other;963;Allogeneic HCT;17/06/2020 00:00;1.0;1.0;Lansky performance status;80;;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;cyclosporine;alemtuzumab;;;;;No;;14/07/2021 00:00;Grade 2;Yes;26/08/2020 00:00;Mild;Yes;16/05/2021 00:00;No;;In full remission;03/10/2020 00:00;Yes;12/08/2020 00:00;Yes;22/07/2020 00:00;;;;Severe;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;10/08/2015 00:00;A;positive;X;X;22/01/2021 00:00;Acute leukemia;Other;963;Allogeneic HCT;30/12/2024 23:59;1.0;1.0;;;;Not assessed;;;Cord blood;;;Myeloablative conditioning regimen;;;Yes;Yes;;;;yes;cyclosporine;;;;;;Yes;12.0;08/04/2024 00:00;Grade 1;Yes;05/02/2024 00:00;;No evidence of;;No;;In full remission;05/02/2024 00:00;Yes;26/01/2024 00:00;Yes;21/01/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;27/02/1992 00:00;O;positive;X;X;17/02/1992 00:00;Hemoglobinopathy;Sickle cell-hemoglobin SS disease;963;Allogeneic HCT;24/09/2020 00:00;1.0;1.0;Karnofsky performance status;100;;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Bone marrow;;Mismatch;Reduced intensity conditioning (RIC);;;Yes;Yes;;Yes;;yes;lymphocyte immune globulin, anti-thymocyte globulin;;;;;;Yes;2.0;03/12/2021 00:00;;No evidence of;;Mild;Yes;15/01/2021 00:00;No;;In full remission;08/01/2021 00:00;;;Yes;17/10/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;30/01/2009 00:00;B;positive;X;X;03/06/2009 00:00;Inborn Errors;Primary immune deficiency disorder;963;Allogeneic HCT;17/03/2021 00:00;2.0;2.0;Not assessed;;;Not assessed;Positive;Unrelated donor;Cord blood;;;Reduced intensity conditioning (RIC);;;;Yes;;;;yes;prednisone;cyclosporine;lymphocyte immune globulin, anti-thymocyte globulin;;;;Yes;2.0;09/03/2023 00:00;Grade 2;Yes;01/04/2021 00:00;;No evidence of;;No;;In full remission;14/06/2021 00:00;;;Yes;31/03/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;28/09/2014 00:00;B;positive;X;X;02/12/2014 00:00;Hemoglobinopathy;Sickle cell-hemoglobin SS disease;963;Allogeneic HCT;07/02/2021 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody positive;Negative;Related donor;Bone marrow;;Mismatch;Reduced intensity conditioning (RIC);;;Yes;Yes;;Yes;;yes;lymphocyte immune globulin, anti-thymocyte globulin;cyclophosphamide;sirolimus;mycophenolate mofetil;;;Yes;2.0;08/05/2022 00:00;;;;;;;No;;Not assessed;08/05/2022 00:00;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;17/07/1971 00:00;O;positive;X;X;16/07/2018 00:00;Plasma cell neoplasm;Multiple myeloma;977;Allogeneic HCT;30/04/2019 00:00;2.0;1.0;Karnofsky performance status;100;Very good partial remission (VGPR);Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;cyclophosphamide;mycophenolate mofetil;cyclosporine;;;;No;;09/08/2019 00:00;;No evidence of;;;No evidence of;;No;;In full remission;09/08/2019 00:00;Yes;13/05/2019 00:00;Yes;17/05/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;25/09/1972 00:00;O;negative;X;X;01/07/2010 00:00;Myeloproliferative disorder;Essential or primary thrombocythaemia (ET);977;Allogeneic HCT;02/06/2018 00:00;1.0;1.0;Karnofsky performance status;80;Patient's condition improved;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;;Yes;;Yes;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;cyclosporine;;;;No;;19/08/2020 00:00;Grade 4;Yes;28/06/2018 00:00;Moderate;Yes;21/08/2019 00:00;No;;Not assessed;12/09/2018 00:00;Yes;29/07/2018 00:00;Yes;14/06/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;27/07/1968 00:00;A;negative;X;X;14/12/2020 00:00;Lymphoma;T-cell lymphoma (clinical);977;Allogeneic HCT;10/02/2023 00:00;1.0;1.0;Karnofsky performance status;100;;Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Match;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;20/01/1970 00:00;A;positive;X;X;12/01/2018 00:00;Myelodysplastic/myeloproliferative disease;Other;977;Allogeneic HCT;16/09/2018 00:00;1.0;1.0;Karnofsky performance status;80;Never treated (supportive care or treatment without chemotherapy);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclosporine;mycophenolate mofetil;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;16/03/2022 00:00;Grade 1;Yes;26/10/2018 00:00;Moderate;Yes;26/10/2019 00:00;No;;In full remission;13/10/2018 00:00;Yes;26/09/2018 00:00;Yes;27/09/2018 00:00;;;;Limited;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;15/09/1967 00:00;A;negative;X;X;08/12/2024 23:59;Myelodysplastic/myeloproliferative disease;MDS/MPN not otherwise specified (NOS);977;Allogeneic HCT;30/08/2024 00:00;2.0;1.0;ECOG Performance Status score;0;In full remission;Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;;Yes;Yes;;Yes;;yes;lymphocyte immune globulin, anti-thymocyte globulin;;;;;;No;;30/08/2024 00:00;;;;;;;;;;;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;06/11/1950 00:00;O;positive;X;X;19/08/2015 00:00;Lymphoma;B-cell non-Hodgkin's lymphoma;977;Allogeneic HCT;23/01/2019 00:00;2.0;1.0;Karnofsky performance status;100;In partial remission;Transplant donor cytomegalovirus antibody negative;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;mycophenolate mofetil;cyclosporine;;;;;Yes;2.0;21/05/2019 00:00;Grade 2;Yes;05/03/2019 00:00;;No evidence of;;No;;In full remission;30/04/2019 00:00;Yes;05/03/2019 00:00;Yes;16/02/2019 00:00;;;;;;Dead;Other;21/05/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;09/03/1956 00:00;O;positive;X;X;11/09/2017 00:00;Lymphoma;T-cell lymphoma (clinical);977;Allogeneic HCT;09/10/2018 00:00;2.0;1.0;Karnofsky performance status;80;In full remission;Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Reduced intensity conditioning (RIC);;Yes;;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;;No;;07/07/2022 00:00;Grade 2;Yes;07/11/2018 00:00;Moderate;Yes;09/06/2020 00:00;No;;In full remission;16/01/2019 00:00;Yes;22/10/2018 00:00;Yes;28/10/2018 00:00;;;;Mild;Yes;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;16/08/1981 00:00;A;positive;X;X;20/03/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;977;Allogeneic HCT;18/10/2019 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Reduced intensity conditioning (RIC);;Yes;Yes;Yes;;Yes;;yes;cyclophosphamide;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;mycophenolate mofetil;cyclosporine;;;No;;15/04/2020 00:00;Grade 2;Yes;14/11/2019 00:00;;No evidence of;;Yes;23/01/2020 00:00;Progressive disease;28/01/2020 00:00;Yes;27/10/2019 00:00;Yes;31/10/2019 00:00;;;;;;Dead;Relapse/progression;15/04/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";female;20/04/1963 00:00;O;positive;X;X;13/03/2019 00:00;Acute leukemia;Other;977;Allogeneic HCT;25/09/2019 00:00;1.0;1.0;Karnofsky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Mismatch;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;mycophenolate mofetil;cyclophosphamide;cyclosporine;;;;Yes;2.0;08/09/2022 00:00;;No evidence of;;Moderate;Yes;26/06/2020 00:00;No;;In full remission;10/01/2020 00:00;Yes;16/10/2019 00:00;Yes;14/10/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXX)""";male;23/04/1987 00:00;O;positive;X;X;27/09/2013 00:00;Acute leukemia;Acute lymphoid leukemia;977;Allogeneic HCT;04/12/2019 00:00;1.0;1.0;Karnofsky performance status;100;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Unrelated donor;Peripheral blood;;;Myeloablative conditioning regimen;;;;Yes;;;;yes;mycophenolate mofetil;cyclosporine;cyclophosphamide;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;Yes;8.0;30/07/2020 00:00;Grade 2;Yes;15/01/2019 00:00;;No evidence of;;Yes;13/05/2020 00:00;In full remission;16/03/2020 00:00;Yes;14/12/2019 00:00;Yes;19/12/2019 00:00;;;;;;Dead;Relapse/progression;30/07/2020 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";female;07/03/2016 00:00;O;negative;XX;XX;26/08/2016 00:00;Acute leukemia;Acute lymphoid leukemia;978;Allogeneic HCT;10/03/2019 00:00;1.0;1.0;Lansky performance status;100;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;methotrexate;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;No;;24/12/2019 00:00;Grade 1;Yes;21/04/2019 00:00;;No evidence of;;Yes;08/06/2019 00:00;Progressive disease;08/06/2019 00:00;Yes;03/04/2019 00:00;Yes;11/04/2019 00:00;;;;;;Dead;Relapse/progression;24/12/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";male;22/03/2018 00:00;A;positive;XX;XX;19/06/2021 00:00;Bone Marrow Failure incl. Aplastic Anemia;Bone marrow Failure Syndromes incl. AA acquired;978;Allogeneic HCT;03/04/2022 00:00;2.0;2.0;Lansky performance status;90;;Transplant donor cytomegalovirus antibody negative;;Unrelated donor;Bone marrow;;;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;methotrexate;cyclosporine;;;;;Yes;2.0;10/07/2022 00:00;Grade 4;Yes;10/04/2022 00:00;;;;No;;In full remission;07/07/2022 00:00;Yes;16/04/2022 00:00;Yes;22/04/2022 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";male;05/11/2005 00:00;B;positive;XX;XX;08/01/2017 00:00;Acute leukemia;Acute lymphoid leukemia;978;Allogeneic HCT;07/04/2020 00:00;1.0;1.0;Lansky performance status;100;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Negative;Related donor;Bone marrow;;Match;Myeloablative conditioning regimen;;;;;;;;yes;cyclosporine;;;;;;Yes;;07/04/2021 00:00;Grade 3;Yes;01/05/2020 00:00;;No evidence of;;No;;In full remission;05/05/2020 00:00;Yes;09/06/2020 00:00;Yes;28/04/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";male;07/01/2015 00:00;O;positive;XX;XX;25/07/2018 00:00;Acute leukemia;Acute lymphoid leukemia;978;Allogeneic HCT;19/04/2019 00:00;1.0;1.0;Lansky performance status;80;Second relapse;Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Cord blood;;;Myeloablative conditioning regimen;;Yes;;Yes;;Yes;;yes;cyclosporine;mycophenolate mofetil;;;;;No;;02/07/2019 00:00;Grade 1;Yes;17/05/2019 00:00;;No evidence of;;Yes;23/05/2019 00:00;Progressive disease;02/07/2019 00:00;Yes;17/05/2019 00:00;Yes;04/05/2019 00:00;;;;;;Dead;Relapse/progression;02/07/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";male;08/10/2011 00:00;O;positive;XX;XX;06/10/2018 00:00;Acute leukemia;Acute lymphoid leukemia;978;Allogeneic HCT;24/12/2023 00:00;2.0;2.0;Lansky performance status;100;Third or higher Complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;;;Yes;;Yes;Yes;yes;methotrexate;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;27/03/2024 00:00;;;;;;;No;;Sustained Full Remission;25/01/2024 00:00;;;Yes;13/01/2024 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";male;28/04/2011 00:00;O;positive;XX;XX;30/12/2019 23:59;Acute leukemia;Acute lymphoid leukemia;978;Allogeneic HCT;31/08/2019 00:00;1.0;1.0;Lansky performance status;100;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Negative;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;;;;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;methotrexate;;;;Yes;12.0;19/12/2021 23:59;Grade 1;Yes;22/09/2019 00:00;;No evidence of;;No;;In full remission;25/11/2019 00:00;Yes;26/09/2019 00:00;Yes;21/09/2019 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;27/01/2021 00:00;O;positive;XX;XX;17/06/2024 00:00;Acute leukemia;Acute myeloid leukemia, disease;978;Allogeneic HCT;22/09/2024 00:00;1.0;1.0;Lansky performance status;100;First complete haematological remission (CR);;Positive;;;;;Myeloablative conditioning regimen;;Yes;Yes;;;;;yes;cyclosporine;;;;;;No;;22/09/2024 00:00;;;;;;;;;;;;;;;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";female;17/10/2008 00:00;B;positive;XX;XX;27/05/2019 00:00;Bone Marrow Failure incl. Aplastic Anemia;Bone marrow Failure Syndromes incl. AA acquired;978;Allogeneic HCT;14/06/2020 00:00;1.0;1.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Cord blood;;;Myeloablative conditioning regimen;;;Yes;Yes;;;;yes;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;;;;Yes;2.0;27/09/2020 00:00;;No evidence of;;;No evidence of;;No;;In full remission;27/09/2020 00:00;Yes;27/07/2020 00:00;Yes;05/07/2020 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";female;14/09/2017 00:00;O;positive;XX;XX;19/08/2017 00:00;Inborn Errors;Inborn error of metabolism;978;Allogeneic HCT;12/08/2018 00:00;2.0;2.0;Lansky performance status;100;;Transplant donor cytomegalovirus antibody positive;Positive;Unrelated donor;Cord blood;;;Reduced intensity conditioning (RIC);;;Yes;Yes;;;;yes;mycophenolate mofetil;alemtuzumab;cyclosporine;;;;No;;06/06/2019 00:00;;No evidence of;;;No evidence of;;No;;Not assessed;09/11/2018 00:00;;;Yes;27/08/2018 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXXXX)""";female;24/09/2018 00:00;A;positive;XX;XX;13/06/2020 00:00;Acute leukemia;Acute lymphoid leukemia;978;Allogeneic HCT;13/07/2023 00:00;2.0;2.0;Lansky performance status;100;Third or higher Complete haematological remission (CR);Transplant donor cytomegalovirus antibody negative;Positive;Unrelated donor;Bone marrow;;;Myeloablative conditioning regimen;;;;;;;;yes;methotrexate;cyclosporine;;;;;Yes;12.0;21/10/2023 00:00;Grade 1;Yes;08/09/2023 00:00;;No evidence of;;No;;Sustained Full Remission;16/08/2023 00:00;Yes;10/08/2023 00:00;Yes;02/08/2023 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;24/04/1992 00:00;unknown;unknown;XX;XX;10/02/2017 00:00;Acute leukemia;Acute lymphoid leukemia;993;Allogeneic HCT;06/07/2018 00:00;1.0;1.0;Karnofsky performance status;80;Second complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;;;Yes;;Yes;;Yes;;yes;lymphocyte immune globulin, anti-thymocyte globulin;methotrexate;prednisolone;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;cyclosporine;;No;;21/12/2019 23:59;;No evidence of;;;No evidence of;;Yes;17/08/2018 00:00;In full remission;17/08/2018 00:00;Yes;17/08/2018 00:00;Yes;17/08/2018 00:00;;;;;;Dead;Relapse/progression;21/12/2019 23:59
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";male;08/09/1984 00:00;unknown;unknown;XX;XX;02/04/2018 00:00;Acute leukemia;Acute myeloid leukemia, disease;993;Allogeneic HCT;26/06/2018 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;methotrexate;cyclosporine;Drug Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin;;;;No;;02/03/2019 00:00;;No evidence of;;;No evidence of;;Yes;13/02/2019 00:00;In full remission;04/10/2018 00:00;;;Yes;04/10/2018 00:00;;;;;;Dead;Relapse/progression;02/03/2019 00:00
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;13/11/1987 00:00;O;positive;XX;XX;15/12/2022 00:00;Myelodysplastic/myeloproliferative disease;;993;Allogeneic HCT;13/10/2024 00:00;;;;;;Transplant donor cytomegalovirus antibody negative;;;Peripheral blood;;;Reduced intensity conditioning (RIC);;;;;;;;yes;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;10/10/2015 00:00;B;positive;XX;XX;26/09/2017 00:00;Hemoglobinopathy;Thalassemia;993;Allogeneic HCT;13/11/2024 00:00;1.0;1.0;;;;;;;;;;Myeloablative conditioning regimen;;;;;;;;yes;methotrexate;;;;;;No;;;;;;;;;;;;;;;;;;;;;;;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;12/02/1974 00:00;O;positive;XX;XX;25/03/2020 00:00;Acute leukemia;;993;Allogeneic HCT;04/12/2020 00:00;1.0;1.0;;;;;;;;;;Myeloablative conditioning regimen;;Yes;;Yes;;;;yes;;;;;;;No;;11/03/2021 00:00;;;;;;;No;;In full remission;11/03/2021 00:00;Yes;11/03/2021 00:00;Yes;11/03/2021 00:00;;;;;;Alive;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;23/06/2018 00:00;A;positive;XX;XX;27/11/2018 00:00;Hemoglobinopathy;Thalassemia;993;Allogeneic HCT;05/11/2024 00:00;1.0;1.0;;;;;;;;;;Myeloablative conditioning regimen;;;;;;;;yes;methotrexate;;;;;;No;;;;;;;;;;;;;;;;;;;;;;;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;10/02/1984 00:00;A;positive;XX;XX;03/03/2024 00:00;Acute leukemia;Acute myeloid leukemia, disease;993;Allogeneic HCT;03/08/2024 00:00;1.0;1.0;;;;;;;;;;Myeloablative conditioning regimen;;;;;;;;yes;cyclosporine;;;;;;No;;;;;;;;;;;;;;;;;;;;;;;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";female;17/06/2008 00:00;A;positive;XX;XX;12/07/2009 00:00;Hemoglobinopathy;Thalassemia;993;Allogeneic HCT;24/12/2024 00:00;1.0;1.0;;;;;;;;;;Myeloablative conditioning regimen;;;;;;;;yes;;;;;;;No;;;;;;;;;;;;;;;;;;;;;;;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""""";male;10/04/2000 00:00;A;positive;XX;XX;25/07/2012 00:00;Lymphoma;B-cell lymphoma (clinical);993;Allogeneic HCT;09/07/2024 00:00;1.0;1.0;;;;;;;;;;Reduced intensity conditioning (RIC);;;;;;;;yes;cyclosporine;methotrexate;;;;;No;;;;;;;;;;;;;;;;;;;;;;;;
XXXXXXXX-XXXX-XXXX-XXXX-XXXXXXXXXXXX;XXXXXXX;"""(XXXXXXX)""";female;12/06/1988 00:00;unknown;unknown;XX;XX;23/06/2019 00:00;Acute leukemia;Acute myeloid leukemia, disease;993;Allogeneic HCT;24/11/2019 00:00;1.0;1.0;Karnofsky performance status;90;First complete haematological remission (CR);Transplant donor cytomegalovirus antibody positive;Positive;Related donor;Peripheral blood;;Match;Myeloablative conditioning regimen;;;;;;;;;;;;;;;;;12/12/2022 00:00;;;;Moderate;Yes;08/03/2021 00:00;No;;In full remission;05/03/2020 00:00;;;;;;;;;;Alive;;
